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The cyto-protective compositions and effects of antiviral Maillard reaction products (MRPs) 
derived from roots of Isatis indigotica F. were examined using biochemical and biophysical 
methods. The Maillard reaction was identified as the main source of compounds with anti-
viral activity, an observation which has led to the proposal of a new class of active 
compounds that protect cells from influenza virus infection.  
In the roots, arginine and glucose were revealed to be the predominant reactants for the 
Maillard reaction. Significant anti-influenza virus effects were demonstrated in the RIE 
MRPs derived from the roots (RIE refers to the ‘radix Isatidis extracts’), and in Arg-Glc 
MRPs which are synthesised with arginine and glucose. Arg-Glc MRPs were confirmed as 
suitable models for the study of the antiviral effects of the root extracts.  Furthermore, RIE 
MRPs and Arg-Glc MRPs were found to bind to the plasma membranes of erythrocytes and 
MDCK cells, and altered their properties. A novel antiviral mechanism was proposed: that 
MRPs achieve their cyto-protective effects by binding to the cell membrane rather than by 
direct action on viral particles.   
To validate the proposed mechanism, the interaction between MRPs and membrane lipids 
was investigated by biophysical experiments with phospholipids bilayers. Arg-Glc MRPs 
affected the rigidity of lipid packing in monolayers and bilayers, while RIE MRPs enhanced 
the fluidity. Both types of MRPs inserted into the hydrophobic core of bilayers, to differing 
extents, and induced the stabilisation or destabilisation of bilayers in a concentration-
dependent manner. At certain concentrations, MRPs prevented the lamellar structure of 
bilayers from being destabilised by a viral fusion peptide, improved the lipid order and 
thereby inhibited cell-virus membrane fusion. The mechanism of the anti-influenza virus 
activity of RIE was therefore correlated to the interaction between MRPs and phospholipid 
bilayers, an integral component of the plasma membrane. 
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A      lateral area/lipid  
aa   amino acid 
Arg     arginine 
Arg-Glc MRPs  Maillard reaction products of L-arginine and D-glucose.  
Arg+Glc   solution of arginine and glucose at equal molar 
BSA   bovine serum albumin 
BAPNA   N-benzoyl-DL-arginine-p-nitroanilide 
C   cells, i.e. MDCK cells 
CC50   50% cytotoxic concentration 
cDNA   complementary DNA 
CPE   cytopathic effect 
d      lamellar d-spacing  
dW      steric water layer thickness  
dC      hydrocarbon chain length  
dH      headgroup thickness  
d-Arg    deuterated arginine, L-Arginine-2,3,3,4,4,5,5-d7 
d-Arg-Glc MRPs   MRPs of d7-L-arginine and D-glucose 
DMEM   Dulbecco's Modified Eagle's Medium 
DMPC    dimyristoyl-phosphatidylcholine  
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DMSO   dimethyl sulfoxide 
DOPC   dioleoyl-phosphatidylcholine 
DOPG   dioleoyl-phosphatidylglycerol 
DSC   differential scanning calorimetry 
DTT   dithiothreitol 
EC50   50% efficient concentration 
ESI   electrospray ionization 
F(q)      bilayer form factor  
G   correction factor 
Glc     glucose 
GP   general polarization 
GRITIP  glycated radix Isatidis trypsin inhibitor protein 
H   horizontal 
HA   haemagglutinin of influenza viruses 
HI   haemagglutination inhibition 
HII    inverted hexagonal phase of phospholipids 
HPLC   high performance liquid chromatography 
IA    Influenza A FM1 (H1N1, mouse-adapted) virus 
IB   influenza B/Shanghai/93-1(C3C2, 1:320 9/2/99) 
IEF   isoelectric focusing 
IHV   fluorescence intensity at vertical position excited by horizontally 
polarised light  
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IHH   fluorescence intensity at horizontal position excited by horizontally 
polarised light 
I0   excitation and emission polarisers in parallel position 
I90   excitation and emission polarisers in perpendicular position 
Im3m    primitive cubic phase  
I(q)      scattered intensity  
kDa   kilo-dalton 
Lα    biologically relevant liquid crystalline phase of phospholipids 
Lβ    gel phase of phospholipids 
LC   liquid chromatography 
LC-MS   liquid chromatography-mass spectroscopy 
LDH    Lactate Dehydrogenase 
LXD   lamellar x-ray diffraction 
MALDI  matrix-assisted laser desorption/ionisation 
MC540   Merocyanine 540 
MCE   boiling water extract of pulps of Momordica charantia Linn. 
MDCK   Madin-Darby canine kidney 
MeDOPE   N-methyl-dioleoyl-phosphatidylethanolamine 
MLVs     multilamellar versicles (liposome) 
MRPs   Maillard reaction products 
MS   mass spectroscopy 
MTT   3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide 
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O.D.   optical density 
PAS   periodic acid-Schiff 
PBS   phosphate-buffered saline 
PC      phosphatidylcholine  
PE      phosphatidylethanolamine   
PFU   plaque forming units 
pI   isoelectric point 
PVDF   polyvinylidene difluorid 
q, s      scattering vector: q = 2π s = 4π sinθ /λ  
QII    inverted cubic phase of phospholipids 
r   anisotropy 
RH   relative humidity 
7-d RIE   RIE extracted from roots incubated at 60°C, 85% rh for 7 d 
RIE   radix Isatidis extract, boiling water extract of the roots 
RITIP   radix Isatidis trypsin inhibitor protein 
RPLC   reversed phase liquid chromatography 
SAXS     small angle x-ray scattering 
SDS-PAGE  Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
SEM   Scanning Electron Microscopy 
SIV   simian immunodeficiency virus  
SP-P1   the 1st peak fraction separated with SP650M ion-exchange HPLC 
SP-P2   the 2nd peak fraction separated with SP650M ion-exchange HPLC  
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SPW-P1  the 1st peak fraction separated with SP-5PW ion-exchange HPLC 
SPW-P2  the 2nd peak fraction separated with SP-5PW ion-exchange HPLC 
S(q)      structure factor 
SUVs     small unilamellar versicles (liposome) 
T   temperature 
t   time 
TH   temperature of lamellar-inverted hexagonal phase transition 
TQ   initiating temperature of lamellar-to-inverted cubic phase transition 
TM    initiating temperature of Lβ-to-Lα transition 
TC0   0% toxic concentration 
TC50   50% toxic concentration 
TCM   traditional Chinese medicine 
TEMED  Polymerisation promoter 
TIU    trypsin inhibitor units 
V   vertical 
ρ(z)      electron density  
ΔHf   heat consumption of phase transition per mole lipid 
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Historically, herbal medicine forms an integral part of traditional Chinese medicine. It has 
featured in a number of evidence-base scientific studies, thereby giving it credibility as an 
alternative to conventional medicine. Commonly recognised as a black coloured and bitterly 
flavoured soup, Chinese herbal medicine has been embraced by patients who have 
experienced its efficacy. Simultaneously it has been challenged by physicians and scientists 
for the ‘blackness’ of how it works. Using the extract of radix Isatidis as an example of 
antiviral herbal medicine, this study seeks to shed light on this “blackness”, and to illuminate 
the molecular mechanism of its effective components, Maillard Reaction Products (MRPs), 
which are typically dark chocolate brown in colour.      
A number of antiviral agents, either chemically synthesised or purified from natural sources, 
have been developed against various pathogenic viruses, e.g. influenza viruses. Most of these 
agents tend to rely upon specific interactions between the drug molecule and a viral 
protein/polysaccharide. The inhibitors, oseltamivir and amantadine, are two examples, and 
used in the treatments for seasonal flu. The specific molecular recognition between the drugs 
and viral compositions has the advantages of high efficiency and low side effects, as well as 
two drawbacks. Firstly, those drugs have very narrow spectra of activity and, secondly, 
viruses may develop resistance against them (in the case of amatadine, resistance involved a 
single amino acid replacement in the M2 protein).  
Within Chinese culture, preparations of natural materials have been used for centuries as a 
treatment or prophylaxis against viruses. Radix Isatidis extract (RIE) has long been 
employed as an antiviral drug in traditional Chinese medicine, and is currently licensed in 
China for use as an anti-influenza agent. Unlike vaccines or neuraminidase inhibitors, RIE’s 
antiviral effects appear to involve binding to the plasma membrane surface of respiratory 
epithelial cells, to protect them from infection by blocking viral attachment. This may 
explain RIE’s broad spectrum of antiviral activities, which may not depend on ligand-
receptor recognition.  
Much of this work focuses on the properties of the Maillard Reaction Products, which 
comprise the principal components of many Traditional Chinese Medicines (TCMs). The 
MRPs are a product of the preparation procedures, which typically involve hot-water 
extractions from sun-dried medicinal plants. My approach to this project was to characterise 
the molecular mechanism of MRPs as a mixture from natural resources or from an artificial 




1.1.  TRADITIONAL CHINESE MEDICINE AND HERBAL MEDICINE 
 
1.1.1.  What is a traditional Chinese medicine? 
What is a traditional Chinese medicine (TCM)? If we use Google, various answers to this 
question can be found, from a number of different perspectives. One definition, from the 
website of Nature Publishing Group (Nature 2010) is as follows:  
“TCM is ‘a system of treatment that emphasises the proper balance or disturbances … 
(which) consists of a group of techniques and methods, including acupuncture, herbal 
medicine, oriental massage and qigong (a form of energy therapy).”  
Some of these techniques and methods, i.e. acupuncture and herbal medicine, have been 
intensively studied in a wide range of medical research settings (Tang, 2006). Although it is 
still arguable whether all the therapeutic claims can be justified, it is becoming clear that 
certain TCMs have proven pharmaceutical activity. There is increasing number of evidences 
from laboratory and clinical studies to support claims such as the pain-reducing effects of 
acupuncture (Fireman et al. 2001), the effectiveness of artemisinin (discovered in the leaves 
of Artemisia annua, a TCM herb) in treating of multi-drug resistant strains of Falciparum 
malaria (Price et al., 1999) (PRICE, 1996), and now the effectiveness of RIE for antiviral 
applications (Chen, Wu, et al., 2006) (Jin, Ren, Meng, & Li, 2007).      
 
1.1.2.  Chinese herbal medicine 
In TCM, herbal medicines have traditional importance and have been studied systematically. 
They are used in more than four fifths of treatments employing Chinese medicines (Bensk, 
Clavey, Erich, Andrew, & Bensky, 2004). What makes the herbal medicines of TCM such a 
unique tonic among the herbal medicines popularly used in different parts of the world? The 
answer seems to reside in the processing of medicinal plants, in terms of sun-drying and hot 
water extraction.  
Ancient practitioners of TCM established a comprehensive system of preparing and 
practicing herbal medicines based on their clinical experience and understanding of the 
human body. This herbal system has two arms. One is a proper way of preparing the herbs 
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that goes much further than preservation and may be recognized as an ancient Chinese 
version of herbal pharmacy. Another is the prescriptions or formulas of sets of herbs grouped 
for certain disorders or diseases. These usually involve several kinds of herbs (4 to 14 kinds 
depends on the type and seriousness of the targeted disease). The herbs in the prescription 
are chosen and dosed with the guidance (Bensk, Clavey, Erich, Andrew, & Bensky, 2004), 
which combines the written Chinese medicine theory and the doctor’s clinical diagnosis. 
Both aspects are crucial for TCM’s therapeutic effects and comprise the unique characters of 
TCM compared to herbal medicines from other parts of world.  However, the processing of 
fresh plants into a medicinal formulation, typically and traditionally a soup, is undoubtedly a 
major factor, irrespective of whether it is a single herb, like Banlangen, or a TCM 
prescription containing a dozen types of herbs.   
 
1.1.3.  General properties of Chinese herbal medicine: processing and 
components  
Leaves, roots, stems and seeds of medicinal plants are the major ingredients of Chinese 
herbal medicine (Chinese Pharmacopoeia Commission 2005). However, instead of being 
applied freshly, most of these materials need to be sundried or boiled before being given to 
patients. Two steps of heating, sun-drying and boiling in water, endow Chinese herbal 
medicine decoctions with a common characteristic of a dark brownish colour, regardless of 
what herbs have been incorporated into the formulas or prescriptions. The dramatic colour 
change indicates the occurrence of a major chemical interaction among the native 
components of herbs.  
In terms of quantity of chemicals involved in this interaction, the Maillard reaction is the 
dominant chemical reaction during this heating process, whose products, MRPs, are the 
major compounds contributing to the dark colour (for details of the Maillard reaction, see 
Section 1.3.). Moreover, my previous studies indicate that MRPs are very possibly the 




1.2.  RADIX ISATIDIS AND ITS MEDICINAL APPLICATIONS 
 
1.2.1.  General introduction of the plant.   
Radix Isatidis, Banlangen in Chinese, is the dried roots of the plant Isatis indigotica Fort. or 
Isatis tinctoria L. (Fam. Brassicaceae), is a widely-used antiviral TCM. As an officially 
approved medicinal material (Chinese Pharmacopoeia Commission 2005), ‘Ban-Lan-Gen’ 
and its hot water extracts have been widely used to prevent and treat several types of viral 
infection, including influenza, epidemic hepatitis and epidemic encephalitis B (Price et al. 
1999). They have even served as major herbal tonics during the outbreaks of Severe Acute 
Respiratory Syndrome (SARS) in China, Hong Kong and Taiwan (Lin & Tsai 2005). 
Regardless of the different subtypes of haemagglutinin and neuraminidase of viruses and 
their constant mutations, RIE was found to be clinically effective against various subtypes 
and strains of influenza viruses (Wang et al. 2006) (Liu, Li & Jiang 2008). This indicates 
that RIE probably targets a common substance of the virus and is therefore generally 
effective over different subtypes of flu viruses. 
*∗ 
1.2.2.  Medicinal history of Banlangen  
Banlangen is cultivated in various regions across China, mainly in Anhui, Hebei and Jiangsu 
provinces in northern China. The earliest record of Banlangen as a medicine is in a Chinese 
medical classic, ‘Qian Jin Fang’, written in C.E. 652 by the famous physician Simiao Sun*. 
Apart from viral infection diseases, Banlangen is also employed in the treatment of bacterial 
infections such as erysipelas, toxic heat, and pneumonia (Niebuhr 1970)(Yeung 1985)(Duke 
& Ayensu 1985)(Bown 1995). It is effective against various types of bacteria, including 
haemolytic streptococcus (Kong et al. 2008a), E. coli (Kong et al. 2008b), C. diphtheriae 
and Salmonella enteritidis (Zhao et al. 2006). Claiming the multifunctional therapeutic 
benefits, Banlangen has becomes a suitable candidate for the application of evidence-based 
                                                
*∗ Simiao Sun is also called Saint Sun as a compliment to his enormous contribution 
to the advancment of Chinese medicine in his time. His book, Qian Jin Fang 
(Prescriptions Worth A Thousand Gold), is one of the most important and dominant 
books in the history of Chinese medicine.  
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pharmaceutical studies of Chinese herbal medicines. Its phytochemical composition and 
identified effective components are discussed later in this chapter (see section 1.2.3. below).  
 
1.2.3.  Phytochemistry of the roots 
A wide range of chemicals has been extracted and identified from the roots of Isatis 
indigotica F.. These range from a dye called indigo, which can also be extracted from 
another plant in the same family, namely ‘dyer’s woad’, to the most common substance in 
plants, saccharides. The major components of the plant’s chemical composition are total 
saccharides (67.0%), reducing sugar (14.2%), protein (13.6%) and free amino acids (4.2%) 
(see Section 7. For details). A single amino acid, arginine, accounts for up to 3.6% dry 
weight of fresh roots or 3.12% in sundried roots; it is the most abundant of the 17 kinds of 
amino acids determined in radix Isatidis. Furthermore, approximately 85% of the free amino 
acids is arginine, which is equal to 39.5% of total amino acids in fresh roots, and 38.1% sun-
dried roots. The extraordinarily high content of arginine in sundried radix Isatidis has also 
been reported by several independent studies (Xiang 2007) (Dong & Liu 2001) (Zou, Hong 
& Koh 2005), and was presumed to be the major effective components of Ban-lan-gen. For 
this reason, arginine has been designated by the Chinese Pharmacopoeia Committee, as a 
major characteristic with which to identify the authenticity of Radix isatidis material 
(Chinese Pharmacopoeia Commission 2005). The high levels of amino acids, proteins and 
reducing sugars in radix Isatidis could easily react with each other during heat processing, 
and could generate a large amount of MRPs.  
 
1.2.4.  Recognized active components of the roots  
To date, fresh plant tissues have been the major materials used in studies to identify the 
effective components of Banlangen. Various extracted compounds have been examined for 
their antiviral activity, including glycosides, peptides, lectins polysaccharides and alkaloids 
(Li, Yan, et al. 2009) (Hu & Zheng 2003) (Xu et al. 2005) (Nagai et al. 1998). In 2005, a 
‘fingerprint’ of the root and its extracts was constructed by analysing these compounds with 
high performance liquid chromatograph (Li, Ma, et al. 2009) (Lin et al. 2005). However, 
none of these particular compounds showed any promising impact on either cell protection 
or direct virus disinfection. Compounds known to have mild inhibitory effects on viruses, 
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such as polypeptides, glycosides and alkaloids, were either presenting at a very low 
concentration, or were insufficiently soluble in aqueous solution to be delivered by oral 
administration. In contrast, most herbal medicines in TCM are served as broth, which is a 
mixture of aqueous solution and colloid suspension (Hou et al. 2004). It should be noted that 
any aqueous insoluble chemical could hardly be the principal component of a clinically 
effective herbal TCM, regardless of how potent it might be observed in the pharmacological 
studies in vitro.   
As one of the major components of RIE, MRPs are readily dissolved in water and may be 
administered orally. As described later in this chapter, the anti-influenza virus activity of 
MRPs from RIE has been demonstrated by in vitro studies, but the mechanism of the 
antiviral action remains unknown.  
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1.3.  THE MAILLARD REACTION AND ITS PRODUCTS 
 
1.3.1.  Chemistry of the Maillard reaction 
The Maillard reaction is named after the French chemist Louis Maillard who first described 
it in 1912 (Maillard 1912). It is a non-enzymatic browning chemistry reaction between 
amino acids (or peptides, or proteins) and a reducing sugar, usually requiring heat. In 1953, 
the first coherent diagram of this reaction was laid out by Hodge (Fig 1.1) (Hodge 1953). As 
a major chemical change which occurs during food processing and physiological aging, 
MRPs have been associated with a number of functions and bioactivities. MRPs production 
has been linked to flavouring, food colouring, modification of proteins and lipids with non-
enzymatic glycosylation, and the formation of antioxidant or mutagenic compounds.  
As shown in Fig 1.1, the Maillard reaction could be described briefly as follows. The 
reaction initiated from a reducing sugar and amino group (i.e. from amino acids or 
aminophospholipid) forms an unstable Schiff base. The Amadori rearrangement product 
(ARP) is formed slowly from the Schiff base by an intramolecular process namely Amadori 
rearrangement. The ARP will then degrade in a pH-dependent manner into three groups of 
possible products:  
Reductones (pH>7), 
Fission products (pH>7),  
Schiff’s base of hydroxymethylfurfural (pH≤7).  
Some reactive carbonyl and dicarbonyl compounds could form in the ‘fission’ pathway 
(Figure 1.1). From reductones or fission products, with the participation of sugar, Strecker 
aldehydes of amino acids and aminoketones are formed. Onwards, the reaction could then 
take either one of two possible directions, depending on whether or not there is an 
intervention of amino compounds. In the presence of amino compounds, the brown 
nitrogenous polymers and copolymers, melanoidins are the end products, while aldol 
condensation and nitrogen-free polymers result in the absence of amino compounds. Lastly, 
at the earlier step of glycation, carbonyl fission products could also be formed from N-
substituted glycosylamine with the mediation of free radicals. This fragmentation of 
saccharide is now known as the Namiki pathway (Hayashi & Namiki 1980).  
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Figure 1.1  The Maillard reaction scheme modified from Hodge’s (Martins, Jongen & Boekel 2001). 
 
A detailed example of the formation of an Amadori product is given in Fig 1.2. The free 
amino group of a protein reacts with the aldehyde of glucose to form a carbinolamine. 
Carbinolamine dehydrates to a Schiff base, which subsequently undergoes a slow molecular 
rearrangement to form the Amadori product. It is important to note that the Amadori product 
exists as a mixture of several cyclic isoforms, although only a single isoform is shown here 




Figure 1.2  Amadori product formed between glucose and amino group of protein (Zhang et al. 2009) 
 
Somewhere between the Amadori product and melanoidins, intermediate glycation products 
(IGPs) and advanced glycation end-products (AGEs) are formed by subsequent oxidative 
decomposition of the Amadori product and the reaction between tissue proteins and reactive 
carbonyl/dicarbonyl compounds. IGPs includes a wide range of reactive carbonyl and 
dicarbonyl compounds, such as glyoxal, methylglyoxal, glycolaldehyde, 3-deoxyglucosone, 
1-deoxyglucosone, 4,5-dioxopentose, and 5,6-dioxohexose (Fig 1.3).   
AGEs forms at a relatively late stage of the Maillard reaction. They appear in a wide range 
of tissues and foods, and are highly correlated with the physiological and pathological 
influence of MRPs in vivo (Nguyen 2006). A group of AGEs compounds that have been 
extensively studied in glycation-related diseases and aging are listed here for reference (Fig 
1.4), including Nε-(carboxymethyl)lysine (CML), Nε-(carboxylethyl)lysine (CEL), S-
(carboxymethyl)cysteine (CMC), pyrraline, 3-deoxyglucosone-derived imidazolium 
crosslink (DOGDIC), pentosidine, glucosepane, glyoxal lysine dimer (GOLD), crosslines, 
and fluorolink (Qibin Zhang, 2009).  
However, this is not the end of story. The Maillard reaction is much more complicated than 
what has been implied by the Hodge diagram (Fig 1.1) (Martins, Jongen & Boekel 2001). 
Not only reducing sugars, but also other carbohydrates, lipids, ascorbic acid, could 
participate in the reaction with their degradation products. For example, two IGPs, glyoxal 
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and methylglyoxal, could also be produced by peroxidation of lipids, instead of Amadori 
product decomposition (Lederer & Klaiber 1999). In addition, the Maillard reaction and lipid 
peroxidation may both include a whole network of complex reactions. They are intimately 
interrelated and produce products that influence each other. AGEs and advanced lipoxidation 
end products (ALEs) are also the very common intermediates and products. The similarity 
and interaction between these two pathways increase the complexity of the Maillard reaction 
chemistry, and lead to the suggestion that they should be included in one general carbonyl 
pathway (HidalgoI & Zamora 2006). 
 
 
Figure 1.3  Representative intermediate glycation products (Zhang et al. 2009). 
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Figure 1.4  Representative advanced glycation end-products (Zhang et al. 2009). 
 
1.3.2.  Biological functions and effects of MRPs 
It is well known that the Maillard reaction products (MRPs) have important influence on 
functional macromolecules, living cells, tissues and the most normal substances, our daily 
foods. The haemoglobin of erythrocytes may be glycated. The reaction also affects the 
oxidative stability and shelf life of many foods, such as milk (Hansen & Hemphill 1984), 
pasta (Anese et al. 1999), cereals (Lingnert & Lundgren 1980) and meat (Bedinghaus & 
Ockerman 1995). Two aspects of MRPs’ biological effects, antioxidant or free radical 
scavenging activity and physiological influence, are described here due to their close 
relevance to the subject of  this study.   
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1.3.2.1.  Antioxidant effects of MRPs 
In 1954, the antioxidant capacity of MRPs was investigated for the first time, by Franzke and 
Iwainsky (Franzke & Iwainsky 1954). Some fractions with potent antioxidant activities were 
separated and compared to the conventional antioxidants commonly used in food (Lingnert 
& Hall 1986).  
By increasing reaction time or temperature, the colour of MRPs darkens while their 
antioxidant activities become correspondingly stronger at the beginning but dropped down 
afterwards (2 h in the glucose-glycine model system) (Yoshimura et al. 1997). But in other 
model systems, the browning of MRPs solution generally corresponds to the increase in 
antioxidant activities (Benjakul, Lertittikul & Bauer 2005) (Antony et al. 2000). However, 
this may not be ‘related to the free-radical scavenging activity of the MRPs at prolonged 
heating conditions’ (Morales & Jiménez-Pérez 2001). The antioxidant activity of MRPs is 
unstable and easy to be lost during separation (Lingnert & Waller 1983). The relationship 
between colour and antioxidant capacity was also demonstrated by the fact that 
decolourisation of MRPs diminished their antioxidant properties. This indicates that brown-
coloured compounds make a major contribution to the antioxidant activity (Yen & Hsieh 
1995). Interestingly, the reducing activity of MRPs decreases, corresponding to the increase 
in heating time, which indicates a mechanism unrelated to a conventional oxidative-reducing 
balance. It is generally believed that MRPs form in certain intermediate stage of the reaction 
have the highest antioxidant or free radical scavenging activities (Morales & Jiménez-Pérez 
2001) (Yoshimura et al. 1997).  
It has postulated that the major mechanism of the antioxidant action of MRPs relies on their 
ability to trap positively charged metabolites, scavenging oxygen radicals or chelating metal, 
particularly iron, to form inactive complexes (Yoshimura et al. 1997). However, this 
hypothesis remains unproven and the compounds responsible for the antioxidant effects have 
yet to be identified.   
 
1.3.2.2.  Physiological effects of MRPs 
According to the majority of experimental data to date, MRPs are commonly considered as a 
risk to health, particularly in terms of AGEs generated under physiological condition in vivo 
(Vlassara et al. 2007). AGEs have been suggested to play an important role in the 
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development of chronic complications of diabetes (Wautier & Guillausseau 2001). As 
chemicals indicating decay of function proteins, MRPs have been blamed for the generation 
of a mutagenic agent, acrylamide (Byrne, Mottram & Martens 2002), and increasing the risk 
of aging and disease like Diabetes (Chuyen 2006), which would result in vascular 
complications and loss of sight (Jakuš & Rietbrock 2004) (Lee, Simpson & Ortwerth 1999). 
However, evidences have been raised against the dietary AGEs being a risk to human health 
(Ames 2007). Some beneficial properties of MRPs, have been documented which includes 
anti-oxidative activity and desmutagenic effects (Chuyen 1998) (Yen & Hsieh 1994) 
(Yoshimura et al. 1997).  
Both positive and negative influences of MRPs on cell reproduction have been reported 
(Rufián-Henares & Morales 2006) (Kundinger 2004) (Harris & Tan 1999) (Einarsson, Snygg 
& Eriksson 1983). MRPs from amino acids and glucose showed significant impacts on the 
growth of the microorganisms (Harris & Tan 1999). This impact varies according to which 
amino acid was used. MRPs derived from reaction of arginine, glycine and histidine with 
glucose, promoted the growth of S. aureus and S. enteritidis, while MRPs of cysteine and 
glucose inhibited the growth of both germs. Furthermore, heating to a higher temperature or 
for a longer incubation time, strengthened the inhibitory effect of Cys-Glc MRPs. It has been 
demonstrated that there is a direct link between antimicrobial ability, the intensity of the 
browning, the pH at the end of synthesis and the reducing capacity of MRPs (Harris & Tan 
1999).   
With the approach of aging or disease, MRPs formed by carbohydrate or lipid-derived 
intermediates with proteins, lead to the formation of advanced glycation and lipoxidation 
end-products (AGE/ALEs) (Thorpe & Baynes 2003). AGEs, which are widely recognised as 
risk markers in aging and diseases, showed angiogenic effects on cultured endothelial cells 
(from the vein of human umbilical cord) at the concentrations ranged from 0.5 to 50 µg/mL, 
showing no change on cell proliferation rates (Tezuka et al. 1993). 
However, the therapeutic benefits of MRPs have not been reported in any published studies. 
In the previous studies, MRPs derived from some herbal Chinese medicines showed the 
ability to protect different types of mammal cells from chemical toxin or pathogen, by a 




1.3.3.  MRPs and herbal TCM 
As described in Section 1.1.3, the Maillard reaction occurs widely during the preparation of 
herbal TCM. MRPs predominate, therefore, in the composition of the herbal soup, and very 
possibly contribute the effective components responsible for TCM’s multi-target therapeutic 
effects. 
However, MRPs have rarely been the subject of research carried out upon TCM or 
phytochemicals. A relevant report appeared in the chemical composition studies (Li et al. 
1999) (Cao, Zheng & Xu 2001) (Suzuki et al. 2004) on the Arginyl-fructosyl-glucose from 
red ginseng (Panax ginseng C.A.Meyer or P.schinseng Nees) (Cho et al. 2008), but no 
therapeutic effect of MRPs was declared (Yoo et al. 1999). The nearly complete neglect of 
MRPs in TCM studies may be due to the complexity of the chemical nature of MRPs 
(Martins & Boekel 2005), and thus the extreme difficulty in their separation and isolation.  
This difficulty has been amplified by the combination of herbs used in TCM. If it is not 
possible to characterise unambiguously the compounds from a simple Maillard reaction 
between amino acid and monosaccharide, how much more difficult would it be to predict the 
chemical fingerprint of MRPs in a four-herb-composite TCM formula? 
1.3.3.1.  MRPs and the roots extracts 
In a study of RIE, it was shown that it inhibited the attachment of influenza A virus to the 
host cells (Chen et al. 2006). During the preparation, a high content of amino acids, proteins, 
sugar and MRPs were produced and accounted for approximately 30% of the dry weight of 
the preparation. Arginine is the most abundant single Maillard reactant in the roots, while 
glucose and sucrose are the most abundant monosaccharide and disaccharide in the roots. 
Sucrose accounts for up to 87% of the mono and disaccharides produced, and may 
hydrolysise to form glucose and fructose at low pH and high temperature. MRPs formed 
from arginine and glucose therefore become a potential representative of the whole family of 
MRPs in RIE (as described later in Section 4.2.2).  
1.3.3.2.  MRPs and Momordica charantia L. extracts 
The Maillard reaction may occur in other medicinal plants. Bitter melon (Momordica 
charantia Linn.), serves as a daily vegetable to people in many regions of southern and 
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eastern Asia, and is widely used in China as an anti-diabetic agent. It is also known as a 
contraceptive and antiviral agent. Like RIE, the preparation of Momordica charantia extracts 
(MCE) includes sun-drying and extraction with boiling water.  
In contrast to its fresh counterparts, sundried Momordica charantia L. pulps have a smaller 
proportion of soluble protein, total saccharides and reducing sugars, which indicates the 
occurrence of Maillard reaction. Glucose, fructose and maltose have been identified from 
fresh Momordica charantia L. pulps. Among them, fructose and glucose equally dominate 
the monosaccharides content of the vegetable pulps.  
Just like as in the roots, arginine and glucose are the predominant components of the free 
amino acids and reducing sugars. Arginine accounts for 32.4% of the total amino acids and 
59.3% of the free amino acids in the fresh pulps of Momordica charantia. Two continuous 
heat-processing steps were performed for preparing the MCE: sundried at 20~30°C for days 
and boiling at 100°C for several hours. The arginine content of sun-dried pulps and MCE 
decreased from 1.44% (w/w, fresh pulps) to 0.47% (sun-dried) and 0.24% (boiled) 
subsequently.  
As shown in Fig 1.5, MRPs from MCE administered orally reversed the progress of cellular 
damage (Fig 1.5a) induced by the autoimmune response in genetic Type 2 diabetic rats, and 
restored the healthy population of pancreatic islet β-cells (Fig 1.5b) at three dosages. The 
cellular-protective or repairing effects was so effective, that antioxidant activity alone could 
not fully explain the mechanism of this action. A series of experiments were conducted to 
determine the mechanism of MRPs on the β-cells, in addition to being a potent antioxidant. 
Cells achieved the better recovery from oxygen free radical damage with MRPs treatment 
prior to the damage than after the damage (Fig 1.6). Oxygen free radicals damage may 
destabilise the cell membrane by oxidising the membrane lipids, thereby destabilising the 
integrity of membrane. Theoretically, pore formation would occur from the membrane 
destabilisation and allow a macromolecule, such as green fluorescence protein (GFP), to pass 
through the cell membrane freely and appear in the cellular plasma. Pre-treatment using 
MRPs of MCE stopped this abnormal cross-membrane transportation, by preventing the 
formation of free radicals induced pores on cell membrane (Fig 1.7). Combining this with 
data from diabetic rats, MRPs of MCE show a clear cellular membrane protective activity 
against free radials. It could be argued that the strong free radical scavenging capacity of 
MRPs may also assist its cellular protective action. This capacity, however, requires a 
relatively high concentration of MRPs, which is unrealistic in both in vivo and in vitro 
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studies, and should not have resulted in different outcomes depending on whether the MRPs 
treatment was applied before or after the free radical interference. If they do protect the 
membrane and stop the entry of GFP, it may be assumed that the MRPs act on the matrix of 
the cell membrane, lipid bilayers, rather than any other components.  
 
 
Figure 1.5  Optical microscopy (HE stains) image of pancreas islet tissue slices of GK/Crj genetically 
modified Type 2 diabetic rats.  
a. Pathological pancreas islet tissue, shows deformed and dysfunctional β-cells. b. MCE administrated 
pancreas islet tissue, shows reduced foam cells, vitreous depositions and hypertrophic islets, increase 
insulin secretion (figures are quoted from unpublished data by Prof.Guangzeng Xi in Xi’an 4th 




Figure 1.6  Protection or repairing effects on alloxan damaged β-cells in vitro by MCE MRPs.  
Alx stands for alloxan (1 mM, 1 h). PBS, phosphate sodium buffer (pH7.2, for cell culture use). MCE 
stands for MCE MRPs (2 mg/mL, 1 h) in the diagram. The cell survival rates were 28.8%, 41.0%, 
63.4% and 23.5% for the ‘repairing group’, ‘protecting group’, ‘repairing plus protecting group’ and 





Figure 1.7 Fluorescent microscopy studies of MCE MRPs protecting HIT-T15 β-cells from alloxan 
damage. 
a.  Normal β-cells in white light: ×100. 
b.  Normal β-cells in fluorescence: ×100. No green fluorescent light was observed. 
c.  Alloxan damaged cells + GFP (Green Fluorescent Protein): ×400. The plasma of damaged cells 
was lighted up by GFP.  
d.  MCE protected cells + alloxan + GFP: ×400. Only weak green fluorescence was investigated on 
the surface of the cells; the damage caused by alloxan was effectively avoided. 
(data not published, quoted from a joint work conducted by Lijing Ke and Xiaonan Huang) 
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1.3.4.  Cytoprotective effects of MRPs on erythrocytes 
Haemagglutination is mediated by the binding of viral envelope glycoprotein haemagglutinin 
(HA) to cellular plasma membrane receptors, sialic acid residues of glycolipids (Rogers et 
al. 1985) (Wiley & Skehel 1987) (Kobasa et al. 2004). As previously reported (Chen et al. 
2006), RIE MRPs inhibited the haemagglutination induced by influenza A viruses which 
indicates blocking the association of HA with its receptor. This is consistent with the results 
from antiviral studies on MDCK cells (described in section 1.4.1), and supports the 
assumption that RIE inhibits the viruses’ attachment to cell membrane. Furthermore, MRPs 
of arginine and glucose inhibited the attachment of influenza virus to erythrocytes in the 
same manner as MRPs from RIE, indicating it is possible to use the MRPs between a single 
amino acid and a reducing sugar in order to diminish the complexity of MRPs derived from 
plant tissues.  
 
1.3.5.  Effects of RIE on the surface charge of cell membrane  
Every cell carries an electric charge, according to its membrane composition. The surface 
charge of the plasma membrane varies according to different species of cells and their 
physiological status (Gallin, Durocher & Kaplan 1975) (Miller et al. 1998) (Briandet et al. 
1999). Capillary electrophoresis (CE) is a sophisticated analytical technique that is capable 
of separating and identifying compounds and particles in a highly complicated system, based 
on their charge-mass ratio. Theoretically, if bioactive molecules, such as MRPs from RIE, 
bind to the plasma membranes of cells, the surface charge potential of the membrane is 
likely to change as a response to the binding. In the previous studies, CE provides a useful 
method for characterising and quantifying erythrocytes or other cells (Lu et al. 2003), and 
has been used successfully to identify the potential changes on the erythrocyte membranes 
caused by treatment with RIE or virus binding (Chen et al. 2006). RIE prolonged the 
electrophoretic retention time of normal erythrocytes by 60 s (~15%), which reveals a 
dramatic change in the membrane charge. This result indirectly illuminates the existence of 
components of RIE, i.e. MRPs, upon the cell membrane surface. However, it remains 
unclear whether the MRPs may affect the morphological and physiological properties of cell 
membrane, or the virus-induced membrane fusion process. 
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1.4.  INFLUENZA VIRUS AND ANTI-INFLUENZA VIRUS AGENTS  
1.4.1.  General background to the viruses 
Influenza viruses are enveloped RNA viruses belonging to the Orthomyxoviridae family. 
Influenza pandemics present a major threat to human and animal health as recently 
witnessed by the outbreaks of influenza virus A:  H5N1 (avian flu) in 2005 and A: H1N1 
(swine flu) in 2009.  
Three sub-viral components form the major part of each influenza virion: an outermost 
envelope, an intermediate layer of matrix protein M1 and a helical viral ribonucleocapsid 
core in the centre (Nayak et al. 2009). The transmembrane proteins haemagglutinin (HA), 
neuraminidase (NA) and M2 are embedded in the lipid bilayer of viral envelope (Fig 1.9). 
There are three types of influenza viruses: A, B and C. Humans can be infected with any of 
the three types. Generally, influenza types A or B viruses cause epidemics of human flu 
almost every winter. Among these 3 types of virus, only influenza A viruses are further 
classified by subtypes based on the two main surface glycoproteins of the virus membrane, 
haemagglutinin (HA) and neuraminidase (NA). There are 16 known HA subtypes and 9 
known NA subtypes, which make 144 known combinations of HA and NA possible. 
However, only a few influenza A subtypes are currently in circulation among people, mostly 
H1N1 and H3N2. Influenza A subtypes and B viruses may be further characterised into 
strains. One subtype of influenza A could have several strains due to the ‘antigenic drift’, 
which refers to small and gradual changes of HA and NA that occur through point mutations 
in the genes of two main surface proteins. Influenza C viruses have a mild influence on 
human and do not cause epidemics or pandemics (CDC 2005). 
As a result influenza A subtypes H1N1 and H3N2 were used in this study, as they represent 
the general characters of pathogenic seasonal flu viruses. 
 
1.4.2.  Composition of the membrane lipids of influenza A virus  
Influenza viruses share some common classes of phospholipids with the plasma membranes 
of their eukaryotic host cells, regardless of subtypes and strains. Five classes of 
phospholipids have been identified as the main composition of membrane lipids in influenza 
A virus (H0N1, WSN strain). They are sphingomyelin (SPH), phosphatidyl choline (PC), 
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phosphatidyl inositol (PI), phosphatidyl serine (PS) and phosphatidyl ethanolamine (PE). 
The proportion of each class, analysed by gel thin-layer chromatography, is 26.4±2.6% 
(SM), 17.8±4.5% (PC), 20.5±0.5% (PI+PS) and 35.8±2.2% (PE), respectively (Lenard et al. 
1976). A comparative study of influenza A and B viruses revealed that the classes of 
phospholipids in both types of virions were in close similarity, although some unique 
differences were also reported in the fatty acid composition of individual phospholipids of 
the viruses (Blough 1971). 
It is well known that influenza viruses leave their host cells by budding from the plasma 
membrane. They obtain their membrane envelopes in this process (Fig 1.10). Moreover, 
Rodriguez Boulan and Sabatini (Boulan & Sabatini 1978) have shown that influenza viruses 
(fowl plaque virus, FPV) budded from the apical domain of cell membrane whereas another 
enveloped virus, vesicular stomatitis virus (VSV), budded from the opposite side of the cell, 
from the basolateral membrane domain. The phospholipid compositions of these two viruses 
varied significantly, which reflects the substantial difference in the composition of the apical 
and basolateral membrane domains of MDCK cells (Meer & Simons 1982).  
Lipid rafts are lipid microdomains enriched in sphingolipids and cholesterol. The viral 
envelope is not composed of the homogeneous lipids but a mosaic mixture of lipid 
microdomains which contain raft-associated proteins and non-raft-associated proteins. Lipid 
rafts have been shown to play critical roles in several aspects of viral life cycle, including 
viral fusion and entry, or viral assembly and budding process (Nayak, Hui & Barman 2004) 
(Nayak & Reichl 2004). The most common lipids found in lipid rafts of human cells contain 
PC or PE. Among the transmembrane proteins of viruses, HA and NA associate with the 




Figure 1.8   
This preliminary negative-stained transmission 
electron micrograph (TEM) depicts some of the 
ultrastructural morphology of the A/CA/4/09 
swine flu virus.   
Picture from CDC website (CDC 2005) 
 
Figure 1.9   
A 3D graphical representation of the biology and 
structure of a generic influenza virus (not 
specific to the 2009 H1N1 virus). 
Picture from CDC website (CDC 2005) 
 
Figure 1.10   
This negative stained transmission electron 
micrograph (TEM) shows recreated 1918 
influenza virions that were collected from 
supernatants of 1918-infected Madin-Darby 
Canine Kidney (MDCK) cells cultures 18 hours 
after infection.  




1.4.3.  Recognized anti-influenza virus agents and their mechanisms 
As an enveloped virus, the infectious cycle of influenza virus typically involves four steps: 
binding, fusion or entry, replication and budding. Together these provide several 
opportunities for antiviral activity to inhibit the viral replication. For example, some 
antibodies inhibit the attachment of viruses to cells (Ugolini et al. 1997) (Reading & 
Dimmock 2007) (Klasse & Sattentau 2002). Peptidylchloroalkylketone inhibitors prevent the 
fusion event by inhibiting cleavage of the precursor of HA (Tashiro & Rott 1996); the 
approved drugs amantadine and rimantadine prevent viral particles from uncoating prior to 
their release into the cytoplasm by blocking the M2 ion channel (Pinto & Lamb 2007) 
(Ilyushina et al. 2007) (Duff 1992). Neuraminidase inhibitor, Oseltamivir for instance, 
competes with sialic acid, blocking activity of viral neuraminidase, to prevent the virus from 
being released from infected cells by membrane budding (Gubareva, Webster & Hayden 
2002) (Moscona 2005). However, all of these drugs rely on their interference with 
membrane proteins like M2 protein (ion channel) and HA, or polysaccharides incorporating 
sialic acid. These sophisticated mechanisms, which are highly dependent on structural 
recognition, are undoubtedly very efficient, but share a common weakness: it is not difficult 
for viruses to develop resistance to these drugs by simple genetic mutations.     
Amantadine and Oseltamivir (trade name ‘Tamiflu’) are two leading anti-influenza virus 
agents in the frontline of the battle against seasonal flu. Although they have been very 
successful in controlling influenza A and B virus epidemics, there have been warnings that 
the rapidly growing number of novel virus strains with resistance to these drugs might out-
weight their efficacy in the next flu pandemic. According to the US Centre for Disease 
Control, all H3N2 viruses and 2009 H1N1 flu viruses have shown resistance to adamantine, 
which is no longer recommended for treatment of flu. Some comments have also been made 
about Oseltamivir, for which a higher dosage and longer duration of treatment have been 
recommended. Great efforts have been made to develop new antiviral compounds, based on 
different mechanisms, to offer high-efficiency, low-resistance treatments for constantly 
mutative seasonal flu. MRPs derived from TCM, more specifically from radix Isatidis, and 
their interaction with lipid bilayers, might provide a new direction in the treatment of 
influenza.    
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1.5.  HYPOTHESIS AND AIMS OF THIS STUDY 
1.5.1.  Hypothesis 
Since we have seen the important role MRPs might play in TCM, and the unusual 
mechanism for protecting cell membranes, a conventional study is carried out here to 
determine the interaction between MRPs and bilayers of membrane lipids, to identify the 
active compounds and to elucidate the underlying molecular mechanism. Due to the complex 
nature of the Maillard reaction, the MRPs involved in this study must be simplified and 
modeled to cancel out any unnecessary background. One of the solutions is to limit the 
reactants to a typical amino acid and reducing monosaccharide, i.e. arginine and glucose, and 
carefully control the conditions of reaction to ensure the reproducibility of Arg-Glc MRPs in 
various experiments. 
The active MRP molecules from RIE may initiate their action on the target cells by specific 
binding to the plasma membrane. The binding may occur on a basis of structure recognition 
or interaction between secondary bonds of MRPs and membrane components, with a minor 
influence on the conventional signalling pathway on cell plasma membrane. MRPs act rather 
like a “firewall” blocking attachment of the virus, and preventing infection of the cells. The 
amphiphilic characteristics of their structures may explain their affinity for cell membranes. 
Possible target molecules on the cell membrane may include: 1) lipids which form the 
bilayer of the plasma membrane; 2) the native proteins and polysaccharides on the cell 
membrane; 3) the MRPs derived from lipids, proteins and polysaccharides on the cell 
membrane. 
Due to the fact that lipids, particularly phospholipids, form the ‘backbone’ of membrane and 
being intensively studied, the lipid bilayer was placed on the top of the list for this study.  
 
1.5.2.  Aims 
This study aims to characterise the antiviral mechanism of MRPs derived from RIE by 
providing answers for the subjects listed below: 1) elucidate the binding of MRPs to 
phospholipids bilayers; 2) effects of MRPs on phospholipids bilayers; 3) influence of MRPs 
on virus-induced membrane fusion; 4) anti-influenza virus mechanism of MRPs. 
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CHAPTER 2  
 
MATERIALS AND METHODS  
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2.1.  MATERIALS 
2.1.1.  MRPs of radix Isatidis Extracts (RIE) 
2.1.1.1.  Species and growth of the plant  
The raw material, radix Isatidis (Bei Ban-Lan-Gen), belongs to the Cruciferae family. It is 
the roots of a tetraploid strain of Isatis indigotica Fortune, which is grown under the 
conditions of Good Agricultural Practice (GAP), in Ruanqiao Town, Taihe County, Fuyang 
City, Anhui Province. The plant grow for 4 months (approximately equal to 2~3 times 
harvest of their leaves), between each June and October, before the harvest in October ~ 
November every year. The collected whole plants were identified as Isatis indigotica Fort. 
by Prof. Chengzi Yang from Fujian Traditional Chinese Medicine College. 
2.1.1.2.  Raw materials processing and preparation of RIE MRPs 
The fresh roots were harvested and sun-dried in Fuyang City, Anhui Province, P.R. China. 
The sun-drying was performed under the conditions shown below: 20~25°C (day), 5~10°C 
(night), 2 ~ 4 weeks depending on the local climate. The yield of sun-drying is 1 kg sun-
dried roots from about 2.5 kg fresh roots.  
To prepare RIE MRPs, 1400 g sun-dried roots were extracted twice with boiling water at 
100°C, for 2 h and 1 h, respectively. The solution was filtered and vacuum concentrated at 
50°C until the relative density reached 1.20. After the stock was precipitated by 60% ethanol 
at 4°C, the suspension was vacuum concentrated at 50°C to produce the RIE MRPs as brown 
powder. 
 
2.1.2.  MRPs of Momordica charantia L. Extracts (MCE) 
Fresh fruits of bitter gourd (Momordica charantia Linn.) and sliced sun-dried pulps were 
purchased from the Exemplary Bitter Gourd Planting Farm (Huxian County, Shanxi 
Province, P.R.China). The boiling water (100°C) extracts of the pulps were vacuum 
concentrated at 70°C to produce the brown powder of MCE MRPs. 
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2.1.3.  MRPs of arginine and glucose 
1 mmol of L-arginine (non-animal source, Sigma) and 1 mmol D-glucose were mixed 
thoroughly, and incubated in a humid atmosphere over a saturated solution of potassium 
bromide (80% RH) at 40°C. After a 7-day incubation, the reaction products were dissolved 
in 5 mL deionised water to obtain Arg-Glc MRPs. 
The deuterated Arg-Glc MRPs (DAG) was prepared with 1 mmol of L-Arginine-
2,3,3,4,4,5,5-d7 (C/D/N ISOTOPES Inc.) and 1 mmol D-+-glucose in H2O following the 
same procedure as described above. 
 
2.1.4.  Influenza viruses 
Influenza strains A/Beijing/95-262(H1N1/C2E3, 1:640 8/2/99) and B/Shanghai/93-1(C3C2, 
1:320 9/2/99) were purchased from the National Influenza Center of China. Influenza A 
virus FM1 (H1N1, mouse-adapted strain) was generously provided by Fujian Centre of 
Disease Control (Fuzhou, Fujian, P.R.China). All viruses were cultured in the allantoic 
cavity of 11-day-old chick embryos at 33°C for 48 h. Isolated virus stocks were stored in 
aliquots of phosphate buffered saline at -80°C. 
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2.1.5.  MDCK cells 
Madin-Darby canine kidney (MDCK) cells were purchased from the China Center for Type 
Culture Collection. Continuous MDCK cells were grown in Dulbecco's Modified Eagle's 
Medium (DMEM) containing 10% calf serum, penicillin G (100 mg/L), streptomycin (80 
mg/L), and sodium bicarbonate (3.7 g/L), at 37°C in a humidified incubator containing 5% 
CO2 (Thermo Forma Series II Water Jacketed CO2 Incubator, Model 3111, USA) (All 
supplements were purchased from GIBCO, Invitrogen Corporation).  
 
2.1.6.  Liquid Chromatographic Materials 
Table 2.1  HPLC columns used in the protein separation and purification 
LC columns Size (mm) Manufactory 
Toyopearl SP-650M strong cation ion-
exchange chromatography 
16.0×250 TOSOH, Japan 
Oligo-R3 C18 RPLC 4.6×250 
PerSeptive Biosystems, 
USA 
TSK-GEL G3000SWXL  
size-exclusion chromatography 
7.8×300 TOSOH, Japan 






2.1.7.  Low osmotic media 
Sodium ehloride was dissolved in de-ionised water to make 0.9% saline and filtered with 
0.22 µm, and diluted to 0.1%, 0.2%, 0.3%, 0.45% to make low osmotic pressure solution.  
 
The reagents and chemicals used in this study are purchased from Sigma-Aldrich, unless 
specified elsewhere. 
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2.2.  METHODS 
2.2.1.  Biochemistry studies 
2.2.1.1.  Extraction of proteins 
100 g roots were frozen in liquid nitrogen, before smashed by high speed pulverizer (800 
rpm). 300 mL extraction buffer (pH 7.2, 0.01 mol/L PB + 0.1 mol/L NaCl) was added and 
stirred at 4°C for 12 h. The supernatant was separated by centrifugation at 12000 rpm for 20 
min, at 4°C (Hitachi, Japan).  
2.2.1.2.  Protein concentration determination 
The total protein content was determined by Kjeldahl assay (Cataldo, Schrader, & Youngs, 
1974), Folin-Phenol assay (Lowry, Rosebrough, Farr, & Randall, 1951) and Bradford assay 
(Bradford, 1976).  
Kjeldahl determines the amount of nitrogen in protein. A protein index of 6.25 was used in 
this study. In Folin-Phenol Assay, bovine serum albumin (BSA) was used as the protein 
standards (Table 2.2). The protein concentration was calculated with Eq 2.1. In Bradford 
assay, BSA was also used as the protein standard. The protein concentration was calculated 
with Eq 2.2. 
Reagents of Folin-Phenol assay (Lowry, Rosebrough, Farr, & Randall, 1951) 
Reagent A, 10 g Na2CO3, 2g NaOH and 0.25 g KNaC4H4O6·4H2O, dissolved in 500 mL 
H2O. Reagent B, 0.5 g CuSO4·5H2O dissolved in 100 mL H2O.  
Reagent C, alkaline copper solution. Mix 50 mL of Reagent A with 1 mL of Reagent B. 
Discard after 1 d.  
Reagent D, diluted Folin reagent. Titrate Folin-Ciocalteu phenol reagent (stored in the dark, 
4°C) with NaOH to a phenolphthalein end-point. On the basis of this titration, dilute the 
Folin reagent (about 2-fold) to make it 1 N in acid.  
Reagents of Bradford assay assay (Bradford, 1976) 
Coomassie Brilliant Blue G-250 (100 mg) was dissolved in 50 mL 95% ethanol. To this 
solution 100 mL 85% (w/v) phosphoric acid was added. The resulting solution was diluted to 
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a final volume of 1 litre. Final concentrations in the reagent were 0.01% (w/v) Coomassie 
Brilliant Blue G-250, 4.7% (w/v) ethanol, and 8.5% (w/v) phosphoric acid. 
 
Table 2.2  The BSA working standard for Folin-Phenol assay 
Tube number Reagents 
1 2 3 4 5 6 
BSA solution 
(mL) 0 0.2 0.4 0.6 0.8 1.0 
H2O (mL) 1.0 0.8 0.6 0.4 0.2 0 
BSA content 
(µg) 0 50 100 150 200 250 
Reagent C (mL) 5 5 5 5 5 5 
Reagent C (mL) 0.5 0.5 0.5 0.5 0.5 0.5 
 
Protein concentration (mg/mL) = 420.99 × A650nm – 7.68, R2 = 0.9943  
Equation 2.1 
Protein concentration (mg/mL) = 1159.60 × A595nm – 41.544 , R2 = 0.9933 
         Equation 2.2 
(The standard curves are not shown, but available on request) 
2.2.1.3.  Saccharides concentration determination 
The saccharides concentration in the roots was determined with the anthrone sulfuric acid 
assay (Dische, 1967). Four milliliters of anthrone (2 mg/mL) was added to 1 mL of D-
glucose solution of 100, 200, 300, 400, 600, 800 µg/mL (cooled on ice, 5 min), produced on 
heating (100°C, 10 min) a cyan colour (λmax= 620 nm). The absorbance was measured after 
cooling for 10 min in water bath. The reducing sugar concentration of sample was measured 
by 1 mL solution of each sample. The same volume of distilled water was used as control. 
Fresh roots were frozen by liquid nitrogen, then smashed by a high-speed pulveriser (800 
rpm). 10 g of smashed roots was extracted with 30 mL deionised water for 12 h. The 
monosaccharide and small molecular weight fraction were removed by dialysis. Then the 
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extraction was hydrolyzed with 3.0 M sulfuric acid for 25 min at 60°C, and neutralised with 
NaOH. The hydrolysates were diluted to 250 mL, and then measured with anthrone sulfuric 
acid assay. The equation below (Eq 2.3) was obtained from the standard curve Fig 2.1 and 
Table 2.3. 
 
Saccharides concentration (mg/mL) = 8.7842×A620nm - 0.0115, R2 = 0.9992  
         Equation 2.3 
 
Table 2.3  Standard curve of glucose concentration. 
Number 1 2 3 4 5 6 
Concentration (mg/mL) 0.01 0.02 0.04 0.06 0.08 0.1 
0.076 0.167 0.340 0.517 0.697 0.853 
0.065 0.150 0.331 0.509 0.717 0.879 A620nm 
 0.141 0.326 0.519 0.706 0.847 




Figure 2.1 Standard curve of glucose concentration measured by the anthrone sulphuric acid assay.  
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2.2.1.4.  Amino acids analysis 
The fresh and sun-dried Isatis roots were weighted and frozen in liquid nitrogen then 
smashed by a high-speed pulveriser (800 rpm).   
Total amino acids 
30 mg smashed sample and 3 mL HCl (6 mol/L) were sealed in a vacuumed glass tube, and 
hydrolyzed at 130°C for 6 h. When the sample had been completely hydrolyzed, opened the 
tube after cooling down, and diluted with distilled water to 25 mL. 5 mL of this diluted 
solution was evaporated to dryness, and the substance was dissolved and diluted in 0.02 
mol/L HCl, centrifuged at 14,000 g for 20 min, then the suspension was subjected to amino 
acid analysis (Hitachi L-8800 automatic amino acid analyser).  
Free amino acids 
1 g of smashed fresh roots, sun-dried roots and heat-dried roots (40°C) were each suspended 
in 30 mL of 0.02 mol/L HCl, and sonicated for 1 h. Each mixture was centrifuged (14,000 g, 
20 min), and the suspension was subjected to amino acid analysis. 
 
2.2.1.5.  Monosaccharides and disaccharides analysis 
Reducing sugars were identified by HPLC method (Karlsson, Winge, & Sandberg, 2005) 
modified to fulfill the requirement of measuring sugars from fresh plants. A TSK-gel Amide-
80 column (250 mm × 4.6 mm I.D., 5 µm, 80 Å, Tosho, Japan) was used for separation at 
60°C. The flow rate was 1.0 mL/min and injection volumes were 10 µL. The mobile phase 
was a mixture of acetonitrile, ethyl acetate and deionised water (60:25:15, v/v). The sugars 
were detected by an evaporative light scattering detector (Sedere Inc., USA), coupled in-line 
after a UV detector. Nitrogen was used as the ELSD nebuliser gas (3.5 bar), at 40°C, with 
the gain set to 8. The standard curve was obtained from a mixture of the rhamnose, xylose, 
arabinose, D-fructose, mannose, D-glucose, D-galactose, sucrose and maltose (0.4, 0.8, 1.0, 
1.2, 1.6, 2.0 mM of each), with a log-log linear curve fit (Excel, Microsoft). All samples 
were dissolved in mobile phase solution and applied to the chromatography column. 
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2.2.1.6.  Protein gel electrophoresis 
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE), is a protein 
separation technique widely used in biochemistry and molecular biology according to its 
electrophoretic mobility. Proteins may have different mobility due to the differences in their 
molecular weight and their secondary, tertiary or quaternary structures. As an anionic 
detergent, SDS binds to the proteins and coats them with uniform negative charges, which 
reduces them to their primary structure. Therefore, the samples in SDS-PAGE have identical 
charge per unit mass, which results in the fractionation of different compositions by their 
size (in terms of molecular weight).  
SDS-PAGE electrophoresis was performed by Laemmli protocol (Laemmli, 1970), which 
generally includes 1) preparing the polyacrylamide gel and assembling the gel devices, 2) 
coating the protein samples by mixing samples with SDS sample buffer and boiling for 10 
min, 3) loading the samples and running the electrophoresis with the ‘running buffer’, 4) 
fixing the gel with ethanol and glacial acetic acid solution, and staining the separated 
proteins with Coomassie Brilliant Blue. 
The proteins can be dissociated by boiling in the presence of SDS and a reducing agent, i.e. 
dithiothreitol (DTT) or 2-mercaptoethanol (β-mercaptoethanol), then are electrophoresed 
through 12.5% polyacrylamide at 120 V. The use of reducing agents brakes down the 
disulfide linkages of proteins and further denatures the proteins, which thereby breaks up the 
oligomeric subunits of protein structure. This method is known as reducing SDS-PAGE, 
which is most commonly used. Non-reducing SDS-PAGE can be used when the natural 
structure of protein is crucial for the analysis. By comparing the results from these two types 







Table 2.4  Buffers and chemicals for SDS-PAGE 
Reagents Compositions Storage 
Buffer A (30% Gel) 
Acrylamide                                29.2 g 
N,N'-Methylenebisacrylamide   0.8 g 
dissolved in deionised water      100 mL 
4°C 
Buffer B (resolving 
buffer) 
1.5 M TRIS-HCl buffer (pH 8.8) 
TRIS                  18.2 g 
SDS                    0.4 g 
HCl                     2 mL 




0.5M TRIS-HCl buffer (pH 8.8) 
TRIS                  6.1 g 
SDS                   0.4 g 
HCl                    4.2 mL 
dissolved in deionised water 100 mL 
4°C 
Polymerisation initiator Ammonium persulphate 0.2g dissolved in deionised water 1 mL 
Room 
temperature 
Polymerisation promoter  TEMED 4°C 
Anode/cathode buffer 
25mM TRIS, 0.01 M GLY, 0.1‰SDS 
TRIS                  3 g 
GLY                  14.4 g 
SDS                   1 g 
dissolved in deionised water 1000 mL 
4°C 
Fixing buffer 
Ethanol                      500 mL 
Glacial acetic acid     100 mL 




Coomassie Brilliant Blue R250 500 mg 
Methanol                                    225 mL 
Acetic acid                                 50 mL 




95% ethanol             250 mL 
Glacial acetic acid                      80 mL 






Table 2.5  The preparation of stacking gel and resolving gel 
Gel buffer 






Buffer A 6.0 mL 7.5 mL 0.8 mL 
Buffer B 4.5 mL 4.5 mL / 
Buffer C / / 1.5 mL 
Deionised water 7.5 mL 6.0 mL 3.7 mL 
Polymerisation initiator 50 µL 50 µL 30 µL 
Polymerisation promoter 12 µL 12 µL 6 µL 
 
 
Periodic acid-Schiff (PAS) Staining  
PAS staining was used to identify the glycoproteins or glycated proteins in the extracts of the 
roots (Glossmann & Neville, 1971). In glycoproteins, two types of carbohydrate-peptide 
linkage have been identified, the N- and the O- linkage. In glycation, either exogenous or 
endogenous, glucose or fructose is often found to bond to the proteins by the Maillard 
reaction. Periodic acid can selectively oxidise the glucose residues to form aldehydes, which 
react with the Schiff reagent and results in a magenta colour.  
Reagents and protocol: 
1. Fixing solution: trichloroacetic acid 50 mL in 450 mL water, 10% (v/v), 60 min. 
2. Washing solution: deionised water, 1 min each time, twice. 
3. Oxidising solution: 1% (w/v) periodic acid in water, stores in dark at 4°C, 60 min. 
4. Washing solution: deionised water, 15 min each time, twice. 
5. Schiff reagent: basic fuchsin 1.0 g in 200 mL water, sodium metabisulphite 3.2 g in 200 
mL water, HCl 4.2 mL, stirring overnight at 4°C, mixes with the activated carbon 2.0 g and 
vortex for 1 min. Samples were stained for 60 min. 
5. Washing solution: deionised water, 1 min. 
6. Reducing solution: 0.25% (w/v) sodium metabisulphite, 3.5% (w/v) acetic acid in 500 mL 
water, at 4°C overnight. 
7. Washing solution: deionised water. 
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Calculation of molecular weight  
The migration distance and gel length were measured to calculate the relative mobility Rf for 
each protein, with Eq 2.4. The molecular weight (Log) was plotted as a function of Rf for 
standards and extrapolate size of unknown. 
Rf = distance migrated / gel length     Equation 2.4 
 
2.2.1.7.  Isoelectric focusing (IEF) 
IEF is an electrophoretic technique for separating proteins based on their pIs in an electric 
field through a medium (i.e. a gel), which has a pH gradient. Proteins carry positive, negative 
or zero net charge depending on the pH of their solution, and thereby migrate different 
distance in the gel according to their net charge (Righetti, 1983) (Righetti, Bossi, & Gelfi, 
1998). The pI of a protein can be determined with IEF.  
IEF was performed according to the instruction manual of AE6541 apparatus (ATTO Co., 
Japan). Briefly, a gel made of agarose, sorbitol and urea was prepared with a pH gradient of 
3.5 to 10.0 (A-C310, ATTO Co., Japan), stored at 4°C and used within 3 months. After 
treated with reducing sample buffer, the protein samples were applied for electrophoresis 
under 300 V for 150 min. The gel was then stained with Coomassie Brilliant Blue R250 
according to the SDS-PAGE staining method (see Section 2.2.1.6) (Reisner, 1975). The full 
length of gel and the migration distance of protein to the cathode were measured for the 
calculation of pI. The standard pH curve was drawn by measuring the pH of every 5 mm 
fraction of a blank gel (no sample loaded), which was identical to the experimental gel 
except the loaded samples. 10 mM KCl was used for extracting the buffer salts from the 
blank gel.  
2.2.1.8.  Purification of protein by HPLC 
High Performance Liquid Chromatography (HPLC) was used as the main method of protein 
purification. HPLC includes utilising different types of stationary phase (i.e. the hydrophobic 
saturated carbon chains), the mobile phases and analytes through the column, and a detector 
(typically a UV/VIS detector or a Refractive Index (RI) detector) that provides a 
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characteristic retention time for the analytes like proteins, peptides and sugars. By changing 
the type of detectors, different characteristics of analytes can be addressed, i.e. the 
fluorescence, light scattering. The retention time of analytes varies depending on several 
apparatuses of the chromatography system, including the strength of their interactions with 
the stationary phase, the ratio and/or composition of mobile solvents used, the flow rate of 
the mobile phase and the size (diameter, length) of the column, which is densely packed with 
the stationary phase. The high density of packing and small particle size of the 
chromatographic resin used in HPLC allows a high efficiency on separation of compositions 
in a highly complicated mixture with a shorter column compared to the ordinary column 
chromatography (Scopes, 1994). 
Cation-exchange liquid chromatography and reversed phase liquid chromatography were the 
major methods of protein separation. Toyopearl SP-650M strong cation-exchange resin was 
used for isolation of RITIP proteins from the fresh roots, while Toyopearl SP-5PW cation-
exchange resin was used for isolation of GRITIP proteins from sun-dried roots. The proteins 
were purified with C18 chromatographic column (Oligo-R3). The purity was checked with a 
size-exclusion HPLC column (TSK-Gel G3000SWXL). 
For separations using the strong cation-exchange column (16 mm×100 mm, SP-650M, 
Toyopearl, Japan). The flow rate was 1 mL/min. The citric acid-sodium citrate buffer (0.02 
M, pH3.0) was used as mobile phase. A salt gradient of 0.5~1.0 M NaCl was used to elute 
the compounds bound to the stationary phase. The detector wavelength was 280 nm. A 
fraction collector was used to collect the separated protein fraction at a rate of 5 mL/tube. 
For separations using the reverse phase LC column (4.6 mm×250 mm, POROS Oligo-R3 
C18, ABI, USA), the flow rate was 1 mL/min. The mobile phase was 0.1% TFA water 
solution. An acetonitrile gradient (0~55%) was used to elute the proteins from the stationary 
phase. The detector wavelength was 280 nm. The isolated fractions were collected manually. 
For separation of glycated proteins, 5 mL of roots extracts was loaded to a cation-exchange 
column (4.6 mm × 250 mm, SP-5PW, Toyopearl, Japan) with a mobile phase containing 
0.02M citrates buffer (pH4.0) at the flow rate of 1 mL/min. The elution gradient was 0~1 M 
NaCl during 60 min. 
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2.2.1.9.  Amino acids sequencing of protein 
The amino acid sequences of purified proteins were determined with Edman degradation. 
Edman degradation, developed by Pehr Edman (Edman, 1950), is a method of sequencing 
amino acids in a protein/peptide. In this method, the amino acid at the N-terminal of 
sequence is labelled with phenyl isothiocyanate under alkaline conditions and cleaved off 
one by one as a thiazolinone derivative under acidic conditions, while the peptide bonds 
between other amino acids were not affected. The thiazolinone amino acid forms a stable 
derivative, phenylthiohydantoin (PTH)- amino acid, which can be characterised by HPLC. 
This procedure can then be repeated to identify the next amino acid. This cycle can 
accurately repeated up to 30 times (means 30 amino acids) with 98% efficiency for each 
amino acid. A beauty of the Edman degradation is that only a small amount of peptide (10 - 
100 picomole) was required for the sequencing procedure. There is also a major drawback of 
this method: it cannot sequence more than 50 to 60 amino acid residues (Niall 1973). It is 
because the efficiency of Edman degradation is not 100%, meaning that the cleavage step 
may not occur every time. Therefore, to obtain the full-length sequence of protein/peptide, 
the large proteins/peptides can be cleaved into smaller peptides before proceeding with the 
Edman degradation.  
After being applied for SDS-PAGE electrophoresis, the protein bands were transferred to 
polyvinylidene difluorid (PVDF) membrane with the transfer buffer (as shown in Table 2.5) 
and stained in 0.1% Coomassie Brilliant Blue R250 in 50% methanol for 1-2 minutes. The 
protein blots were destained with several changes of 10% acetic acid in 50% methanol until 
the bands became visualized (usually about 5 minutes). The blot was washed twice with 
deionised H2O then dried with air. 
 
Table 2.6  Preparation of transfer buffer 
Chemicals Amount 
Gly 9 g 
Tris 1.93 g 
SDS 1 g 
20% methanol 200 mL 
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2.2.1.10.  Molecular cloning 
The genes of the purified proteins were cloned from fresh tissue of the roots, following the 
protocol below: Primer design → Isolation of mRNA → First strand cDNA synthesis → 3’-
RACE (Rapid Amplification Of cDNA Ends) PCR → 5’-RACE PCR → Agarose gel 
electrophoresis → Purification PCR products from a PCR reaction or a gel → Cloning of 
purified DNA into plasmid vectors → Transformation of E. coli → M13 amplification of 
insert from E. coli → Automated DNA sequencing was carried out (Generay Biotech Inc., 
Shanghai, China) → Bioinformatics analysis. 
Raw sequence data from replicates were read by Chromas (Version 1.45) software and then 
edited. Translations of nucleic acid data (in all six frames) were conducted using the 
Translate tool on ExPASy Molecular Biology Server (http://ca.expasy.org/tools/dna.html). 
The correct reading frame was manipulated by using the Vector NTI (Version 9.0) software. 
Sequences were compared to EMBL and GENBANK nucleic acid databases using the 
FASTA and BLAST programs using default values. Wu-blast 2 programs were used to 
compare sequences with those contained in nucleotide and protein databases (SwissProt, 
Release 53 and EMBL Release 90) by aligning the query sequences with previously 
characterised genes. 
2.2.1.11.  Mass spectroscopy 
Mass spectrometry is widely used for the characterisation of proteins, either in their pure 
form or in a mixture. Proteins need to be ionised before detected by the mass monitor. There 
are two primary methods for the ionisation of whole proteins: electrospray ionisation (ESI) 
and matrix-assisted laser desorption/ionisation (MALDI) (Link et al. 1999) (Fenn et al. 
1989) (Loo, Udseth & Smith 1989). Two approaches are used for characterising proteins. 
Firstly, known as the "top-down" strategy, the intact proteins are ionised and introduced to a 
mass analyser. Secondly, proteins are enzymatically hydrolysed into smaller peptides by a 
protease (i.e. trypsin). Subsequently these peptides are loaded into the mass spectrometer and 
identified by peptide mass fingerprinting. Hence, the second approach (also known as the 
"bottom-up" proteomics strategy) is able to identify the peptides and infer the existence of 
proteins. In this study, the molecular weight of the protein was determined by ESI-mass 
spectroscopy.  
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Two methods are widely used to fractionate proteins and/or the peptides from their 
enzymatic digestion. The whole proteins could be analysed with two-dimensional gel 
electrophoresis, while HPLC is used to separate and characterise peptides after the 
enzymatic digestion (Perkins et al. 1999). In my studies, the later method was used for 
analysing the glycation sites on the proteins. 
2.2.1.12. LC-MS analysis of enzymatic protein hydrolysates 
The analysis was performed with LC/MSD Trap XCT (Agilent, USA). RPLC was performed 
by using a C18 column (Phenomenex, Gemini C18, 250 mm × 4.6 mm, 5 µm) and the 
elution gradient of 0~100% CH3CN, containing 0.1% TFA. The elution volume was 60 mL 
at a flow rate of 1 mL/min. The UV detector wavelength was 214 nm. The LC fractions were 
ionised and immediately analysed by an electronspray ionisation mass spectrometer 
immediately. This was performed in cationic mode, 2000 m/z, spray air pressure 40 psi, 
nitrogen drying flow rate 12 L/min, drying temperature 350°C, capillary voltage 3.5 kV, 
with a ion scanning over the range from m/z 50 to 2200. 
Table 2.7  Gradient (B%) 
Time B% Flow Rate (ml/min) 
0 0 1.0 
10 0 1.0 
70 100 1.0 
80 100 1.0 
2.2.1.14.  Glycation sites analysis  
Genes of purified native proteins from the roots were cloned and the cDNA sequences were 
obtained. Simulated hydrolysis was performed with cDNA sequences by a software package 
called Peptidemap (http://prowl.rockefeller.edu/prowl/peptidemap.html). The peptide 
sequences from the simulation were manually paired with peptide fragments from the pepsin 
hydrolysis and mass spectroscopy. The glycation sites, together with the types of glycation, 
were identified by overlapping the peptide fragments obtained from enzymatic hydrolysis 
simulation and mass spectrum (Moreno et al. 2008).  
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2.2.2.  Bioactivity characterisation 
2.2.2.1.  Cytotoxicity assay 
Cytotoxicity of sample was evaluated on MDCK cells with the published assay (Schmidtke 
et al., 2001). MDCK cells (2×104 cells per well) were plated at in 96-well flat-bottomed 
microtitre plates, and incubated for 2 d at 37°C in a 5% CO2 humidified incubator. After 
removal of the medium, 200 µL of medium with serial concentrations of samples were 
added. The cells were then incubated at 37°C for 72 h. Six duplicates were use for each 
sample concentration. 200 µL/well of medium was used as control.  
After the incubation, the supernatant was removed with pipette and the cells were washed 
with 300 µL sodium chloride saline for three times to remove dead cells. The cells were then 
fixed and stained with 50 µL of crystal violet (0.03%, w/v) in 20% methanol solution for 10 
mins. After washing with 300 µL of water for further 6 times, the stained cell monolayers 
were treated with 100 µL lysis buffer (0.898 g of sodium citrate and 1.25 mL of 1 N HCl in 
98.05 mL 47.5% ethanol) for 20 mins to elute the crystal violet. Finally, the absorbance of 
each well was measured by an ELISA reader (DG5031, Beijing) at 630 nm. Cell viability 
was evaluated by the percentage of the mean absorbance of each dilution to that of the 
background control:  
Cell survival rate = (mean O.D.sample / mean O.D.control) × 100% Equation 2.5 
The 50% cytotoxic concentration (CC50) was calculated by plotting cell survival rates at dose 
response curve, using EXCEL. 
2.2.2.2.  Infection of virus to MDCK cells 
Following established protocols (Levi, Beeor-tzahar & Amon 1995) (Sladowski et al. 1993), 
MDCK cells (105 cells/well) were plated in 96-well plates 24 h prior to virus infection. The 
medium was then replaced by 100 µL DMEM viral suspension containing approximate 50 
PFU (plaque forming units) influenza viruses, with or without serial concentrations of 
antiviral agents. As the control, 100 µl/well DMEM and sample solution were added to 6 
wells. The mixture of cells and viruses was incubated for 60 min at 33°C in a 5% CO2 
humidified incubator, to allow viruses’ attaching to cells. The supernatant was then carefully 
removed. The cells were washed with PBS for 3 times, before the culture medium was 
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added. The infected cultures were incubated at the same conditions as above for 3 d. The 
monolayer of cells was then washed with PBS to remove dead cells and the cell viability was 
determined by MTT assay.  
2.2.2.3.  Colourimetric MTT assay  
The cell proliferation was determined with MTT assay as reported (Loosdrecht et al. 1994). 
In this method, the yellow tetrazolium salt (MTT) is reduced to form insoluble purple 
formazan crystals by the metabolically active cells. The formazan crystals are dissolved in 
DMSO and applied for the absorbance quantification using spectrophotometre. The linear 
relationship between cell number and absorbance varies between different types of cells. It 
has to be established for each type of cells to enable an accurate and reliable quantification 
of the proliferation rates. Among the applications for the method are drug sensitivity/ 
resistance, cytotoxicity, response to growth stimulators, and cell activation/replication. 
Briefly, by the end of the cell incubation, 100 µL of MTT (3-[4,5-Dimethylthiazol-2-yl]-2,5-
diphenyltetrazolium bromide) solution (1 mg/mL in PBS, stored in dark at 2-8°C) was added 
to each well after the culture media was removed, and incubated at 37°C for 4 h. The MTT 
solution was then replaced by 150 µL DMSO. After thoroughly dissolving and mixing, the 
absorbance of each well was measured with an ELISA reader (DG5031) at 570 nm. The cell 
proliferation rate was calculated with Eq 2.6.  
Cell proliferation rate (%) = [(mean O.D.sample - mean O.D.control)/ mean O.D.control] × 100  
Equation 2.6 
2.2.2.4.  Growth of influenza viruses 
The viruses were grown in embryonated eggs to maintain their titres. The 10-day-old 
embryonated and pathogen-free eggs were purchased from local breeding farm. The eggs 
were placed in front of a light source one by one, in order to locate the allantoic cavity just 
next to the air sac, as shown in Fig 2.2. The location was marked with a marker pen.   
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Figure 2.2  Allantoic inoculation of influenza viruses (Racaniello 2009). 
The egg was sterilised with 75% ethonal solution before a hole (10×6 mm) was drilled at the 
top of the air sac. A small amount of virus inoculum (0.2 mL) was injected through the hole, 
which was sealed with a sterilised medical tape. Three eggs were used for each strain of 
viruses. The eggs were then incubated at 33°C for 3 d before harvest. A daily check on the 
viability of embryos was performed to abandon the embryos died within 24 h of inoculation. 
Before harvest, eggs were stored at 4°C overnight. The top part of egg was sterilised with 
75% ethanol solution. The shell of air sac and the membrane of allantoic cavity were 
removed with a medical tweezers. The allantoic fluid was sucked out with 10 mL Pasteur 
pipettes. Next, the fluid was centrifuged at 3000 rpm for 5 min to remove blood and cells. 
Haemagglutination was performed immediately to determine the HA titre of viruses (as 
described in Section 2.2.2.5 below). The HA titre of influenza A viruses H1N1/PR8 was 
1024, when that of H3N2 was 128. 
2.2.2.5.  Determination of anti-influenza virus activities of MRPs 
The antiviral effects of RIE MRPs, Arg-Glc MRPs and their purified components are 
investigated in vitro on H1N1 and H3N2 influenza viruses. This study was carried out in 
cooperating with Guangzhou Respiration Diseases Institute, China. 
The inhibitory effects of the MRPs on influenza virus were evaluated by the following 
methods: haemagglutination inhibition, influenza virus titration, MTT assay, plaque 
reduction assay. The details of these methods are given in the corresponding sections of this 
chapter. 
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2.2.2.6.  Haemagglutination Inhibition test (Micro-HI)  
Haemagglutinin (HA) on the influenza virus membrane can recognise and bind to its 
receptor, sialic acids, on the plasma membrane of erythrocytes, and subsequently induce the 
haemagglutination. By observing the degrees of haemagglutination, the inhibitory activity of 
MRPs on the HA-receptor binding was determined (Potter & Oxford 1979) (Arenas et al. 
1990). 
Fresh chick blood was collected using heparin as anticoagulants. The red blood cells were 
washed with normal saline for 3 times and collected by centrifuge at 1000 rpm for 10 min. 
The cells were re-suspended and diluted with normal saline (0.9% NaCl) to make an 1% 
(v/v) suspension, stored at 4°C before each test. The antiviral medicines, ribavirin (50 
mg/mL) and amatadine (1 mg/mL) were used as control. Influenza A viruses H1N1/PR8 and 
H3N2 were used in the tests. The suspensions of these two viruses were diluted with normal 
saline by 256 times and 32 times, respectively, to obtain working virus suspension (HA 
titre=4) for HA inhibition tests.  
Two-fold dilutions of samples were prepared by mixing 50 µL sample with 50 µL normal 
saline. The virus suspension (HA titre=4, 50 µL) was mixed with each dilution of samples, 
and stored at 4°C for 45 min. 50 µL 1% chicken red blood cells were then added and stirred, 
stored at 4°C for 30 min. A morphological observation was performed with a normal 
laboratory microscope. The results were presented as 4+, 3+, 2+, 1+, ±, -.  
2.2.2.7.  Plaque reduction assays 
The assay was performed according to previously reported protocol (Gaush & Smith 1968) 
(Burleson, Chambers & Wiedbrauk 1992) with some modifications. Briefly, MDCK cells 
were allowed to growth in 6-well plates for 2 days till the cells become confluent. After the 
culture medium was removed, cells were infected by 1 mL of the influenza viruses (50 PFU) 
in DMEM medium with or without antiviral agents. After incubation for 1 h at 33°C, the 
infection medium was replaced by 2 mL of medium containing 0.4% agarose. The normal 
cells were used as control in all tests. All of the cells were incubated for 72 h at 33°C and 
then stained overnight by 0.1% neutral red and 0.4% agarose in medium. 0.25% trypsin was 
included to improve the infection activity of the virus. Plaques were counted and the 
percentages of plaque inhibition were calculated with Eq 2.7. 
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Plaque inhibition rate (%) = [(control -sample)/ control] × 100    
         Equation 2.7 
2.2.2.8.  Scanning Electron Microscopy (SEM) 
The scanning electron microscope (SEM) scans the sample with a high-energy electron beam 
to generate a image of sample surface. It reveals the information about the sample regarding 
surface topography, composition and electrical conductivity, etc. This image is so precise 
that the disordering of HA spikes on the surface of viruses can be seen when the pH of their 
circumstance becomes acidic (Ruigrok et al. 1986) (Wharton et al. 1995). In the infection of 
influenza virus, the viral particles may be found on the surface of the host cells (i.e. MDCK 
cells in this study), either when the viruses are penetrating into or budding from the cells. 
These particles can be observed with SEM.  
MDCK cells were grown to confluence on polyethyleneimine-coated cover slips (10 mm 
diameter) in 24-well plastic tissue culture plates (16 mm well diameter). The administration 
of RIE (15 mg/mL) was carried out as described in Section 3.2.1.5 in order to observe the 
drug’s influence on different aspects of viral infection. Two incubating conditions were used 
in order to control the process of infection. To investigate the inhibitory effects of RIE on the 
viral cytopathic impacts, the cells were incubated with viruses at 33°C for 1 h, then the free 
viruses were removed and cells were incubated in 200 µL medium for further 6 h. To 
investigate RIE’s effects on virus binding, the cells were incubated with viruses at 4 °C for 1 
h and then the free viruses were removed. 
After being washed with PBS buffer for 3 times, the cells were fixed with 2.5% 
glutaraldehyde-2.0% paraformaldehyde in 0.1 M cacodylate buffer (pH 7.4) for 1 h at room 
temperature, and post-fixed with 1% OsO4 in the same buffer for 45 min, followed by 
thoroughly washing and dehydrating in ethanol, being treated with isoamyl acetate and dried 
to a critical point with HCP-2. The cells were mounted on stubs, coated with gold and 
observed with a scanning electron microscope (SEM; JSM5310/LV, JEOL). 
2.2.2.9.  Trypsin inhibition: BNPNA-based assay  
Trypsin inhibitory activities of RITIP1/2/3 were assayed by a BNPNA-based assay (Baker et 
al. 2009) (Smith et al. 1980) (McManus 1995). N-benzoyl-DL-arginine-p-nitroanilide 
(BAPNA) was purchased from Maikun Chemical Inc. (Shanghai, China). For control, 2 mL 
sample solution was mixted with 5 mL BAPNA solution (0.4 mg/mL in 0.1 M Tris-CaCl2 
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buffer, pH 8.2) and incubated at 37°C for 10 min. 2 mL of trypsin solution (20 µg/mL, in 1 
mM HCl) from porcine pancreas (Amersco Inc., OH, USA) and 1 mL acetic acid was added 
into the sample and BAPNA mixed solution. For the measurement of sample activity, the 
sample solution was mixed with trypsin at certain proportion. The pre-heated BAPNA (37°C, 
5 mL) was added and incubated at 37°C for 10 min. The acetic acid was added (1 mL) 
immediately to terminate the hydrolysis. Trypsin activity was monitored at 410 nm with a 
spectrophotometer (Model 752, Shanghai). The trypsin activity unit was defined as 1 unit per 
0.01 absorbance intensity. The inhibitory activity was presented as trypsin inhibitor units 
(TIU). The inhibition rate was calculated with Eq 2.8. 
Inhibition rate (%) = TIU/trypsin activity units×100   Equation 2.8 
 
2.2.2.10.  Enhancement of Arg-Glc MRPs on mechanical strength of cell 
membrane 
Incubation of Arg-Glc MRPs with erythrocytes 
Erythrocytes were separated from 10 mL blood (healthy female volunteer), in which EDTA 
was added to prevent haemaaggregation, by centrifuged at 350 g for 5 min. Cells were rinsed 
by 0.9% saline for 3 times and then diluted to 1% (by volume) suspension. The cells were 
sedimented from 1 mL 1% suspension by centrifuge, and then mixed with various 
concentration of Arg-Glc MRPs or arg+glc solution. The mixture of cells and sample was 
incubated at 37°C for 2 h, being stirred up every 15 min. The cells were sedimented again to 
remove the supernatant, and washed with saline for 3 times until resuspended in low osmotic 
pressure solution at 37°C for 1 h. The LDH activity and haemoglobin content of supernatant 
were determined.  
Lactate Dehydrogenase (LDH) Assay  
LDH assays performed here is to assess LDH released into the media as a marker of dead 
cells. The supernatant of erythrocytes was tested for the LDH activity by following the 
referenced protocol (Wu et al. 1992) (Watanabe 1995). 
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2.2.3.  Membrane biophysical studies 
2.2.3.1.  Langmuir balance 
Lipid monolayers were assembled using a Langmuir film balance (NIMA Technology, 
Coventry, UK) to measure the area per lipid molecule at constant surface pressure or surface 
tension change when the area of lipid monolayers was reduced gradually. 24 µg of lipid was 
used to form the monolayer. The surface pressure was set to 20 mN/m. The barrier speed 
was set to 200 cm2/min. In experiments with MRPs, until the formation of lipid monolayer, 
RIE-MRPs were dissolved in pH7.4, 0.1 mol/L PB and transferred to the subphase by 
pipetting the solution underneath the trough barrier, to provide a final subphase 
concentration of 300 µM. The barrier movement was programmed to maintain the initial 
surface pressure, and we recorded any changes in surface area. 
2.2.3.2.  Neutron diffraction 
Neutrons are particles bound to the atomic nucleus of almost all atoms. Free neutrons 
produced by a nuclear reactor, or spallation source, can exhibit wave phenomena like 
diffraction. Diffraction occurs when waves encounter obstacles of a comparable size to their 
wavelength. By slowing down a neutron beam emanating from a reactor, the wavelength of 
the beam can be adjusted to about one Ångström, so that they can be used to conduct a 
diffraction experiment. For a sample with the regular structure, i.e. the lamellar bilayers in a 
multibialayer stack, the scattering would occur at well-defined angles (θ) according to 
Bragg's law (Bragg 1913). 
Sample Preparation 
Lipids were purchased from Avanti Polar Lipids or Sigma. 20 mg samples were dissolved in 
chloroform and deposit onto quartz microscope slides by a nitrogen-propelled artist's 
airbrush. The slides were then placed in a vacuum over for 2 h in order to remove all traces 
of the solvent. Samples were hydrated in a humid atmosphere with water contained 8.06% or 
25% 2H2O. The samples were protected from light whenever possible in order to reduce the 




Figure 2.3  Constructive and destructive wave interference.  
According to the angle of deviation (2θ), the resulting phase shift causes constructive (left) or 
destructive (right) interference (Wikipedia 2010). The interference is constructive when the phase 
shift is a multiple of 2π, which can be used to re-construct the lipid packing in the bilayers.  
 
Constructive interference on the phospholipid bilayers can be expressed by Bragg's law 
(Yeagle 1993). The lattice spacing of a multibilayer stack can be calculated from Eq 2.9.  
nλ = 2d×Sinθ       Equation 2.9 
 
where n is an integer, λ is the wavelength of the incident beam (i.e. neutron, X-ray), d is the 
lattice spacing between the planes of bilayers, and θ is the angle between the incident ray 
and the scattering planes. 
Data collection 
Neutron-diffraction measurements were carried out on the D16 membrane diffractometer at 
the Institut Laue et Langevin, Grenoble, France, or the V1 membrane diffractometer at the 
BENSC, Helmholtz Zentrum Berlin, Germany. Humidity control was achieved by changing 
the temperature of the sample can (at the ILL) or changing the saturated salts solutions in the 
sample can (at BENSC). At the ILL, the difference between the ambient temperature in the 
sample can and the temperature of water slots at the bottom of the sample can was adjusted 
individually with water baths. 
Each sample was quickly transferred straight from a humid tube into the sample can. After a 
minimum 6 h equilibration, a series of continuous θ-2θ scans were initiated (from θ= 1.5° to 
20.0° for DOPC, 1.8° to 16.0° for DMPC). The samples were run at 298 ~ 303 K for DOPC, 
and at 310K for DMPC.  
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Data analysis 
The two-dimensional array of detector counts for each frame of data was corrected for 
variations in pixel response. The complete set of frames from each scan were then collapsed 
into a linear spectrum and combined to generate a pseudo θ-2θ scan. All the analysis at this 
stage were carried out by the software LAMP on D16 or CARESS on V1. The background 
around each peak was fitted and subtracted using PeakFit (Systat Software Inc., USA) or 
Igor Pro (Version 6.0, WaveMetrics Inc., Oregon, USA). Gaussian distributions were then 
fitted to the Bragg reflections and the angular position, width and area of each peak 
recorded. Absorption and Lorentz corrections were applied and the square-root of the 
intensities taken to produce the structure factor amplitudes. 
 
Figure 2.4  Schematic representation of the V1 neutron membrane diffractometer.  
Picture from BENSC website (Hauss 2010). 
 
2.2.3.3.  Differential Scanning Calorimetry 
Dry the lipid   
The concentration of DMPC and DOPE-Me were 100 mM, including various MRPs 
concentrations ranging from 100:0 to 100:100 by molar ratio. Lipids were dissolved in 500 
µL chloroform and vortexed with certain amount of MRPs aqueous solution thoroughly. The 
suspension of lipids and MRPs were then sonicated for several minutes until the mixture 
become translucent. The chloroform and water was evaporated under nitrogen immediately 
and left in vacuum for at least 2 h to remove the traces of solvent.    
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Rehydration  
The dried lipids and MRPs were rehydrated with buffer (pH 7.4, 20 mM PIPES + 1 mM 
EDTA + 150 mM Sodium Chloride + 0.3 mM Sodium Azide) at 40°C. A cycle of vortex-
sonicating-liquid nitrogen freezing-thawing of rehydrated lipid suspension was repeated for 
6 times to improve the alignment of lipid packaging in MLVs.  
Measurement  
The suspension was then sealed with a press in an aluminium pan. The weight of pan was 
recorded before and after sealing, which allows the amount of lipids in the pan to be 
calculated by its weight accurately. A Pyris 1 differential scanning calorimeter (Perkin 
Elmer, US) was employed, at a scan rate of 40 °C/min. 30 µL of sample was sealed in a pan 
which could hold a maximum volume of 50 µL. Heating scans were performed in a range of 
-30°C to 85°C (Epand et al. 2005), but varied between different lipids. The transition 
temperature (initial temperature) and delta Hf was measured and calculated by Pyris data 
analysis software (Version 7.0.0.0110, 2004, Perkin Elmer Inc.), which recognizes transition 
peak with Gaussian distribution and does a automatic calculation of initial temperature and 
ΔHf, according to the thermal consumption of MLVs and the weight of lipids in the chamber. 
2.2.3.4. Laurdan fluorescence spectroscopy 
Multilamellar vesicles (MLVs) and small unilamellar vesicles (SUVs) were prepared. 5 
mol% of Laurdan were added into lipids (at a concentration of 50μM). After equilibration 
at 37°C for 1 h, measurements were carried out by a FLUOROMAX-3 spectrofluoro-
photometer (JOBIN YVON, Horiba, Japan). The generalised polarisation (GP) of excitation 
at 350 nm was calculated by Eq 2.10, where Ig and Ilc are the steady-state emission intensities 
at 440 nm and 490 nm, respectively (Ashley et al. 2006) (Parasassi et al. 1990). 
GP = (Ig- Ilc)/(Ig + Ilc)       Equation 2.10 
 
2.2.3.5.  Merocyanine 540 anistropic fluorescence spectroscopy 
Steady-state MC540 anisotropy measurements were obtained by a fluorometer (Xe-900, 
Edinburgh Analytical Instrument) equipped with polarisers. The slit of laser light was set at 
2 mm, the excitation slits was 2 mm and the emission slits was set at 5-6 mm in order to 
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receive enough counts for calculation. MLVs of DMPC and DOPC were prepared as 
described previously. Lipids and MC540 were dried by nitrogen stream in the tube and put in 
vacuum overnight to remove trace of solvent, then was re-hydrated and diluted to proper 
concentration right before applying to fluorometer. MRPs was added into the system after re-
hydration. Sample should be avoided from lights during the preparation. The measurement 
was carried out at 37°C. Each sample was calibrated in the cuvette for 5 min to reach the 
temperature. The intensity at both 90° and 0° was used for calculating G value and r, by the 
formula as below.  
G = IHV/IHH,  H: horizontal, 90°; V: vertical, 0°   Equation 2.11 
 r = (I0-GI90)/(I0+2GI90)      Equation 2.12 
 
2.2.3.6.  X-Ray diffraction 
Two methods, small angle X-ray scattering (SAXS) and lamellar X-ray diffraction (LXD), 
were employed to investigate the effects of MRPs and/or SIV fusion peptide on the phase 
transition and structural transforming of lipid bilayers. In SAXS, the elastic scattering of X-
rays (wavelength 1~2 Å) on a homogeneous sample is monitored at very low angles, 
typically ranged from 0.1° to 10°. SAXS is capable of analysing the structure of 
macromolecules with a size between 50 and 250 Å. It may be applied to study the structure 
of phospholipid multilayers. The resulting scattering profiles contain structural information 
including the shape and size of lipids, characteristic distances of lipid leaflets, thickness of 
the water layer, and other data (Glatter & Kratky 1982). In contrast to neutron diffraction, 
SAXS provides a way of observing the real-state structure and phase behavior of lipids in 
liposome dispersion.  
LXD has been successfully used to measure the size of the hydrophobic region of DLPC 
bilayers (Hung & Chen 2003), and peptide-induced pore formation (Chen, Lee & Huang 
2003). It differs from SAXS. Instead of controlling the phase transition by adjusting the 
temperature, the humidity was adjusted to induce the transition. This provides steady-state 
structural information of lipid bilayers under various levels of hydration.  
The details of SAXS and LXD measurements are given in Section 8.2.  
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Figure 2.5 Principle of the SAXS experiments on lipid bilayers.  
The liposomal dispersion (MLVs) is exposed to X-rays and the scattering intensity is recorded as a 
function of the scattering vector. The structural information was obtained through the electron density 
profiles by analysing the diffraction pattern (Rappolt & Pabst 2008). 
 
2.2.4.  Data analysis and statistics  
Results will be generally derived from at least three independent experiments. Means±S.D. 
will be calculated and groups of data will be compared using Student’s t test. Statistical 
significance and high significance will be set at P < 0.05 and P < 0.01, respectively. The 




CHAPTER 3    
 
THE INHIBITORY EFFECTS OF RIE MRPS ON INFLUENZA 




3.1.  AIMS OF THIS CHAPTER 
As an officially approved Chinese herbal medicine by the State Food and Drug 
Administration of China, the aqueous extracts of Isatis indigotica Fort. have been used to 
treat various viral infections and diseases, particularly seasonal flu. Its anti-influenza virus 
effects have been the subjects of pharmacological studies in vitro and in vivo (Jin et al. 2007) 
(Liu, Li & Jiang 2008) (Wang et al. 2009) (Li et al. 2009). However, due to the complexity 
of its chemical composition and the numerous chemical changes that occur during the 
heating process involved in its production, little is known about the mechanism of its 
antiviral activity nor the effective components.  
Among the studies reported so far, different strategies have been employed to investigate the 
actions of the roots on influenza virus infection. For example, Hu et al. measured the lectin 
activity of the roots and its capacity to inhibit haemagglutination (Hu & Zheng 2003). Li et 
al. tested the direct effects of the herb on infectivity of influenza A by culturing the viruses 
in chick embryos in the presence of herbal extracts (Li et al. 2009). However, the results 
were not conclusive about the in vivo antiviral mechanism of the roots preparations.   
Two questions have to be addressed. Firstly, what is the major target of the action of RIE, 
the host cells or viral particles? The infectious cycle involves a serial of interactions, 
reactions and key stages, which have been targeted by some well-known antiviral agents (Fig 
3.1). For instance, Tamiflu targets the repackaging and release of viral particles from their 
host cells (Moscona 2005), and has become a major antiviral drug against the worldwide 
threats of H5N1 avian flu and H1N1 swine flu. Amantadine is another option of fighting 
against seasonal flu epidemic. It targets two stages (Whittaker 2001), the un-coating of the 
genetic material and the synthesis of viral proteins (Schmidtke & Bauer 2006). Apart from 
basing on a number of biochemical pathways, the antiviral drugs act either on cells or on 
viruses. Before understanding the molecular mechanism of RIE’s antiviral actions, we have 
to distinguish the target at the cell-virus level.  
Secondly, what is the impact of the heating process on the efficacy of RIE? In another 
words, are the chemical reactions that occur during the preparation of the herbal decoction 
important to the medicinal function of RIE? The fresh roots contain hundreds of active 
compounds. The sun-dried roots and their boiling water extracts may contain even more due 
to the heating process of preparation. Before trying to isolate the major effective 
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components, it is necessary to determine which category of compounds has the stronger 
antiviral activity, native or modified compounds.  
In this chapter, these two questions are addressed by testing the cell viability of Madin-
Darby canine kidney (MDCK) cells infected with different subtypes of influenza virus, by 
studying the inhibition of haemagglutination by herbal extracts, and by looking at the 
inhibitory effects on viral replication. The MDCK cell study should be able to identify the 
main target of RIE activity as either cells or virusal particles by comparing RIE’s efficacy 
when it is applied at different stage of virus infectious life cycle. Three kinds of extracts 
were prepared respectively from fresh roots, sun-dried roots and 7-day incubated roots and 
examined for their antiviral activities, in order to determine the impacts of the heating 
process on RIE’s therapeutic functions.  
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3.2.  THE ANTI-INFLUENZA VIRUS EFFECT OF RIE ON MDCK CELLS 
AND ITS HYPOTHESIZED MECHANISM 
In earlier work (Wu 2005) (Chen et al. 2006), RIE was demonstrated to prevent influenza A 
virus induced haemagglutination. Furthermore, capillary electrophoresis of erythrocytes 
revealed remarkable changes in the electrical charge of erythrocyte membranes (Lu et al. 
2003) and implied that RIE’s anti-haemagglutination is possibly due to interaction with 
erythrocytes rather than influenza virus. However, this conclusion cannot be extrapolated to 
RIE’s antiviral action because inhibition of haemagglutination is not fully equivalent to 
antiviral activity. The influence of RIE treatments on viral infection was investigated with 
MDCK cells by MTT assays, plaque reduction assays and scanning electron microscopy. 
The target of RIE’s antiviral action was identified, and the results are reported here. 
 
3.2.1.  Materials and Methods 
3.2.1.1.  Preparation of RIE 
RIE was prepared as described in Section 2.1.1.   
3.2.1.2.  Viruses  
Influenza viruses used in this study were cultured as described in Section 2.1.4.   
3.2.1.3.  Cytotoxicity measurement 
Madin-Darby canine kidney (MDCK) cells were cultured as described in Section 2.1.5. 
Cytotoxicity of RIE was measured as described in Section 2.2.2.1.  
3.2.1.4.  Antiviral effects of RIE in vitro 
MDCK cells were infected by viruses as described in Section 2.2.2.2.  
Two methods were employed to evaluate the antiviral activity of RIE in vitro: 1) increases in 
the survival rates of MDCK cells determined by MTT assay; 2) plaque reduction assay. The 
EC50 values were calculated by Reed-Muench method (Reed & Muench 1938). 
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1) Cell protection rate measured by colourimetric MTT assay 
After virus infection with or without prior RIE administration (1 h at 33°C), the cell 
monolayer was washed by PBS, and cultured in medium for 3 d. 100 µL of MTT (3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) solution (1 mg/mL in PBS) was 
added to each well and incubated for 4 h, and then replaced by 150 µL isopropanol. After 
thorough dissolving, the absorbance of each well was measured by an ELISA reader 
(DG5031) at 540 nm. The normal MDCK cells and viruses infected cells were used as 
controls. Five duplicates were used for each group. The cell protection rate was calculated by 
means of absorbance with Eq 3.1. 
Cells protection rate (%)=(O.D.VR－O.D.V)/(O.D.R－O.D.V)×100％ Equation 3.1 
O.D.VR = Virus and RIE; O.D.V = Virus only; O.D.R = RIE only 
2) Plaque reduction assay 
The assay was performed as described in Section 2.2.2.4. RIE was hired as antiviral agent. 
3.2.1.5.  Comparison of RIE inhibitory effects on viral infection at different 
timing of viral replication cycle 
The infectious cycle of an enveloped virus primarily involves four phases: binding to a 
receptor on the membrane, membrane fusion or entry, replication and assembly, and budding 
(Fig 3.1). However, the methods mentioned above are not able to identify in which phase the 
antiviral agent acts. In order to distinguish at which phase of virus infection is affected, RIE 
was introduced to cells or viruses at three different time points corresponding to phases of 
virus infection. Cells were allocated to three groups, as described below, in order to observe 
the effects of RIE at each time point. The EC50 of RIE (50 mg/mL) was used for both of 
influenza virus A (H1N1) and B. RIE was incubated with cells or viruses for 3 h. Virus 
infection was performed as described in Section 2.2.2.2. The cell viability was determined 
by MTT assay after 3 day’s culture, using normal cells and infected cells as control. 
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Figure 3.1 Schematic representation of replication cycle of an influenza virus and the possible targets 
of RIE.  
Adapted from Whittaker’s diagram (Whittaker 2001).   
 
1) Protection group (C+RIE+IA or C+RIE+IB in Fig. 3.4A )* 
Cells were incubated with RIE for 3 h at 33°C in cell incubator, prior to exposure to viruses 
(50 PFU) at 33°C for 1 h.  After incubating with RIE, cells were washed twice with PBS 
buffer to remove free RIE. Cell culture medium was then added. 
2) Repair group (C+IA+RIE and C+IB+RIE in Fig. 3.4B)* 
Cells were incubated with virus at 33°C for 1 h, to allow viral infection to occur. The cells 
were then washed twice with PBS buffer to remove any free viruses in the supernatant, 
before incubating with RIE for 3 h at 33°C. The cells were washed twice with PBS buffer 
again to remove the free RIE, then cell culture medium was added. 
3) Direct action group (IA+RIE+C and IA+RIE+C in Fig. 3.4C)** 
                                                
* ‘IA’ refers to Influenza A FM1 (H1N1, mouse-adapted) virus, ‘IB’ refers to influenza 
B/Shanghai/93-1(C3C2, 1:320 9/2/99), ‘C’ refers to MDCK cells. 
RIE 
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The viruses were incubated with RIE at 33°C for 3 h to allow any direct action of RIE to 
occur. After that, the mixture was centrifuged at 100,000 g for 90 min at 4°C. The 
sedimented virus was suspended again with PBS buffer and introduced to cells at 33°C for 1 
h to allow the occurring of viral infection. The suspension was thoroughly removed, then the 
cells were washed twice with PBS and the culture medium was added.    
 
3.2.1.6.  Scanning electron microscopy   
MDCK cells were grown to confluence on polyethyleneimine-coated cover slips (10 mm 
diameter) in 24-well plastic tissue culture plates (16 mm well diameter). The administration 
of RIE (15 mg/mL) was carried out as described in Section 3.2.1.5. in order to observe the 
drug’s influence on different aspects of viral infection, two incubating conditions were used 
in order to control the process of infection. To investigate the inhibitory effects of RIE on the 
viral cytopathic impacts, the cells were incubated with viruses at 33°C for 1 h, then the free 
viruses were removed and cells were incubated in 200 µL medium for further 6 h. To 
investigate RIE’s effects on virus binding, the cells were incubated with viruses at 4°C for 1 
h and then the free viruses were removed. 
After being washed with PBS buffer for 3 times, the cells were fixed with 2.5% 
glutaraldehyde-2.0% paraformaldehyde in 0.1 M cacodylate buffer (pH 7.4) for 1 h at room 
temperature, and post-fixed with 1% OsO4 in the same buffer for 45 min, followed by 
thoroughly washing and dehydrating in ethanol, being treated with isoamyl acetate and dried 
to a critical point with HCP-2. The cells were mounted on stubs, coated with gold and 
observed with a scanning electron microscope (SEM; JSM5310/LV, JEOL). 
 
3.2.2.  Results  
3.2.2.1.  Cytotoxicity results 
In order to evaluate the potential cytotoxic effects of RIE on cells, MDCK cells were 
incubated with RIE for 72 h before the cell survival rate was measured with MTT assay. As 
shown in Fig 3.2, at low concentrations of RIE, ranging from 1 mg/mL to 10 mg/mL, the cell 
survival rates were not significantly different to that of normal cells. The lowest cell survival 
rate of all assayed RIE concentrations was 53% (at 100 mg/mL). There is a significant 
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decrease in the cell survival rates when the concentration of RIE rises from 40 to 100 
mg/mL. Therefore, the 50% cytotoxic concentration in MDCK cells was higher than the 
maximum assayed concentration (100 mg/mL) of RIE. These results indicate that RIE has a 
low cytotoxicity to MDCK cells, when no cytotoxicity was observed at concentration lower 
than 10 mg/mL.  
 
Figure 3.2  Cytotoxic effect of RIE on the MDCK cells.  
The cells incubated with RIE at the serial concentration were marked as (■). The control group was 
marked as (●). n=6; RIE=1 mg/mL, P>0.05; RIE=10 mg/mL, P<0.05; others, P<0.01.  
 
3.2.2.2.  In vitro antiviral activity of RIE 
Is RIE effective on a single strain of influenza viruses or on different types of viruses? To 
answer this question, the protective effects of RIE on two different strains of influenza A 
viruses and one strain of influenza B virus were evaluated and compared, in terms of cell 
protection rate and plaque inhibition rate. RIE inhibited all three influenza virus strains. As 
shown in Fig 3.3A and B, the EC50 values of RIE’s protection effects on MDCK cells against 
infection of viruses are 12.6 mg/mL for influenza A FM1, 17.6 mg/mL for influenza A 
H1N1 and 47.1 mg/mL for influenza B, measured by MTT assay. Influenza B viruses 
requested the highest concentration of RIE.   
Similar results were achieved by plaque reduction assay. The EC50 values were 13.6 mg/mL, 
19.0 mg/mL and 50.1 mg/mL, for influenza A FM1, H1N1 and influenza B viruses, 
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respectively. Generally, the two influenza A viruses appeared more sensitive to the inhibition 
of RIE than did the influenza B virus. But there is no significant difference on the inhibitory 
effects of RIE in the mechanism studies shown below (Fig 3.4). The different impacts of RIE 
on influenza A and B viruses warrants further study. Since the EC50 of influenza B virus was 
around 50 mg/mL, the following mechanism studies of the RIE’s antiviral effects on both of 
influenza virus A and B were conducted at this concentration. Moreover, in this test, the 
incubation of 100 mg/mL RIE with cells and influenza A virus together for 1 h at 33°C raise 
the cells survival rate up to 91%. This result indicates the short time exposure of cells to RIE 
conducts much less cyto-toxicity than the 72 h incubation employed in the cytotoxicity tests. 




A.  Effects of RIE pre-treatment on the cell survival rate, measured by MTT assay. 
 
B.  Inhibitory effects of RIE pre-treatment on plaque formation measured by the plaque reduction 
assay. 
Figure 3.3  Anti-influenza virus effects of RIE on MDCK cells.  
Three strains of influenza virus were used in the experiments: influenza A FM1 (H1N1, mouse-
adapted) virus (●) and influenza A/Beijing/95-262(H1N1/C2E3, 1:640 8/2/99) (■) (n=6. RIE=1.0 
mg/mL, P>0.05; others, P<0.01); influenza virus B/Shanghai/93-1(C3C2, 1:320 9/2/99) (▲) (n=6. 
RIE=1.0 mg/mL, P>0.05; RIE=10 mg/mL and 20 mg/mL, P<0.05; others, P<0.01) 
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3.2.2.3.  In vitro anti-viral mechanism studies on RIE: cell viability study  
The infectious cycle of an enveloped virus primarily involves four steps: binding, fusion or 
entry, replication and budding, which together provide several opportunities for viral 
inhibition. Antiviral agents act on either host cells or viruses to achieve the inhibitory effects 
on viral infectious cycle. For example, some antibodies inhibit the attachment of viruses to 
cells (Ugolini et al. 1997) (Reading & Dimmock 2007) (Klasse & Sattentau 2002). 
Peptidylchloroalkylketone inhibitors prevent the fusion event by inhibiting cleavage of the 
precursor of HA (Tashiro & Rott 1996); as shown in Fig 3.1, the approved drugs amantadine 
and rimantadine can stop viral particles releasing into the cytoplasm by inhibiting the 
uncoating of viral particles (Pinto & Lamb 2007) (Ilyushina et al. 2007) (Duff 1992); 
neuraminidase inhibitor, i.e. Tamiflu, prevents the budding of progeny virus from the cell 
membrane (Gubareva, Webster & Hayden 2002) (Moscona 2005). 
To understand the molecular mechanism of RIE’s antiviral activity, the targets of RIE’s 
action have to be firstly narrowed down to either cells or viruses. MRPs are possibly the 
major composition of RIE, like in a big population of traditional Chinese herbal medicines. 
Another TCM herbal tonic, namely MCE, has shown its cyto-protective effects on pancreatic 
islet cells (Xiang et al. 2007). It has been revealed that MRPs forms a significant amount of 
components of MCE (Ke et al. 2010). Sharing MRPs as a mutual composition with MCE, 
RIE is assumed to have cyto-protective effects on virus host cells. To illuminate the 
assumption, RIE was applied to cells or viruses according to three different phases of viral 
replication cycle, as described in Section 3.2.1.5.  
It is important to notice that the efficacy of RIE depends on when it was introduced to cells 
and viruses, as shown in Fig 3.4. In contrast with virus-infected cells, only the ‘protection 
group’ achieved a significant improvement on cell survival rates among the three groups. 
When RIE was introduced to cells after virus binding to cells (referred to as ‘repair group’, 
shown in Fig 3.4B), the cell survival rates were only 29 ± 2% in influenza A and 41 ± 8% in 
influenza B, and were not significantly different from controls of viruses infected cells.  
However, the same figures were almost doubled if RIE was introduced to cells prior to the 
viruses’ appearance (referred to as ‘protection group’, shown in Fig 3.4A). The cell survival 
rates were 63 ± 6% to influenza A viruses and 65 ± 14% to influenza B viruses, respectively 
(P< 0.01). It is about two third of cells remained uninfected in both types of influenza 
viruses, which is a remarkable protection effect. At the same time, much fewer virus 
particles appeared on the surface of RIE pre-treated cells than on the cells without RIE 
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treatment (counted by SEM, see Section 3.2.2.4). There was no direct action of RIE on both 
strains of viruses, because direct incubating RIE and viruses together didn’t neutralise the 
infectivity of viruses. Corresponding with cell survival rates, the virus titres in suspensions 
measured by the haemagglutination assay, only decreased in the ‘protection group’ of cells 
(data not shown, but available on request). 
3.2.2.4.  In vitro anti-viral mechanism studies on RIE: morphological study 
The cytopathic effect (CPE) of MDCK cells was observed by scanning electron microscopy 
(SEM). As shown in Fig 3.5, CPE appeared in the influenza virus infected MDCK cells (Fig 
3.5B) and the cells of ‘repair group’ and ‘direct action group’ (Fig 3.5C&D). In contrast, 
there is no CPE observed in the cells from the ‘protection group’, in which cells were 
incubated with RIE (15 mg/mL) prior to virus infection (Fig. 3.5A). This is consistent with 
RIE’s protection effects, as described in the last section, on cell viability against virus 
infection, investigating with MTT assay. 
In addition, the cells were incubated with the same amount of virus at 4°C for 1 h. The 
suspending viruses were then removed by a thorough washing with PBS. The electronic 
micrographs were taken immediately (Fig 3.5E&F). At this time point and temperature, 
viruses had been associated to cell membrane, but not yet internalised (Matlin et al., 1981). 
Numerous virus particles (arrows) bound to the MDCK cell plasma membrane in the 
absence of RIE (Fig 3.5F). On the contrary, attached virus particles were rarely observed on 





Figure 3.4  In vitro protective effects of RIE on MDCK cells against influenza viruses.  
Influenza A H1N1 (mouse-adapted) virus was used in IA, while influenza B/Shanghai/93-1(C3C2, 
1:320 9/2/99) was used in IB. 50 mg/mL of RIE was used in all of the groups. Normal MDCK cells 
(C) and cells infected by viruses (C+IA, C+IB) were used as controls. Both of the IA, and IB groups 
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Figure 3.5  Scanning electron micrographs of MDCK cells infected with 50 PFU influenza A H1N1 
(mouse-adapted) virus (IA) in the time point-depended RIE administration experiments.  
A: ‘Protection group’, cell grown at 33°C, magnified ×2000;  
B: ‘Virus infected Control’, the virus infected cells, grown at 33°C, magnified ×2000;  
C: ‘Repair group’, cells grown at 33°C, magnified ×5000;  
D: ‘Direct action group’, cells grown at 33°C, magnified ×5000; 
E: ‘Protection group’, cells were incubated with viruses at 4°C, magnified ×350;  
F: ‘Virus bound cells’, cells were incubated with viruses at 4°C, magnified ×350;  
Arrows: virus particles binding to the microvilli and other parts of plasma membrane. (These photos 
were scanned by a Flat Scanner, Acer S2W 3300U, using Adobe Photoshop 6.0) 
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3.2.3.  Conclusions and Discussions 
RIE and its MRPs are effective in vitro in inhibiting viral infections caused by two subtypes 
of viruses, influenza A (H1N1) viruses and influenza B viruses, on Madin-Darby Canine 
Kidney (MDCK) cells. RIE promoted the proliferation of both normal and virus infected 
cells, reduced plaque formation and blocked virus entry across the membrane. A very low 
cytotoxicity of RIE was observed on MDCK cells (CC50 > 100 mg/mL).  
As described in 3.2.2.3, three assumptions are drawn from the results.   
Firstly, as RIE failed to prevent viral infection by direct actions on viruses and neutralising 
them, RIE is assumed to act on MDCK cells rather than influenza viruses.  
Secondly, RIE can bind to cell plasma membrane or enter cell plasma and affect the early 
events of viral infection, such as binding and fusion of membrane, uncoating of virus 
particles in cytoplasm. As any free RIE was thoroughly washed off after incubation with 
cells in all three groups, only those RIE who bound to the cell plasma membrane or 
internalised into the cell plasma would contribute to the rise of cell survival rates. 
Furthermore, because of the stronger effects of ‘protection group’ than ‘repair group’, it is 
crucial for RIE to participate cell-virus interaction in an early stage, particular prior to the 
presence of viruses.  
Thirdly, RIE probably binds to, and acts on, the cell’s plasma membrane. This is because, if 
internalisation of RIE made an equal contribution to its inhibitory effects, the RIE treatment 
after virus infection (‘repair group’) should have resulted more positively than it did. This 
assumption is supported by the inhibitory effects of RIE on haemagglutination induced by 
influenza A viruses (Chen et al. 2006), in the same manner with results from MDCK cells. 
Haemagglutination is a result of the binding of viral envelope glycoprotein haemagglutinin 
(HA) to its plasma membrane receptors, sialic acid residues of glycolipids (Thompson, 
Barclay & Zambon 2004) (Cox & Subbarao 1999). Since direct treatment of RIE to virus did 
not decrease the infectivity and haemagglutination of virus, it is more confident to assume 
that cell plasma membrane, instead of the membrane of virus, is the target of RIE.  
Hence, the inhibitory effects of RIE on viral infection may be confined to the binding and 
fusion stage of infection. RIE may mainly work on the plasma membrane of MDCK cells to 
inhibit the binding and fusion process of virus. This assumption is supported by SEM studies 
assayed, in which very few virus particles were seen to bind to the RIE incubated MDCK 
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cells. There are two kinds of possible binding sites for RIE on the plasma membrane, 
membrane lipids or membrane glycoproteins. However, due to its high EC50 value and 
extraordinarily low cytotoxicity, RIE is assumed to act on cell membrane not through the 
ligand-receptor pattern. Membrane lipids are therefore most possibly the binding sites for 
RIE.  
The EC50 of RIE ranges from 12.6 to 50.1 mg/mL, which seems too high to be an efficient 
antiviral agent. However, two factors have to be taken into account.  
Firstly, the evaluation assay of EC50 employed in this study was not optimal method, due to 
the cell protection model of RIE. Pre-treatment of cells with RIE is obligated to achieve the 
maximum protection effects. However, during EC50 evaluation, RIE was introduced to cells 
with the virus together instead of prior to virus incubation. The EC50 of RIE obtained by this 
method is undervalued.   
Secondly, as a mixture, RIE contains hundreds of compounds, within which the proportion 
of the effective ingredients is expected to be low. The EC50 of the effective compositions 
will not be determined accurately until the compositions are purified.  
Both of these two factors may diminish the efficacy of RIE and consequently requires a high 
effective concentration. A new method, in accordance with RIE’s virus binding inhibitor 
property, should be established for further studies to appropriately quantified inhibitory 
effects of RIE on virus infection.  
Based on the observation above, effective components in RIE, which are responsible for the 
anti-haemagglutination and anti-influenza effects, could be classified into two categories: 
native compounds from the fresh plant and modified compounds formed in the processing of 
plant material. The native compounds may include various active molecules like lectin or 
neuraminidase inhibitors, and are generally unstable to heat processing. Even if there is 
potent antiviral capacity among these native compositions, it is hard to believe they will 
survive through the boiling water extraction involved in the preparation of RIE. Taking 
lectin as an example, although the fresh roots contained lectin (Hu & Zheng 2003), which 
may inhibit haemagglutination, it would hardly remain active after the boiling water 
extraction. Furthermore, the fact that RIE’s EC50 on influenza virus A H1N1 is less than 20.0 
mg/mL while the effective concentration of isolated lectin on the same type of virus is 45.3 
mg/mL, indicates the lectin can not the effective antiviral component, at least not the major 
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one. Since the native compounds of roots cannot explain antiviral effects of RIE, it is 
worthwhile to study the modified compounds and their bioactivities. 
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3.3.  DIFFERENCES IN THE CYTOTOXICITIES AND ANTIVIRAL 
ACTIVITIES OF FRESH ROOTS, SUN-DRIED ROOTS AND RIE 
The previous section has shown that RIE inhibits influenza viruses by binding to cells and 
blocking the early events of influenza virus infectious cycle. However, as described in 
Section 1.2.4, none of compositions from fresh roots shows promising antiviral activities. 
Does RIE become effective only because it is a highly concentrated preparation of native 
compounds from the roots, or, because of the major chemical changes that occured in the 
heat extraction procedure?      
To answer this question, the cytotoxicity and anti-influenza virus tests were conducted on 
three preparations of the roots: the cold water (4°C) extracts of fresh roots; the cold water 
extracts of sun-dried roots; and the 7-d RIE, a boiling water extracts of 7-day incubated sun-
dried roots. The samples represent three typical intermediates of RIE preparation, and help to 
track the gradual evolution of chemical species and biological activities of the roots.  
3.3.1.  Materials and Methods 
3.3.1.1. Preparation of fresh roots extracts  
Fresh roots extracts were obtained by cold aqueous extraction at 4°C, eliminating the 
occurrence of Maillard reaction. The fresh roots were crushed into powder with a food 
grinder. 35 g of powder was suspended in 105 mL PBS buffer (0.01 mol/L, pH 7.2, 
Na2HPO4-NaH2PO4; 0.1 M NaCl), stirring overnight at 4°C. The supernatant (72 mL) was 
collected by centrifuging at 21,400 g for 15 min, and stored at -20°C before use. 
3.3.1.2. Preparation of Sun-dried roots extracts 
Sun-dried roots extracts were obtained by cold aqueous extraction at 4°C, eliminating the 
occurrence of Maillard reaction. The sun-dried roots were crushed into powder with a food 
grinder. 35 g of powder was suspended in 105 mL PBS buffer (0.01 mol/L, pH 7.2, 
Na2HPO4-NaH2PO4; 0.1 M NaCl), stirring overnight at 4°C. The supernatant (52 mL) was 
collected by centrifuging at 21,400 g for 15 min, and stored at -20°C before use. 
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3.3.1.3. Preparation of 7-d RIE 
7-d RIE was prepared as described here. 50 g of sun-dried roots was incubated at 60°C, 85% 
rh, for 7 days. The roots were then boiled in 400 mL pure water in a beaker for 2 h. The 
supernatant was collected by filtering with cotton gauze. The solid residues were boiled in 
400 mL pure water for 1 h. The supernatant was collected and combined with the previous 
supernatant, and then applied to centrifuge at 21,400 g, 15 min. The supernatant of 
centrifuge was collected and then diluted with pure water to 155 mL. Extracts were stored at 
-20°C before use.  
3.3.1.4. Ribavirin 
The antiviral drug, Ribavirin, was used as a control. Ribavirin was purchased from Henan 
Topfond Pharmaceutical Co., Ltd. and used without further purification.  
3.3.1.5.  Cytotoxicity measurement 
Madin-Darby canine kidney (MDCK) cells were cultured as described in Section 2.1.5. 
Cytotoxicity of RIE was measured as described in Section 2.2.2.1. Each of the RIE sample 
was diluted into a serial of concentrations for evaluation (1:3, 1:9, 1:27,…). TC0 and TC50 
were calculated accordingly by Reed-Muench method.  
3.3.1.6 Haemagglutination inhibition test  
The haemagglutination inhibition was conducted as described in Section 2.2.2.6.  
The HA titre of influenza A viruses H1N1/PR8 was 1024, when that of H3N2 was 128. This 
suspension of these two viruses was diluted with normal saline by 256 times and 32 times, 
respectively, to obtain working virus suspension (HA titre=4) for HA inhibition tests. Fresh 
chick blood was collected and made into 1% (v/v) suspension, stored at 4°C. 
Two-fold dilutions of the samples were prepared by mixing 50 µL sample solution with 50 
µL normal saline. The virus suspension (HA titre=4, 50 µL) was mixed with each dilution of 
samples, and stored at 4°C for 45 min. 50 µL 1% chicken red blood cells were then added 
and stirred, stored at 4°C for 30 min. Morphological observation was performed with a 
normal laboratory microscope. The results were presented as 4+, 3+, 2+, 1+, ±, −.  
4+: 100% of erythrocytes agglutinated. 
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3+: 75% of erythrocytes agglutinated. 
2+: 50% of erythrocytes agglutinated. 
1+: 25% of erythrocytes agglutinated. 
±: slightly agglutinated, less than 25% of erythrocytes. 
−: No visible agglutination. 
 
3.3.1.7.  Plaque reduction assays 
Plaque reduction measurement was performed as described in Section 2.2.2.7, with some 
modifications. MDCK cells were grown in 12-well plates, 2.5×105 cells per well. The 
experiments were conducted on confluent MDCK cell monolayers after 48 h. After removal 
of culture media, cell monolayers were wash with PBS to clean up bovine albumin from the 
media. Cells were then inoculated with 200 µL of 50 plaque forming units (pfu) virus 
suspension in test medium. Virus adsorption was carried out at 35°C, 5% CO2, for 2 h. The 
infectious medium was removed and the cell monolayers were overlaid with 1.5 mL DMEM 
medium containing 0.4% agar and serial concentrations of samples. Each concentration and 
control had in 3 duplicates. After agar aggregated, cells were incubated at 37°C, 5% CO2 for 
48-72 h. Plates were checked everyday for viral pathological changes. When the untreated 
virus control reach 4+, the testing medium was removed and cells were fixed with 10% 
formalin solution for 30 min.  Plates were then stained with crystal violet solution to count 
the number of plaques. The plaque forming units of each concentration were calculated with 
Eq 3.2. 
plaque forming units (pfu/mL) = (mean plaque number of each well) / (pfu of virus 
inoculation) × (dilution times)      Equation 3.2 
3.3.2.  Results 
3.3.2.1.  Impacts of heat processing on the cytotoxicity of the roots 
The cytotoxicities of three preparations of the roots were compared to evaluate the impacts 
of heat processing, meaning sun-drying (25°C - 40°C), incubating in humid circumstance 
and boiling (100°C), on the toxicity of RIE upon MDCK cells. As shown in Fig 3.6 and 
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Table 3.1, the cold water extracts of sun-dried roots and the boiling water extracts of 7-day 
incubated roots (namely 7-d RIE) present much lower toxicities than the cold water extracts 
of fresh roots and the control drug Ribavirin. TC0 of sun-dried roots extracts was 22 mg/mL, 
while TC50 of which was 35.5 mg/mL. 7-d RIE achieved the highest numbers on these two 
figures, which are 31.5 mg/mL and 62.5 mg/mL, indicating a lowest toxicity among the three 
roots samples. TC0 and TC50 of fresh roots extracts were 0.8 mg/mL and 2.4 mg/mL, 
respectively. Sun-drying made the major contribution to decrease of cytotoxicity by lowering 
the TC0 and TC50 by 15-25 times. On top of sun-drying, incubation at 60°C and boiling 
water extraction decreased the cytotoxicity even more, by 25-40 times comparing to that of 
fresh roots extracts. 
Ribavirin is a conventional antiviral drug, with an efficacy against a wide range of RNA and 
DNA viruses. TC0 of ribavirin conducted here was 1.6 mg/mL, which is consistent with 
previous report (Crance et al. 2003). Sun-dried roots extracts and 7-d RIE are less toxic than 
the Ribavirin, while the fresh roots extracts is more toxic than Ribavirin. However, it has to 
be born in mind that the concentrations of three samples were calculatedfrom the dry weight 
of roots, which contains a large portion of insoluble compositions. The concentrations of 
effective soluble compositions are less than the numbers represent as dry weight. In case of 
7-d RIE, 100 mg dry weight of roots is equal to 25.8 mg of soluble compositions.  
The results above imply that heat processing modifies ingredients in the roots and results in a 
much lower toxicity upon cells. The decrease on toxicity is correlative with strength of 
heating, including temperature and length of heating time. Furthermore, since Maillard 
reaction popularly occurred in the heat processing, as a major outcome, the formation of 
MRPs may contribute to the weakening of toxicity.  
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Figure 3.6  Mean dose-response curve of cytotoxicity determined with fresh roots extracts, sun-dried 
roots extracts and 7-d RIE by MTT assays on MDCK cells. (n=8, P<0.01) 
 
Table 3.1 The cytotoxicity of three types of the roots extracts 
 TC0 (dry weight mg/mL) TC50（dry weight mg/mL） 
Fresh roots extracts 0.8 2.4 
Sun-dried roots extracts 22.0 35.5 
7-d RIE 31.5 62.5 
Ribavirin 1.6 17.9 
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3.3.2.2.  Impacts of heat processing on the cytoprotective effects of the roots 
The capacities of fresh roots extracts, sun-dried roots extracts and 7-d RIE on preventing 
influenza A viruses induced cell death were examined on MDCK cells by MTT assay, and 
present as ‘cell protection rate’ in Fig 3.7. The concentrations of these samples were chosen 
on the basis of their TC0 values. The concentration gradient was started at a maximum value, 
at which no cytotoxicity was observed, and continued by diluting 2 times each for 7 
concentrations.  
As a control, ribavirin significantly protected cells from viral infection at most of the assayed 
concentrations. No cytoprotective effects were observed on this antiviral drug at 
concentrations lower than 0.03 mg/mL. The efficacy of Ribavirin proved the method is 
suitable for evaluating cell protective activity of the roots samples. 
In contrast to RIE’s enhancement of cell viability, the cold-water extracts of fresh roots 
induced an even more severe cell death in cooperating with viruses, than by viruses alone. 
Certain compounds from the raw roots must have promoted the infection of virus and caused 
cell death. The sun-dried roots extracts did not help much on improving the cell viability 
against viruses. However, at 20 mg/mL, a concentration very close to its TC0, the extracts 
slightly increased the cell survival rate. Being constant with results from cytotoxicity tests, 
7-d RIE had been helpful for cells to survive through viral infection. At concentrations 
higher than 4 mg/mL, 7-d RIE protected cells from virus-induced death, and reserved up to 
40% more cells at 32 mg/mL. The protection rates dropped along dilutions of the sample, 




Figure 3.7 Mean dose-response curve determined with fresh roots extracts, sun-dried roots extracts, 
7-d RIE and ribavirin by MTT assays in MDCK cell monolayers infected with influenza A viruses 
(H1N1). (n=4, P<0.01) 
 
3.3.2.3.  Impacts of heat processing on the haemagglutination inhibitory 
activities of the roots 
The conventional antiviral drugs studied, including ribavirin and amantadine, nearly 
conducted any inhibition on haemagglutinin of H1N1 and H3N2, except amantadine on 
H3N2 viruses induced haemagglutination at concentrations greater than 125 µg/mL. It is a 
very high concentration for amantadine. The maximum concentration of this drug was only 
25 µg/mL on a resistance study over 12 influenza A virus strains (Schmidtke & Bauer 2006).    
In general, haemagglutination inhibition was observed in all three aqueous extracts of the 
roots, upon two influenza A virus strains, while HI titre was increased corresponding to 
progress of heat processing. 7-d RIE presented the strongest HI titre 128 (as shown in Table 
3.2) on H1N1 viruses, which was more than 8 times higher than that of fresh roots extracts. 
The minimum effective concentration of 7-d RIE was 2.2 mg/mL (dry weight of roots). Sun-
dried roots extracts lied in between the fresh roots and 7-d RIE. However, 7-d RIE possessed 
a much weaker inhibition on H3N2 viruses induced haemagglutination at a HI titre of 16.  
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Table 3.2  Inhibition of haemagglutination induced by influenza A virus (H1N1)  
           Dilutions 
Samples 2 2
2 23 24 25 26 27 28 29 HI Titre 
Fresh roots 
extracts – – – 1+ 3+ 4+ 4+ 4+ 4+ 14 
Sun-dried roots 
extracts – – – – 1+ 2+ 4+ 4+ 4+ 28 
7-d RIE – – – – – – – 4+ 4+ 128 
Ribavirin – 4+ 4+ 4+ 4+ 4+ 4+ 4+ 4+ 2 
Amantadine 1+ 2+ 4+ 4+ 4+ 4+ 4+ 4+ 4+ ﹤4 
 
Table 3.3  Inhibition of haemagglutination induced by Influenza A virus (H3N2)  
    Dilutions 
 
Samples 
2 22 23 24 25 26 27 28 29 HI Titre 
Fresh roots 
extracts — — 1+ 4+ 4+ 4+ 4+ 4+ 4+ 7 
Sun-dried roots 
extracts — — — 1+ 4+ 4+ 4+ 4+ 4+ 14 
7-d RIE — — — — 4+ 4+ 4+ 4+ 4+ 16 
Ribavirin 1+ 4+ 4+ 4+ 4+ 4+ 4+ 4+ 4+ <2 
Amantadine — — — 4+ 4+ 4+ 4+ 4+ 4+ 8 
 
3.3.2.4.  Impacts of heat processing on plaque-reduction activities of the 
roots 
The cold-water extracts of fresh roots did not reduce the formation of plaque. In contrast, 
they increased the number of plaque, indicating a promotion on virus infection. At 0.4 
mg/mL, fresh roots extracts increased the formation of plaque by 80%.  
Sun-dried roots extracts achieved the better inhibitory effects than fresh roots by 
significantly reducing the formation of plaque at concentrations higher than 1.25 mg/mL, in 
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a dose-responsible manner. The greatest inhibition was achieved at the maximum tested 
concentration of 20 mg/mL. 
7-d RIE completely inhibited the formation of plaque at all assayed concentrations, which 
were ranged from 1.0 mg/mL to 31.5 mg/mL. The soluble ingredients of 7-d RIE were 
weighed as freeze-dried powder. It was about 25 mg of the soluble compositions per 100 mg 
dry weight of roots. Therefore, the tested minimum effective concentration of 7-d RIE is 1.0 
mg/mL (dry weight of roots), equal to 0.25 mg/mL soluble ingredients. And it is reasonable 
to anticipate that 7-d RIE would be effective in inhibiting haemagglutination at a 
concentration lower than the minimum concentration tested here.  
 
 
Figure 3.8  Dose-response curve determined with fresh roots extracts, sun-dried roots extracts, 7-d 
RIE by Plaque reduction assays in MDCK cell monolayers infected with influenza A viruses (H1N1) 
(n=3).  
Concentrations of samples: (1) Fresh roots extracts: 0.8, 0.4, 0.2, 0.1, 0.05, 0.025 mg/mL; (2) Sun-




3.3.3.  Conclusions and Discussions 
By using the same amount (dry weight) of raw materials, complexity of the native chemical 
composition from the fresh roots extracts, the sun-dried roots extracts and the boiling water 
extracts was cancelled out. By comparing the influences of three samples on cell 
proliferation, it was discovered that the heating process reduced the cytotoxicity of native 
plants while increased the antiviral cytoprotective effects of aqueous extracts of the roots.  
The extracts of sun-dried roots conducted a stronger cytoprotective effect and a lower 
cytotoxicity than that of fresh roots, although both extracts were prepared with cold-water 
extraction to minimize the speed of chemical reactions between compositions of roots. 7-d 
RIE has the highest degree of heat-dependant reaction, and also possessed the highest 
cytoprotective effect and lowest cytotoxicity.  
Chemical reactions and their products should be responsible for these progresses in 
physiological impacts of these water extracts of the roots. As described in Section 1.3.1, 
Maillard reaction generally occurred in many heat process like preparation of the roots 
decoction. This reaction, controlled by parameters like temperature, reactants and time, has 
dominant impacts on heat-induced chemical reactions in plants. Its products, MRPs, are 
consequently the important candidates of effective compositions, which are correlative to the 
new physiological properties generated during the preparation of sun-dried roots and boiling 
water extracts.    
Two subtypes of influenza A viruses showed different susceptibility to amantadine. It is 
consistent with earlier report on amantadine resistance among 3 subtypes of porcine 
influenza A viruses. 9 out of 12 viruses studied, including H1N1, H1N2 and H3N2, are 
resistant to amantadine, examined by plaque reduction assays (Schmidtke & Bauer 2006). 
Furthermore, except M2 protein, haemagglutinin (H7) has been suggested to play a role in 
amantadine resistance of H7N7 viruses (Ilyushina et al. 2007). H1N1 viruses are more 
susceptible to 7-d RIE than H3N2, measured by haemagglutination inhibition assay. The 
susceptibilities of different subtypes viruses to either amantadine or 7-d RIE are therefore 
correlated to the types of HA.  
As described in Section 3.2, RIE inhibits viral absorption and infection on MDCK cells, on 
H1N1 and H3N2 influenza A viruses and influenza B virus. It is in an agreement with RIE’s 
haemagglutination inhibition activities on the H1N1 and H3N2 viruses. These results imply 
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that RIE is possibly effective to a range of influenza viruses regardless the genetic 
differences among their HA and NA proteins.  
Furthermore, haemagglutination inhibitory effects of RIE support the hypothesis drawn in 
Section 3.2.2.3, that RIE acts on the host cell plasma membrane to conduct its antiviral 
activity. It is because HA on the membrane of virus interacts with sialic acid receptors on the 
cell plasma membrane to induce the haemagglutination. RIE has to interfere the interaction 




3.4.  HYPOTHESIS 
A hypothesis was drawn from the above observations and conclusions for this study. RIE 
acts on the cellular plasma membrane to conduct its inhibitory effects on influenza virus 
infection. The heating process during preparation of RIE generates and enhances the 
antiviral effects. Maillard reaction dominates the heat-incorporated chemical reactions in the 
roots, and conducts a significant improvement on cell membrane interactive capacity of RIE 
with its products, MRPs. Further studies were carried out accordingly with the aim of 






PURIFICATION AND CHARACTERISATION OF  
ACTIVE MRPS-RELATED COMPONENTS 
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 4.1.  AIMS OF THIS CHAPTER 
In the last chapter, the target of RIE’s anti-influenza virus activity has been addressed to the 
host cell, while the impacts of the heating process on the efficacy of RIE and its active 
components have been intensively studied. In this chapter, the major compositions of the 
roots, including proteins, saccharides and their derivates, are investigated, with the aim of 
identifying the major ingredients responsible for RIE’s antiviral effects. 
As discussed previously, the heating process has been shown to play an important role in 
regulating the anti-influenza virus activity of RIE. The Maillard reaction is the dominant 
reaction during the heat processing. In order to occur, the Maillard reaction requires the 
participation of corresponding reactants. To gain further understanding of the antiviral 
ingredients of RIE, it is necessary to isolate and characterise the components of the roots that 
participate in the Maillard reaction. These components could typically include amino acids, 
reducing sugars, proteins and peptides. The relative content of each of these components will 
be analysed, the pure molecules will be isolated and characterised, and their biological 
activities will be examined accordingly. An appropriate representative of the MRPs of RIE 






4.2.  BIOCHEMISTRY OF THE ROOTS 
4.2.1.  Materials and Methods 
4.2.1.1.  Protein concentration 
As described in Section 2.2.1.2, the protein concentration was determined by Kjeldahl assay 
(Cataldo, Schrader & Youngs 1974), Folin-Phenol assay (Lowry et al. 1951) and Bradford 
assay (Bradford 1976). The protein concentration was calculated with Eq 2.1 and Eq 2.2.  
4.2.1.2.  Determination of carbohydrates content  
The starch content of the fresh roots was measured by the anthrone sulphuric acid assays as 
described in Section 2.2.1.3.  
4.2.1.3.  Amino acids analysis 
The amino acids composition was analysed with an automatic amino acid analyser (Hitachi 
L-8800, Japan) using a standard ion-exchange HPLC protocol based on the reported methods 
(Hamilton, Bogue & Anderson 1960) (Hill et al. 1979). The samples were prepared as 
described in Section 2.2.1.4. The HPLC measures were conducted by Ms. Aiping Qian at 
Fujian Academy of Agricultural Sciences. 
4.2.1.4. SDS-PAGE of proteins 
SDS-PAGE electrophoresis was performed by the Laemmli protocol (Laemmli 1970). The 
proteins were dissociated with SDS and β-mercaptoethanol and electrophoresed through 
12.5% polyacrylamide at 120 V. 
4.2.1.5.  Isoelectrofocusing   
IEF was performed as described in Section 2.2.1.7.  
4.2.1.6.  Periodic acid-Schiff (PAS) Staining  
Periodic acid-Schiff (PAS) staining was used to identify the glycoproteins (Glossmann & 
Neville 1971). 
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4.2.1.7.  Identification of reducing sugars  
As described in Sectioni 2.2.1.5, an HPLC method (Karlsson, Winge & Sandberg 2005) with 
a TSK-gel Amide-80 colum (TOSHO, Japan) was applied. The sugars were detected by an 
evaporative light scattering detector (SEDERE Inc., USA). 
4.2.1.8.  Purification of the representative proteins and MRPs molecules  
As described in Section 2.2.1.8, HPLC was used as the main method of purification. Cation-
exchange liquid chromatography and reversed phase liquid chromatography were the major 
methods of protein separation. Toyopearl SP-650M strong cation ion-exchange resin was 
used for isolation of RITIP proteins from fresh roots, while Toyopearl SP-5PW cation-
exchange resin was used to isolate GRITIP proteins from sun-dried roots. The proteins were 
purified with a C18 chromatographic column (Oligo-R3). The purity was examined with a 
size-exclusion HPLC column (TSK-Gel G3000SWXL). The chromatographic columns used 
in this study were summarised in Section 2.1.6. 
4.2.1.9.  Preparation of Arg-Glc MRPs 
1 mmol of L-arginine (non-animal source, Sigma) and 1 mmol D-glucose (Sigma) were 
mixed thoroughly and incubated in a humid atmosphere over a saturated solution of 
potassium bromide (80% RH) at 40°C. After 7-days of incubation, the Arg-Glc MRPs was 
dissolved in 5000 µL deionised water. 
4.2.1.10.  Enzymatic hydrolysis of proteins from the roots 
Hydrolysis of proteins from the roots was conducted by the published method (Corzo-
Martínez et al. 2010) with a few modifications. The conditions of enzymatic hydrolysis was 
optimised by adjust concentration of enzyme, time of hydrolysis, pH and temperature.  
Pepsin in powder form (Sigma P7000, 1:10000, 542 U/mg, from porcine stomach mucosa) 
was dissolved in 0.1 M KCl-HCl buffer (pH 2) to make a 1.92% (w/v) solution. The purified 
proteins from the roots were dissolved in 0.1 M KCl-HCl buffer (pH 2.0) to make 1 mg/mL 
solution. Pepsin solution was added to protein solution at a volume ratio of 1:20, before 
incubation at 37°C for 3 h. At the end of incubation, the solution was heated to 100°C for 10 
min to deactivate the enzyme. The hydrolysates were then applied to RPLC and mass 
spectroscopy for analysing the peptide fragments.   
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4.2.1.11.  LC-MS analysis of protein hydrolysates 
The analysis was performed with LC/MSD Trap XCT (Agilent, USA). RPLC was performed 
by using a C18 column (Phenomenex, Gemini C18, 250 mm × 4.6 mm, 5 µm) and the 
elution gradient of 0~100% CH3CN, containing 0.1% TFA. The elution volume was 60 mL 
at a flow rate of 1 mL/min. The UV detector wavelength was 214 nm. The LC fractions were 
ionised and immediately analysed by an electronspray ionization mass spectrometer 
immediately. This was performed in cationic mode, 2000 m/z, spray air pressure 40 psi, 
nitrogen drying flow rate 12 L/min, drying temperature 350°C, capillary voltage 3.5 kV, 
with a ion scanning over the range from m/z 50 to 2200. 
4.2.1.12.  Glycation sites analysis 
Genes of purified native proteins from the roots were cloned and the cDNA sequences were 
obtained. Simulated hydrolysis was performed with cDNA sequences by a software package 
called Peptidemap (http://prowl.rockefeller.edu/prowl/peptidemap.html). The peptide 
sequences from the simulation were manually paired with peptide fragments from the pepsin 
hydrolysis and mass spectroscopy. The glycation sites, together with the types of glycation, 
were identified by overlapping the peptide fragments obtained from enzymatic hydrolysis 
simulation and mass spectroscopy.  
 
4.2.2.  Results 
4.2.2.1. Protein and saccharide content 
Tables 4.1 and 4.2 showed the protein and carbohydrate content of the roots, and that of the 
pulps of Momordica charantia Linn. The soluble protein content of the roots was measured 
with three methods (Kjeldahl assay, Folin-Phenol assay and Bradford assay) described in 
Section 4.2.1.1. Sun-drying slightly reduced the protein content of the roots, and allowed a 
remarkably higher proportion to be extracted with water (Table 4.1). This is consistent with 
the ability of the Maillard reaction to increase the solubility and heat stability of proteins 
(Pan et al. 2005) (Watanabe, Sato & Kato 1980). Similar to the protein, the total saccharides 
contents were almost the same in fresh and sun-dried roots. However, a larger proportion of 
the saccharide in sun-dried roots is reducing sugars (Table 4.2), while Maillard reaction 
supposed to consume a number of reducing sugars during the sun-dry process. There are two 
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possible explanations for this unexpected high proportion: the influence of MRPs on the 
anthrone sulphuric acid assay, which gave a fake reading; or hydrolysis of polysaccharides 
by endogenious enzymes from the roots.  
In contrast to the roots, the sun-dried pulps (of Momordica charantia Linn.) has smaller 
proportions of soluble proteins, total saccharides and reducing sugars, which indicates that 
the Maillard reaction has been more extensive. The reducing sugars account for a much 
higher proportion of saccharides in the pulps compared to the roots; over 50% in the former 
compared to only 14% in the latter. The high content of water in the pulps allows the 
Maillard reaction to occur more readily, and resulting in a lower concentration of reducing 
sugar. 
Similar to the protein, total saccharide content was almost the same in fresh as in sun-dried 
roots, while reducing sugar content was raised by 10% in sun-dried roots (Table 4.2). The 
unexpected rise of reducing sugars in sun-dried roots may probably be attributed to two 
reasons: broke-down of polysaccharides caused by sun-drying; or the influence of MRPs on 
the anthrone sulphuric acid assay.  
Table 4.1  Protein contents of fresh and sun-dried plants 
 
Total Protein Content 
(%, w/w) 1 
Soluble Proteins  
(mg/mL) 2 
Fresh roots 13.6 2.6 
Sun-dried roots 11.4 10.6 
Fresh pulps 15.3 4.2 
Sun-dried pulps NA 2.6 
1. Total protein contents of the roots and the pulps were determined by Kjeldahl assay. 2. The soluble 
protein contents were determined by the Lowry method. BSA was used as the protein standard. The 
protein concentration was calculated with Eq 2.1. 
Table 4.2  Carbohydrate contents of fresh and sun-dried plants. 




Fresh roots 67.0 14.2 
Sun-dried roots 65.0 25.7 
Fresh pulps 8.8 4.7 
Sun-dried pulps 6.8 1.9 
Carbohydrate content of the roots and the pulps, determined by anthrone sulphuric acid assay (Dische 
1967). D-glucose solutions of 100, 200, 300, 400, 600, 800 µg/mL were used to determine the 
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standard curve. The absorbance at λ= 620 nm was measured to determine the reducing sugar 
concentration of samples. The same volume of distilled water was used as control. 
 
4.2.2.2.  Amino acids Analysis  
As shown in Table 4.3, of the 17 different amino acids detected in the roots, 5 are 
particularly abundant: aspartic acid, glutamic acid, lysine, arginine and proline. The content 
of arginine is remarkably high, at 3.59% of dry weight of fresh roots and 3.12% of sun-dried 
roots. In fresh roots, 39.49% of total amino acid is arginine. Within the arginine, about 
85.51% of it is free amino acid.  
The total amino acid content dropped from 9.09% to 8.18% after sun-drying. The amount of 
free amino acids decreased successively from 4.21% through to 3.87%, 1.69% and 1.16%, 
according to the strength of heating process, by means of sundry at 20~30°C, baking dry at 
40°C and boiling at 100°C. Among the individual amino acids, arginine contributed the most 
dramatic decrease after the heating process, from fresh 3.07% (fresh) to boiled 0.67% 
(boiled).   
As shown in Table 4.4, arginine is the most abundant amino acid in the fresh Momordica 
charantia pulps, which was 32.4% of their total amino acids and 59.3% of their free amino 
acids. The figures for their sun-dried counterparts were 33.8% and 51.8%, respectively. 
Arginine decreased progressively from 1.44% (w/w) to 0.47% and 0.24%, again according to 
the strength of heating process, by means of sun-drying at 20~30°C and boiling at 100°C. 
As an alkaline amino acid, arginine is an active reactant in the Maillard reaction. Due to the 
particularly high proportion of this amino acid, arginine is presumed to make a major 
contribution to the formation of MRPs in RIE and MCE. This was why it was chosen for 
preparing the Arg-Glc MRPs used in this study as a simplified model to simulate the 
chemical compositions and biological functions of RIE MRPs and MCE MRPs.  
The free amino acid of the roots decreased successively from 4.21% through to 3.87%, 
1.69% and 1.16%, correlating with the strength of heating process, by means of sundry at 
20~30°C, baking dry at 40°C and boiling at 100°C. Among individual amino acids, arginine 
accounted for the most dramatic decrease, from the fresh 3.07% to the boiled 0.67%. As an 
alkaline amino acid, arginine is one of the most active reactants in Maillard reaction. With its 
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extraordinary high content, arginine has been presumed to be one major source of RIE MRPs 
and MCE MRPs. 
Table 4.3 Amino acid content of the fresh and sun-dried roots. *  
 
 
    Total amino acids  
(%, w/w) 
   Free amino acids  
(%, w/w) Amino Acids Fresh Sun-dried Fresh Sun-dried Baked 
dried 
Boiled 
Aspartic acid 0.65 0.57 0.08 0.07 0.04 0.03 
Threonine 0.38 0.35 0.18 0.09 0.09 0.06 
Serine  0.29 0.26 0.05 0.06 0.03 0.02 
Glutamic acid 0.88 0.73 0.05 0.02 0.01 0.01 
Glycine  0.26 0.26 0.01 0.01 0.00 0.00 
Alanine  0.29 0.31 0.07 0.11 0.04 0.02 
Cystine 0.03 0.02 0.01 0.02 0.00 0.00 
Valine  0.38 0.38 0.07 0.10 0.05 0.03 
Methionine 0.00 0.03 0.00 0.01 0.00 0.00 
Isoleucine  0.24 0.23 0.03 0.04 0.02 0.01 
Leucine  0.38 0.37 0.03 0.07 0.03 0.02 
Tyrosine  0.12 0.12 0.01 0.02 0.01 0.00 
Phenylalanine 0.24 0.22 0.02 0.05 0.03 0.01 
Lysine  0.56 0.47 0.13 0.16 0.08 0.04 
Tryptophan  － － － － － － 
Histidine  0.26 0.22 0.11 0.09 0.05 0.03 
Arginine  3.59 3.12 3.07 2.65 1.02 0.76 
Proline  0.53 0.51 0.29 0.31 0.17 0.10 
Total  9.09 8.18 4.21 3.87 1.69 1.16 
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Table 4.4 Amino acid content of the fresh and sun-dried pulps.∗ 
Total amino acids  
(%, w/w) 
Free amino acids  
(%, w/w) 
Amino Acids 
Fresh Sun-dried Boiling Fresh Sun-dried 
Aspartic acid 0.31 0.10 0.32 0.07 0.02 
Threonine 0.20 0.08 0.10 0.00 0.04 
Serine 0.17 0.04 0.13 0.05 0.01 
Glutamic acid 0.68 0.23 0.61 0.00 0.02 
Glycine 0.13 0.05 0.18 0.01 0.00 
Alanine 0.14 0.07 0.19 0.04 0.02 
Cystine 0.05 0.01 0.03 0.00 0.01 
Valine 0.19 0.06 0.11 0.09 0.03 
Methionine 0.03 0.02 0.02 0.02 0.02 
Isoleucine 0.12 0.03 0.08 0.05 0.01 
Leucine 0.18 0.04 0.10 0.06 0.02 
Tyrosine 0.13 0.03 0.05 0.05 0.01 
Phenylalanine 0.19 0.05 0.09 0.12 0.03 
Lysine 0.19 0.05 0.03 0.06 0.01 
Tryptophan _ _ _ _ _ 
Histidine 0.18 0.03 0.03 0.14 0.01 
Arginine 1.44 0.47 0.24 1.12 0.29 
Proline 0.12 0.04 0.05 0.02 0.01 




                                                
∗ Total amino acid and free amino acid contents of the Isatidis roots or the pulps of 
Momordica charantia Linn. were expressed as a percentage of the dry weight of pulps (%, 
w/w). 
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4.2.2.3.  Analysis of monosaccharide and disaccharide 
As shown in Figure 4.1, xylose, fructose, glucose, sucrose and maltose have been identified 
from fresh roots tissue, while glucose, fructose and maltose were identified from fresh 
Momordica charantia L. pulps by the same method. In both plants, glucose was the major 
monosaccharide (>40% of monosaccharides in the roots), while sucrose was the most 
dominant sugar in the roots. Fructose and glucose were almost equally rich in pulps of 
Momordica charantia Linn. Sucrose accounted for 65.9% of total monosaccharides and 
disaccharides of the roots, of which glucose accounted for 9.9%. Sucrose may be partially 
hydrolysed during the boiling water extraction, especially at acidic condition, to produce the 
equal molar amount of glucose and frutose. In summary, glucose is expected to make a 
major contribution to the formation of MRPs in both herbs. 
 
4.2.2.4.  Starch content determination 
The starch content of fresh roots was determined with two dilutions of its cold-water extracts 
and gained a mean values of 31.1±1.0% (w/w). The hydrolysates of starch might also have 































































Figure 4.1  Analysis of monosaccharide and disaccharide content of the fresh roots by HPLC. 
A. The chromatogram of standard sugars. Mobile phase: acetonitrile, ethyl acetate and deionized 
water (60:25:15, v/v). Flow rate: 1.0 mL/min. Injection: 10 µL. L-rhamnose, D-xylose, L-arabinose, 
D-fructose, D-mannose, D-glucose, D-galactose, sucrose and maltose were used as standard sugars, 
and are listed here in the sequence of their chromatographic peaks.  B. The chromatogram of 
monosaccharides and disaccharides from the roots. Mobile phase: acetonitrile, ethyl acetate and 
deionized water (60:25:15, v/v). Flow rate: 1.0 mL/min. Injection: 10 µL. D-xylose, D-fructose, D-
glucose, sucrose and maltose were identified and quantified, D-xylose: 0.17 mg/mL, D-fructose: 0.12 
mg/mL, Dglucose: 0.21 mg/mL, sucrose: 1.40 mg/mL, maltose: 0.23 mg/mL, respectively. The 
retention times of these five sugars were: 13.66 min, 17.65 min, 21.77 min, 38.55 min and 43.86 min, 
respectively. 
 
Table 4.5 Starch content of the fresh roots.* 
Dilution Times 




Starch Content  
(%, w/w)* 
Average (%) 
200 0.54 313.92 31.4 
400 0.26 308.5 30.8 
31.1±1.0 
                                                
* The weight of fresh roots was used in the calculation. Experiment design and data analysis 
were performed by Lijing Ke; data was collected by Ms. Huiqin Wang. 
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4.2.2.5.  Full-wavelength scanning of Arg-Glc MRPs 
MRPs derived from the reaction between arginine and glucose was prepared as described in 
Section 4.2.1.9, and used in this study to simulate the functions of low molecular weight 
MRPs derived from RIE.  
The full-wavelength (190 nm to 1000 nm) absorbance scanning was performed with Arg-Glc 
MRPs at serial concentrations. The solution of Arg-Glc MRPs at the maximum 
concentration of 600 mM presented a dark brownish colour, with the strongest absorbance at 
a wide range of wavelength, ranging from 190 nm to 900 nm. As the concentration reduced, 
the absorbance intensity decreased dramatically, particularly in the range of visible lights. At 
wavelength around 300 nm, MRPs at the low concentrations (1.9 mM and 0.5 mM) 
presented a single absorbance peak, which implies the double bonds of C=O (Fig 4.2).  
As shown in Fig 4.3, the intensity of absorbance is proportional to the concentration of Arg-
Glc MRPs at all the wavelengths and concentrations tested. Taking the intensities at 500, 
600, 700 and 800 nm as examples, the concentration of MRPs is linear to the intensities. In 
Fig 4.4, absorbance spectra were compared between Arg-Glc MRPs and RIE MRPs. They 
look rather similar within the wavelength range of visible lights, in terms of intensity and 
curvature. This indicates that it is possible to determine the concentrations of MRPs derived 
from other sources with a concentration-absorbance standard curve of Arg-Glc MRPs. 
Among the 4 wavelengths above, 500 nm falls in the range of red-brown light, which is close 
to the colour of MRPs, with a fairly strong intensity. It was therefore chosen to estimate the 




Figure 4.2 Full wavelength absorbance scan of Arg-Glc MRPs at 3 concentrations. 
 
 






Figure 4.4 The absorbance curves of Arg-Glc MRPs and RIE in the wavelength range of visible light. 
 
4.2.2.6.  Determination of the un-reacted reactants in Arg-Glc MRPs 
The Maillard reaction has to go through a highly complex reaction pathway until its end 
product, melanoidin, was formed. The rates of reaction could be managed by adjusting 
temperature, time, accessibility of water, pH, etc. It is possible to slow down the reaction by 
using reactants in powder form and reacting them in a controlled humidity. As described in 
the methods, Arg-Glc MRPs is prepared with arginine and glucose powder, with equal molar 
amount of them at 80% RH, 40°C, for 7 d. A part of the reactants might not have been 
consumed, and needs to be determined.  
As shown in Table 4.6, 30.8% of arginine remained un-reacted after being incubated with 
equal molar amount of glucose. Two independent Arg-Glc MRPs samples were prepared 
under the same conditions, to ensure the accuracy of arginine quantification. 
As shown in Table 4.7, 39.0% of glucose remained un-reacted in the Arg-Glc MRPs after the 
incubation. This is consistent with the remaining of arginine in Arg-Glc MRPs. To ensure 
the accuracy of measure, 10 mg/mL glucose was added as an internal standard into Arg-Glc 
MRPs solution. 38.5% of glucose was identified to remain un-reacted. 
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By summarying the data above, about two third of arginine and glucose actually reacted for 
generating Arg-Glc MRPs. The remaining arginine and glucose in Arg-Glc MRPs must be 
considered when the effects of Arg-Glc MRPs on lipid bilayer or cells are investigated. 
Argininen and glucose were used as controls in the neutron diffraction, X-ray diffraction and 
cell pathological studies. 
 







Remains  (%) 
Arg-Glc MRPs 1 3484 1136.14 32.6 
Arg-Glc MRPs 2 3484 1007.59 28.9 
Average 3484 1071.87 30.8 
 









Concentration  (mg/mL) 14.03 14.10 24.14 23.61 
Average (mg/mL) 14.07 23.88 
Percentage of Remains  39.0% 38.5%* 
The content of glucose was measured by anthrone sulphuric acid assay. 
 
                                                
* Calculated by subtracting 10 mg/mL from the measured mean value of Arg-Glc MRPs+Glc. 
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4.2.2.7.  Purification of glycation-related proteins from the fresh roots  
Water-soluble proteins were extracted with two types of solvent: pure water at the natural pH 
of roots, and PBS buffer (pH7.2). The protein compositions of both solution are identical, as 
shown in Fig 4.5. However, some significant differences were observed between fresh roots 
and sun-dried roots. As revealed by SDS-PAGE gel electrophoresis, protein bands of sun-
dried roots are generally blurred and widened when comparing with those of fresh roots, 
which reflects the common occurrence of protein glycation (Eble, Thorpe & Baynes 1983). 
The widened bar of protein indicates the changes in molecular weight, possibly caused by 
cross-link between proteins and other reaction derivates. Proteins with molecular weights 
about 25 kDa, were targeted for purification due to their particularly high content in the roots 
and the significant degree of glycation. Since PBS buffer extract was slightly more 
concentrated than pure water extract, it was used for isolating the precursors of glycated 
proteins from the fresh roots.  
Firstly, proteins were separated from the crude extracts of fresh roots by precipitation in 60% 
(NH4)2SO4 solution. Protein precipitants were then dialysed to remove sulphate residues 
before applied to ion-exchange liquid chromatography. The dominant proteins were found in 
the second elution fraction of chromatographic separation, named as SP-P2, using SP-650M 
cation-exchange resin (Fig 4.6, Fig 4.8). SP-P2 was then separated to 8 elution fractions with 
reverse-phase liquid chromatograpy (RPLC) using C18 column. Among these fractions, 
three proteins were subsequently purified to electrophoretic homogeneity. They were named 
as radix Isatidis trypsin inhibitor proteins (RITIP) (Fig 4.7), because their amino acid 
sequences shared a high similarity with the trypsin inhibitor family from plants. As shown in 
Figures 4.8 and 4.9, their molecular weights are 26.8 kDa, 25.5 kDa and 24.6 kDa, 
respectively, which were calculated based on the Rf values of standards. They were named 
RITIP-1, RITIP-2 and RITIP-3 in order of decreasing molecular weight. Their purities were 
above 98.0%, as measured by high-performance size-exclusive liquid chromatography 
(TSK-GEL G3000SWXL) (data not shown, but available on request). 
For tracking the Maillard reaction occurred during sun-drying, the glycoproteins in the roots 
extracts, the SP-P2 proteins and three purified glycation-relevant proteins RITIP1/2/3 were 
stained with PAS method firstly (Fig 4.10A), and then with Coomassie Blue (Fig 4.10B). 
The proteins of sun-dried roots were more intensively stained by PAS than those of fresh 
roots, which indicated a higher degree of glycation in sun-dried roots. Three purified 





Figure 4.5  SDS-PAGE electrophoresis (12.5%) graphs of extracts and fractions of the roots. 
M, markers; 1, PBS buffer extract of fresh roots (0.02M PSB+0.1M NaCl pH7.2); 2, water extract of 
fresh roots; 3, water extract of sun-dried roots; 4, PBS buffer extract of sun-dried roots (0.02M 
PSB+0.1M NaCl pH7.2). 
 
 
Figure 4.6 SP-650M cation exchange liquid chromatography of fresh roots extract.   
Flow rate: 1 mL/min. Buffer: 0.02 M, pH3.0 Citric acid-sodium citrate buffer. Elution gradient: 
0.5~1.0 M NaCl. Detector wavelength: 280 nm. Column: SP-650M 16 mm×100 mm. Fraction 
collector: 5 mL/tube. 





Figure 4.7 POROS R3 C18 reverse phase liquid chromatography of fresh roots extract.   
Flow rate: 1 ml/min. Buffer: 0.1% TFA, 0~55% acetonitrile gradient. Detector wavelength: 280 nm; 
Column: POROS Oligo-R3 C18 4.6 mm×250 mm. 
 
Figure 4.8 SDS-PAGE electrophoresis of purified proteins from roots.  
 
Running Voltage: 120 V; Running gel: 12.5%; Coomassie blue staining.  Marker: standard proteins. 
SP2: the SP2 fraction from cation-exchange chromatography.  
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Figure 4.10 SDS-PAGE eletrophoresis of purified proteins from the fresh roots. 
A. Periodic acid-Schiff (PAS) Staining. Running Voltage: 120 V. Running gel: 12.5%. 
B.  Coomassie blue staining. Running Voltage: 120 V. Running gel: 12.5%. 
Sun-dried       Fresh SP-P2  RITIP1 RITIP3 RITIP-2 
Sun-dried       Fresh SP-P2  RITIP1 RITIP3 RITIP-2 
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4.2.2.8.  Purification of glycated proteins from sun-dried roots  
In the previous section, three glycated RITIP proteins have been identified from the fresh 
roots extracts. To locate the chemically modified amino acids of these proteins caused by the 
Maillard reaction, their counterparts in sun-dried roots are required to be purified and 
identified. The purified proteins were used for the analysis on the glycation sites and types in 
Section 4.2.2.11. 
The purification was following a similar protocol with purification of RITIP proteins. After 
(NH4)2SO4 precipitation, soluble proteins from sun-dried roots were then separated by 
cation-exchange HPLC (Toyopearl SP-5PW). The target proteins were obtained in fraction 
P2, namely 5PW-P2 (Fig 4.11), which was further separated by RPLC method (POROS 
Oligo R3 C18). Two finely isolated fractions were obtained (Fig 4.12), and were identified 
as electrophoretic homogeneity (Fig 4.13). They were named GRITIP1 and GRITIP3 
according to their molecular weights, which were 25.1 kDa and 22.5 kDa, respectively. 
Glycation of these proteins, including 5PW-P2, GRITIP1 and GRITIP2, was examined with 
PAS staining by SDS-PAGE electrophoresis. The results are shown in Fig 4.14. The bands 
of GRITIP proteins were blurred and expanded when stained with Coomassie blue. PAS 
staining presented a notable amount of carbohydrates on the proteins, indicating the progress 
in glycation or glycosylation of protein during the drying process.    
 
Figure 4.11  Cation-exchange liquid chromatographic separation of proteins from sun-dried roots.  
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Toyopearl SP-5PW cation-exchange column (4.6 mm × 250 mm). Sample loaded: 5 mL. Mobile 
phase 0.02M citrate buffer (pH4.0), elution gradient 0.02M citrate buffer (pH4.0) + 1 M NaCl, 60 
min; flow rate= 1 mL/min. 
 
Figure 4.12  Reverse-phase liquid chromatographic separation of 5PW-P2 from sun-dried roots.  
POROS Oligo R3 C18 reversed-phase column (4.6 mm × 150 mm); Mobile phase: solution A, 0.1% 
TFA; solution B, 0.1% TFA+ 80% CH3CN; flow rate= 1 mL/min; detector, 280nm; sample upload 5 
mL; elution gradient, 0~100% in 120 min. 
                    
                 M     2      3     4      5 
Figure 4.13  SDS-PAGE of glycated proteins purified from sun-dried roots. 
M. Marker; 2. RITIP1; 3. GRITIP1; 4. RITIP3; 5. GRITIP3. Running Voltage: 120 V; Running gel: 









                                                 5PW-P2  GRITIP1  GRITIP3 
Figure 4.14 SDS-PAGE of isolated glycated proteins from sun-dried roots stained with PAS assay.  
Running Voltage: 120 V; Running gel: 12.5%; Periodic acid-Schiff staining. 
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4.2.2.8.  Biochemical properties of purified proteins 
Mass Spectroscopy 
The precise molecular weight of RITIP1 was 22430 Da determined by Q-TOF MS, as shown 
in Fig 4.15. The molecular weight of RITIP1 determined by gel-electrophoresis was 26.8 
kDa, which is about 4000 Da bigger than that from MS. The secondary structure and 
glycosylation of protein might contribute to the false result in gel electrophoresis. It also 
provides an example of differences in the molecular weights of proteins when determined by 
different methods.   
Isoelectric Point of purified proteins 
The isoelectric point (pI) of RITIP1 has previously been determined, by isoelectric focusing 
electrophoresis (IEF), to be 5.4. The pI of RITIP2 is 5.3 and that for RITIP3 is 5.4. In 
contrast, pI of GRITIP1 and GRITIP3 was 6.7 and 6.6. The pI of proteins from sun-dried 
roots was significantly higher than that of proteins from fresh roots. This implies that 
glycation decreases the electric charges on the surface of proteins.  
4.2.2.9.  Sequencing of purified proteins 
The N-terminal sequences of two proteins, RITIP1 and RITIP3, were determined by Edman 
degradation (Table 4.8). In RITIP1, the first 9 amino acids were identified., while 19 amino 
acids in RITIP3.  
The two proteins showed a high similarity in their amino acid sequences. Among the first 9 
amino acids of both sequences, only the second amino acid is different, which is tryptophan 
in RITIP1 but valine in RITIP3. Valine, instead of arginine, took the highest proportion 
among amino acids of the proteins (Fig 4.17). This indicates that these RITIPs proteins do 
not make a major contribution to the high content of arginine, even as the dominant proteins 
in the roots. The N-terminal sequence of RITIP3 was used to design the primer for cloning 
gene of RITIP3, as reported in the next section.   
4.2.2.10.  Gene cloning and sequencing of purified proteins 
This work was conducted under the collaboration with Dr. Jianwu Zhou and Mr. Guanzhen 
Gao from Institute of Biotechnology Fuzhou University. The gene cloning was conducted by 
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Dr. Jianwu Zhou and Mr.Guanzhen Gao. The sequence analysis was performed by the 
author. 
According to analogous analysis of RITIP proteins with proteins from Arabidopsis thaliana, 
RITIP1 and RITIP3 are similar to proteins from a trypsin inhibitor family and were predicted 
to have antifungi activity (Table 4.9). Some proteins contain a similar sequence were listed 
here as reference. 
 
 
Figure 4.15 Q-TOF Mass Spectrum of RITIP1.  
The MS measurement was performed by Dr. Chunteng Guo at Ulster University, North Ireland. Data 
analysis was conducted by the author. 
 
Table 4.8 The N-terminal amino acids sequence of two purified proteins 




The sequence of RITIP-3 was used to design the primer for gene cloning and obtained two 
cDNA sequences. There were only a few differences between these two sequences. One of 
these two sequences is presented here as an example, as shown in Fig 4.16. The full-length 
protein sequence (199 aa) of RITIP-3 was translated from the cDNA sequence (Fig 4.17).  
The analogous analysis of RITIP-3 with proteins of Arabidopsis thaliana was conducted 
with BLAST programs, using default value. The results are presented below (Fig 4.18, Table 
4.10). RITIP-3 is similar to the proteins from a family of Kunitz-type trypsin protease 
inhibitors in plants. RITIP-3 was anticipated to have protease inhibitory activity and used in 
the further enzymological studies, as shown in section 4.3. The potential function of RITIP-3 
was predicted by BLAST and FASTA using EMBL and GENBANK databases (Last 
accessed on 10th June, 2007). 
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Figure 4.16 Full DNA sequence of RITIP3.  (1 bp – 737 bp, direct) 737 bp 
 
 
Figure 4.17 Full amino acid sequence of RITIP3.  (1 aa – 191 aa) 199 aa 
 
   
 




4.2.2.11.  Analysis of glycation sites of glycated proteins  
This work was carried out in cooperation with Dr. Jianwu Zhou, Mr. Guanzhen Gao from 
Institute of Biotechnology Fuzhou University.  
As previously described，three glycation-related proteins were isolated from the fresh roots. 
The full-length cDNA sequences of these two proteins were also obtained. Two glycated 
derivates of these proteins, namely GRITIP1 and GRITIP3 in the sun-dried roots were 
purified to electrophoretic homogeneity. The glycated proteins were subsequently digested 
by pepsin. The hydrolysates were analysed with RPLC-ESI/MS, for characterisation of 
glycated polypeptide segments. An online database searching tool, ‘Peptidemap’, was 
employed to simulate pepsin hydrolysis on RITIP3 and subtract the molecular weight of 
Maillard reaction products from the molecular weight of glycated proteins determined by 
MS.  
The sequences of hydrolysed polypeptides from GRITIP3 were anticipated based on the full-
length sequence of RITIP3, with the help of computer simulation of enzymatic hydrolysis.  
The results were manually matched to reveal the glycation sites and types of GRITIP3. 
Glycation sites on GRITIP1 were identified with the same method. In case of RITIP3 and 
GRITIP3, there were 37 peptides sequences finely matched. The coverage of these peptides 
on the full-length protein sequence was over 92% (Fig 4.19).  
Glycation on arginine and lysine side chains of GRITIP1 and GRITIP3 was characterised 
with this method. In case of GRITIP3, K7 was modified to Nε-carboxyethyl-lysine (CEL) or 
pyrraline (Pyr), K38 was modified to pyrraline (Pyr) or Fructosyl-lysine -1H2O (FL-1H2O), 
K171 was modified to Fructosyl-lysine -2H2O (FL-2H2O), R195 was modified to 1-Alkyl-2-
formyl-3,4-glycosyl-pyrrloe(AFGP). In case of GRITIP1, R3 was modified to AFGP. 
 
      1 VVREVVKDTA GNAVQTYEQY FIQPVKSNGG GLIPLPVKVP 
      41 LCPLGINQVL RRDVPGLPVS FGNPYRPSVV HNVYTTEFVN 
      81 IELKPSSDND WPVCKGFSNL WTVDGHSSAS DEPPILVGGK 
     121 PGHSYFKIER DEHFVGGNVY KLSTIFDGII GTVQGPLLGL 
     161 PQLVLTNDTA KTLLVKFIKV ENATTTSRAG KLALRMFPLY 
 
Figure 4.19 The coverage of peptides hydrolysed from GRITIP3 on the full-length sequence of 
RITIP3. 
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Table 4.9 An analogy analysis of RITIPs with proteins from Arabidopsis thaliana 
Protein Amino acids sequence Function 
RITIP1 VWREVVKDI Trypsin inhibitor/antifungi 
RITIP3 VVREVVKDIAGAVQTNEQY Trypsin inhibitor/antifungi 









NP_188110/BBA97055 REVVVSLDGDIAGAV unknown protein 









NP_850363/BAC43551 REVVRDI------KEQF unknown protein 
AAL87333 REVVKEI unknown protein 
AAF87852 REVVKEVA unknown protein 
NP_173640 REVVKEVA catalytic/ trehalose-phosphatase 
NP-173593/AAD41429 REVVKEI unknown protein 
NP_177874/AAG51662/AA
N86155 REVVKEI unknown protein 
 
Table 4.10 The analogous analysis of full sequence of RITIP3 with proteins from Brassica and 
Arabidopsis thaliana. 
Proteins Organism Sequence Length 
Score 
(bits) 
heat stress-induced protein  Brassica oleracea var. capitata 218 aa 165 
water-soluble chlorophyll protein Brassica oleracea var. acephala 212 aa 164 
Kunitz-type cysteine protease 
inhibitor Brassica oleracea var. botrytis 226 aa 162 
BnD22 drought induced protein Brassica napus 218 aa 159 
Trypsin and protease inhibitor 
family protein / Kunitz family 
protein / drought-induced protein 
Arabidopsis thaliana 215 aa 155 
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4.3.  BIOACTIVITIES OF COMPOSITIONS OF THE ROOTS 
4.3.1.  Materials and Methods 
4.3.1.1.  Cell reparative activity 
The ‘cell reparative rate’ was determined with Eq 4.1. The methods are described in Section 
3.2.1.4 and 3.2.1.5. H1N1 influenza A viruses were used to infect MDCK cells.   
Cells reparative rate (%) = (O.D.repair－O.D.virus)/(O.D.normal－O.D.virus)×100％  
         Equation 4.1 
4.3.1.2. Determination of cell proliferation rate 
The ‘cell proliferation rate’ of Arg-Glc MRPs MDCK cells was determined with MTT assay 
(Mosmann 1983), as described in Section 2.2.2.3.  
4.3.1.3.  Trypsin inhibitor activity  
As described in Section 2.2.2.9, the trypsin inhibitory activities of RITIP1/2/3 were 
determined by an improved BNPNA assay (Baker et al. 2009). 
4.3.1.4.  Haemagglutination inhibition activity 
As described in Section 2.2.2.6 and Section 3.3.1.6, the anti-haemagglutination activities of 
Arg-Glc MRPs, RITIP proteins and GRITIP proteins were measured with chick 
erythrocytes. The concentration of stock solutions of RITIP and GRITIP proteins was 1 
mg/mL. 9 dilutions of each sample were measured. The conventional anti-influenza virus 
medicines Ribavirin (50 mg/mL) and Amantadine (1 mg/mL) were used as a control. 
 
4.3.2.  Results 
4.3.2.1.  Inhibitory effects of Arg-Glc MRPs on virus-induced cell death 
The effects of MRPs derived from amino acid compositions and protein compositions of the 
roots were determined respectively, to illuminate whether they are responsible for the 
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antiviral effects of RIE. The results of MRPs derived from amino acids, being represented by 
Arg-Glc MRPs, were presented here.  
Arg-Glc MRPs was tested with MDCK cells after the attachment of virus to cells, by a 
modified method which was used in the previous chapter (Section 3.2.1.5). MRPs was added 
into the cell culture medium after the virus infection, and incubated with cells for 48-72 h. 
The results are shown in Fig 4.20. Arg-Glc MRPs inhibited the growth of influenza virus in 
MDCK cells. The maximum reparative rate was about 80% at 50 mM Arg-Glc MRPs. Along 
the concentration gradient, the activities of Arg-Glc MRPs declined quickly. There was no 
activity being observed at 6.25 mM and the lower concentrations.  
Apart from the protection effects, Arg-Glc MRPs promoted the proliferation of MDCK cells  
(Fig 4.20). At the same concentration, where Arg-Glc MRPs inhibited virus the most, Arg-
Glc MRPs boosted the growth of cells by nearly 50%. But this proliferation promoting 
activity declined along the dilutions of MRPs, and disappeared at 12.5 mM and the lower 
concentrations. 
4.3.2.2.  The trypsin inhibitory activities of RITIP proteins 
As shown in Table 4.11, four different kinds of extracts were prepared and determined for 
the trypsin inhibitory activities. Cold-water extracts of fresh roots had the highest inhibitor 
activities, 41.5 TIU/mg in term of protein concentration. Sun-drying decreased the activity of 
cold-water extracts when increase the activity of boiling-water extracts. Boiling-water 
extraction decreased the activity of fresh roots, but increased that of sun-dried roots. The 
inhibitor activities, which were calculated as a function of protein or sugar concentration, are 
listed for comparison.  
The trypsin inhibitory activities of RITIP proteins, and their heat stability and pH stability 
were studied by BNPNA assay (Fig 4.21, 4.22 & 4.23). The IC50 values of RITIP1, RITIP2 
and RITIP3 were rather similar, and were 0.97 mg/mL, 1.07 mg/mL and 1.04 mg/mL, 
respectively. RITIP proteins gradually lost their inhibitory activities when temperature 








Figure 4.20 Effects of Arg-Glc MRPs on the proliferation rates of normal MDCK cells and cell 
survival rates infected by H1N1 virus. (n=4, P<0.01) 
 






Inhibitor Activity  
(TIU/mg sugars) 
Cold-water extracts of 
fresh roots 
82 41.5 9.9 
Boiling-water extracts of 
fresh roots 
11.9 14.3 3.2 
Cold-water extracts of 
sun-dried roots 
89 12.6 3.1 
Boiling-water extracts of 
sun-dried roots 





Figure 4.21  Dose-response curve of the trypsin inhibition activity of RITIP1*. 
    
Figure 4.22 Dose-response curve of the trypsin inhibition activity of RITIP2*.  
  
 
Figure 4.23 Dose-response curve of the trypsin inhibition activity of RITIP3*. 
* 
                                                
* This work was conducted under a cooperation with Mr.Huangzhao Xu from Institute of 
Biotechnology Fuzhou University. The data were collected by Mr.Huangzhao Xu; sample 
preparation and data analysis was carried out by the author. 
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4.3.2.3.  Anti-haemagglutination activities of isolated proteins 
The haemagglutination inhibition activity of RITIP proteins was also investigated with the 
same method decribed in Section 3.3.1.6. Arg-Glc MRPs did not inhibit the 
haemagglutination induced by influenza A virus H1N1, but inhibit that of H3N2 at a titre of 
16. 
RITIP proteins, as a mixture of three proteins RITIP1/2/3, slightly inhibited the 
haemagglutination induced by influenza A virus H1N1 and H3N2. The lowest effective 
concentration was 250 µg/mL. The titre of RITIP’s haemagglutinin inhibitory activity was 4 
on H1N1, 2~4 on H3N2. GRITIP proteins were weaker than RITIP in inhibitory effects.  
 
Table 4.12  Inhibition of haemagglutination induced by influenza A virus (H1N1) 
Samples 2 4 8 24 25 26 27 28 29 Titre 
Arg-Glc MRPs 4+ 4+ 4+ 4+ 4+ 4+ 4+ 4+ 4+ < 2 
RITIP proteins1 – ± 4+ 4+ 4+ 4+ 4+ 4+ 4+ 4 
GRITIP proteins2 1+ 4+ 4+ 4+ 4+ 4+ 4+ 4+ 4+ ﹤4 
Ribavirin – 4+ 4+ 4+ 4+ 4+ 4+ 4+ 4+ 2 
Amantadine 1+ 2+ 4+ 4+ 4+ 4+ 4+ 4+ 4+ ﹤4 
 
1: ‘RITIP proteins’ refers to SP-P2 chromatographic fraction of fresh roots extracts, can be considered 
as a mixture of RITIP1/2/3. The concentration of ‘RITIP proteins’ is 1 mg/mL. 
2: ‘GRITIP proteins’ refers to 5PW-P2 chromatographic fraction of sun-dried roots extracts, can be 
considered as a mixture of GRITIP1/3. The concentration of ‘GRITIP proteins’ is 1 mg/mL. 
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Table 4.13  Inhibition of haemagglutination induced by Influenza virus A (H3N2) 
           Dilutions 
 
Samples 
2 22 23 24 25 26 27 28 29 Titre 
Arg-Glc MRPs — — — — 4+ 4+ 4+ 4+ 4+ 16 
RITIP proteins1 1+ 1+ 4+ 4+ 4+ 4+ 4+ 4+ 4+ 2~4 
GRITIP proteins2 4+ 4+ 4+ 4+ 4+ 4+ 4+ 4+ 4+ 2 
Ribavirin 1+ 4+ 4+ 4+ 4+ 4+ 4+ 4+ 4+ < 2 
Amantadine — — — 4+ 4+ 4+ 4+ 4+ 4+ 8 
 
1: ‘RITIP proteins’ refers to SP-P2 chromatographic fraction of fresh roots extracts, can be considered 
as a mixture of RITIP1/2/3. The concentration of ‘RITIP proteins’ is 1 mg/mL. 
2: ‘GRITIP proteins’ refers to 5PW-P2 chromatographic fraction of sun-dried roots extracts, can be 
considered as a mixture of GRITIP1/3. The concentration of ‘GRITIP proteins’ is 1 mg/mL. 
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4.4.  CONCLUSIONS AND DISCUSSION 
In the roots of Isatis indigotica Fort., proteins and saccharides are the major components. By 
adding them together, they contribute 80% of the dry weight. This figure does not change 
much in sun-dried roots. The water content of fresh roots and sun-dried roots are 59.6% and 
12.2%, determined by Wang (Wang 2008). The soluble proteins concentration of cold water 
extracts of fresh roots and sun-dried roots are 2.6 mg/mL and 10.6 mg/mL, which are equal 
to 1.9% (w/w) and 2.2% (w/w) in dry weight of roots. As Wang reported, while the roots 
was incubated at 60°C for serial of time, the proportion of soluble proteins increased 
accordingly. This indicates an increase in the solubility of proteins, induced by Maillard 
reaction occurred during the heat incorporated process.  
Arginine is dominant in the free amino acids, and an active reactant of Maillard reaction. Its 
concentration dropped dramatically after sun-drying and boiling, while the absorbance 
constantly increased at the range of visible lights wavelength, indicating the occurrence of an 
intense Maillard reaction (Hofmann & Heuberger 1999) (Morales & Jiménez-Pérez 2001).  
As determined by an HPLC method, glucose is the major reducing monosaccharide in the 
roots, participating in the formation of amino-acid-MRPs and glycated proteins. The high 
content of sucrose and starch in the roots may help to aid the rapid consumption of reducing 
sugars in Maillard reaction. These saccharides can be degraded to reducing monosaccharides 
by enzymatic or acidic hydrolysis at a physiological temperature, or at the higher 
temperature employed in heat processing of roots (Echeverria 1990) (Echeverria & Burns 
1989). Glucose is engaged as a representative of reducing sugars from the roots in this study.  
Arginine and glucose were therefore chosen for a model MRPs for further studies, namely 
Arg-Glc MRPs. The concentration of Arg-Glc MRPs is linear with the visible lights 
absorbance at 500 nm. The wavelength is used for estimating the concentration of unknown 
MRPs. However, about 31% of arginine and 39% of glucose remained not reacted in Arg-
Glc MRPs, even after a long time of reaction (7 d) or at a high reaction temperature (100 
°C). The influence of arginine and glucose remained in Arg-Glc MRPs need to be cancelled 
out for revealing the real biological impacts of MRPs. In the later biophysical studies of 
MRPs, including analysis of phase transition energy consumption and positioning of MRPs 
on phospholipids bilayers, the influences of arginine and glucose were examined and 
subtracted.  
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Arg-Glc MRPs prevented the death of 80% of MDCK cells by inhibiting the replication of 
H1N1 viruses and promoting cell proliferation in due course, at a high concentration (50 
mM).  Arg-Glc MRPs shared similarity in chemical origin with RIE MRPs, and improve cell 
survival rates against virus infection. However, RIE MRPs remained highly effective to 
MDCK cells at a relative low concentratioin of 1 mg/mL (dry weight of roots), when the 
concentration of Arg-Glc MRPs is about 15 mg/mL (an estimated value based on 50 mM 
arginine and 50 mM glucose). Although it requires a much higher concentration for its 
efficacy, Arg-Glc MRPs still fairly represent some physiological functions of MRPs derived 
from the roots. Its cell membrane protective effects need a further study with other 
experimental methods. The effective compositions of Arg-Glc MRPs have not been isolated 
and identified.  
Besides the MRPs derived from amino acids and reducing sugars, glycated proteins form 
another class of MRPs that need to be investigated. Three glycation protein precursors, 
namely RITIP1/2/3, were isolated from the fresh roots. Two genes of these proteins were 
cloned, and the full-length cDNA was sequenced by using N-terminal amino acid sequence 
of RITIP3 as template for primer design. RITIP protein sequences are homologous with a 
trypsin inhibitor family.  
The trypsin inhibitory activity of RITIP proteins was determined at different concentrations 
of protein, temperature and pH, as a mixture and as a purified single compound. The heat-
involved process generally decreased the activities, with an exceptional increase in the 
boiling-water extract of sun-dried roots. Heat processing, either in a dry (sun-drying) or 
aqueous substance (boiling-water extraction) can denature the proteins and cause the decline 
in protease inhibitory activity (DiPietro & Liener 1989) (Jiao et al. 1992). The glycation, in 
which glucose is incorporated, has been reported to decrease the protease inhibitor’s activity 
in several trypsin inhibitor families (Kato & Matsuda 1997), and in the plasma protease 
inhibitor, i.e. heparin-cofactor II (Ceriello et al. 1990). My measures on the glycation caused 
by sun-drying were consistent with the finding above, whereas the glycation of boiling-water 
extraction caused an opposite consequence: an increase in the inhibitory activity. The 
mechanism behind this remains unclear.  
The IC50 values of RITIP1/2/3 were almost the same, about 1 mg/mL. The proteins were 
tolerant to acidic environment. The similarity in inhibitory activities of RITIP proteins is 
consistent with their homogeneous amino acid sequences. The trypsin inhibitors have also 
been known as potential antifungal agents (Cowan 1999). The antifungal activities of RITIP 
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proteins were examined by Gao et al. (Gao et al. 2008). RITIP proteins showed significant 
antifungal activity on 3 out of 20 strains of addressed fungus. These experimental results 
supported the assumption that RITIP proteins are members of the trypsin inhibitors / 
antifungal proteins family. The proteins may play a role in the defending system of the plant 
against microorganisms.  
The protease inhibitors have been massively studied as an antiviral or anti-influenza virus 
agent (Lamarre et al. 2003) (Patick & Potts 1998) (Serkedjieva 2009). RITIP proteins are 
about 25 kDa, and will easily be denatured by the heat-involved process, i.e. boiling water 
extraction. These inhibitors, at least their active core domains, would have to be resistant to 
pepsin hydrolysis to reserve the integrity of the secondary structure which is obligated for 
delivering the inhibitory effects. Furthermore, these protease inhibitors have to be absorbable 
to human digestive system. These two properties would be vital for RITIP proteins to deliver 
their clinical efficacy, if there is any. Therefore, it is difficult to anticipate antiviral effects of 
RITIP proteins in their native form. 
The anti-haemagglutination activities of RITIP proteins and GRITIP proteins were 
determined with erythrocytes by measuring the virus titres. RITIP proteins inhibited the 
haemagglutination at 250 µg/mL or higher concentrations while the glycated counterpart, 
GRITIP proteins, conducted the weaker inhibitory effects. The anti-influenza virus activities 
of RITIP proteins and GRITIP proteins were determined with cultured MDCK cells by 
Wang et al (data not shown, but available on request). Both samples inhibited H1N1 viruses 
infection or replication at the much lower concentrations than those of haemagglutination 
inhibition, ranged from 2.0 µg/mL to 12.5 µg/mL, when they were introduced to the viruses 
attached cells. RITIP presented a stronger inhibitory effect than GRITIP, which is in an 
agreement with the anti-haemagglutination activity. These proteins are different from RIE in 
the way of conducting the antiviral effects. RIE conducts the cell protective effects while 
RITIP and GRITIP proteins performing cell reparative effects. The anti-influenza virus 
activities of these proteins need further investigations on the individual purified protein, by 
measuring the proliferation rates interfering with viral infection, and by plaque reduction 
assay.  
Since none of these proteins was directly from RIE, which is the boiling-water extracts of 
sun-dried roots, they are hardly the representative of RIE MRPs for the biophysical studies. 
In contrast, being prepared through an intensive heating process with two pure active 
reactants, Arg-Glc MRPs represent the much more advanced products of Maillard reaction 
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than GRITIP proteins. It was used in the studies later due to its chemical similarity with RIE 
MRPs. 
Two glycated proteins, GRITIP1 and GRITIP3 were purified from the sun-dried roots. The 
molecular weights of these two glycated proteins were approximately 25.1 kDa and 22.4 
kDa. Their pI values were 6.58 and 6.68. They are very similar in terms of molecular size, 
amino acids seuqence and electric charge. Revealing by PAS staining, these two proteins 
presented the higher degree of glycosylation than their native forms, indicating that they had 
reacted with reducing sugar to generate non-enzymatic glycosylation (glycation) residues on 
the surface of proteins. Several lysine and arginine residues were identified as glycation sites 
on both of proteins. However, it would be totally different situation when it comes to the 
glycated proteins in RIE, which is highly glycated by a violent heating process. By doing the 
analysis on GRITIP proteins, the method of locating and identifying glycation sites and 
residuals was established and ready to be applied on the analysis of other glycated proteins 
from Chinese medicine.  
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CHAPTER 5   
 





 5.1.  AIMS AND INTRODUCTION 
 
The anti-influenza virus activities and cell protective effects of MRPs have been examined in 
the previous chapters, in terms of for their biochemistry. The interaction between MRPs and 
cell membranes is thought to be the preliminary mechanism of these activities. Various 
membrane components, such as proteins, lipids, polysaccharides, could be the targets of 
MRPs’ actions.  
As discussed in the last chapter, Arg-Glc MRPs inhibited haemagglutination by binding to 
erythrocytes, thereby improved the viability of MDCK cells against influenza viruses. Does 
the interaction between Arg-Glc MRPs and cells enhance the mechanical strength of 
phospholipid bilayer, or that of the plasma membrane of living cells? To address this 
question, the effects of Arg-Glc MRPs on the integrity and mechanical strength of cell 
membrane need to be tested. Two haemolysis models were introduced here for this purpose, 
to observe the influence of Arg-Glc MRPs on the stability and elasticity of erythrocyte 
membranes.  
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5.1.1.  Hypotonic haemolysis 
The semipermeable lipid membrane separates the red blood cells from the aqueous 
environment, but allow some solutes (usually small molecule like sodium chloride) to pass 
through driven by osmosis. This allows the adjusting of the solutes concentration gradient 
between intercellular solution and intracellular plasma. The behaviour of erythrocytes varies 
in the hypotonic, isotonic and hypertonic solutions (Tatsumi, 1981). 1) Erythrocytes remain 
in their normal size and biconcave shape in an isotonic solution, 0.9% NaCl solution for 
example. 2) In a hypertonic solution, the increased osmolarity (400 mOs or higher) forces 
water to flow out of the cells, and causes the cells to collapse or form the spiky appearance. 
3) In a hypotonic solution, i.e. at 200 mOs or lower, water flows into the erythrocytes and 
causes the cells to undergo swelling and bursting (Saari & Beck, 1975). The cell contents, 
including haemoglobin (red coloured) and lactate dehydrogenase, are then released to the 
solution. The degree of haemolysis therefore can be monitored by measuring the content of 
these cellular proteins in the supernatant.  
The possible stabilisation effects of Arg-Glc MRPs on lipids bilayers can be evaluated by 
measuring the resistance of erythrocytes to hypotonic pressure in the presence of Arg-Glc 
MRPs. In this approach, the erythrocytes are suspended in saline at various concentrations. 
Low osmotic pressure is introduced with diluted saline. The leakage of cell plasma was 
measured by two methods: lactate dehydrogenase assay and the absorbance at 540 nm.  
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5.1.2.  Temperature dependence of haemolysis 
Mammalian blood, from human or rodent sources suffers from spontaneous haemolysis 
when it is heated above the normal body temperature, even by a small temperature rise, such 
as that caused by fever (Gershfeld & Murayama, 1988). Various mechanisms have been 
proposed for the thermally-induced haemolysis, including: 1) denaturation of vital enzymes 
and proteins; 2) formation of haemolytic agents in cell plasma; 3) structural transition of 
plasma membrane lipids, i.e. gel-liquid crystal transition or lamellar-to-nonlamellar structure 
transition. 
The former two mechanisms, however, are irrelevant to the haemolysis induced by the 
modest heating of fever. Enzymes and structural proteins are rather stable at a few degrees 
higher than the physiologically preferable temperature of 37°C. Enzymes like ATPase even 
present their optimal activities at temperature of 42°C (Brandts et al. 1978). The severe loss 
or irreversible changes in enzyme activity or protein structure only occurred if more extreme 
temperatures were applied, i.e. temperature > 60°C, for a prolonged time. Even if the 
potential denaturalisation at the lower temperature occurred, their negative effects on the cell 
function can also be minimized by the heat shock proteins/chaperonins (Sigal 2002). At the 
experimental conditions of this study, erythrocytes were exposed to supraphysiological 
temperature (56°C) only for a short period (30 min). Loss of enzyme activity or 
denaturalization of protein was unlikely to make a major contribution to haemolysis. Thus, 
structural transformation of membrane lipids may play an important role in heat-induced 
haemolysis.  
Furthermore, the structural transformation can include gel-liquid crystalline phase transition 
and lamellar-nonlamellar phase transition. Since the transition temperature of the gel-liquid 
crystalline phase for erythrocytes membrane lipids is far below 37°C (Gershfeld & 
Murayama 1988) (Gottlieb 1974), the melting of the lipid bilayer cannot be responsible for 
inducing haemolysis at temperatures above 37°C. On the other hand, the formation of 
nonlamellar structure of membrane lipids could account for the haemolysis induced by mild 
heating.  
The non-lamellar structures of lipid vesicles, including inverted cubic phase (QII) or inverted 
hexagonal phase (HII), are the key intermediates of some important biological processes like 
endocytosis and virus-induced membrane fusion. Membrane lipids with small head-groups 
and unsaturated fatty-acid tails, e.g. DOPE, are readily form non-lamellar structures. As 
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revealed by studies using lipid vesicles composed of more than one species of synthetic 
phospholipids, the accumulation of unsaturated lipids (i.e. DOPE) in microdomains, resulted 
in an uneven distribution of lipids across the lipid bilayer. This reassortment of lipid can 
assist the formation of non-lamellar structures (Morein et al. 1996); Rietveld & Simons, 
1998). A similar process would occur in the lipid membrane of living cells, like erythrocytes, 
if the environmental temperature of cells exceeded the lamellar to non-lamellar phase 
transition temperature of their major lipid components.  
The major lipid components of human erythrocyte membranes are cholesterol (45 mol%), 
phosphatidylcholine (17 mol%), sphingomyelin (17 mol%), phosphatidylethanolamine (16 
mol%) and phosphatidylserine (6 mol%) (Yeagle 1993). The phospholipids are 
asymmetrically distributed across the bilayer. Sphingomyelin and phosphatidylcholine are 
located primarily in the outer leaflet while phosphatidylethanolamine and phosphatidylserine 
are located in the inner leaflet (Schrier et al. 1983).  
The non-lamellar phase transition temperature, above which the lamellar structure of cell 
membrane starts transforming to non-lamellar structure, is usually higher than the gel-liquid 
crystal transition temperature (Gershfeld 1993). The plasma membrane of human and 
chicken erythrocytes is optimally stable below this temperature, which is around 37°C. 
Although the erythrocyte’s lipid bilayers can accommodate a minor rise in temperature with 
the aid of their cytoskeletons, and change their shapes, there is limit. When the temperature 
exceeds this limit, the lipid bilayers would be destablised and cells would undergo 
haemolysis. This response occurs as a function of time and temperature (Gershfeld & 
Murayama 1988). At temperature lower than 45°C, it took 5-10 h to see a significant 
haemolysis, whereas it only took 20 min to trigger a haemolysis at 54.5°C (Abe et al. 1981).  
Therefore, incubation of erythrocytes at a temperature higher than 37°C, in case of human or 
chicken, will cause a thermally induced destabilisation of the membrane and haemolysis. 
The degree of haemolysis can be used as an indirect parameter for evaluating the lipid 
bilayer stabilising activities of haemolysis inhibitory agents. 
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5.2.  Methods and Materials 
 
5.2.1.  Inhibition of hypotonic haemolysis  
The hypotonic haemolysis was performed with Seeman’s protocol (Seeman 1967). 154 mM 
NaCl (equal to 0.9%, w/w) was dissolved in distilled water to make the isotonic solution, or 
‘normal saline’. Blood was donated by healthy volunteers and the erythrocytes extracted. 
EDTA was used as anticoagulant. Erythrocytes were separated from blood by centrifuging at 
350 g for 5min, and washing with normal saline three times. Cells were re-suspended in 
isotonic normal saline to make a 1% suspension for all the tests. 1mL of 1% erythrocyte 
suspension was centrifuged at 350 g for 5 min, and the supernatant was removed. Cells were 
re-suspended evenly in 1mL normal saline containing Arg-Glc MRPs and Arg+Glc at 
various concentrations. 
Arg-Glc MRPs was tested for their inhibition effects on hypotonic haemolysis, at serial 
concentrations of 0.24, 0.47, 0.94, 1.88, 3.75, 7.50, 15.0, 30.0 mM.  Mixed solutions of 
arginine and glucose at the same concentrations were used for control.  The hypotonic 
environment was created by diluting normal saline to 0% and 0.45% NaCl. Serial 
concentrations of NaCl have been used to impose differential hypotonic pressure on cells.  
0.45% NaCl efficiently induced haemolysis and was chosen as the working concentration for 
measuring the inhibitory effects of the MPRs. 
In order to measure the inhibition of hypotonic haemolysis, erythrocytes were incubated with 
samples for 2.5 h at 37°C, prior to exposure to low osmotic pressure. The cell suspension 
was stirred every 15 min to maintain an even distribution of cells. The cells were collected 
by centrifuge and washed with normal saline three times after incubation with samples. Cells 
were then re-suspended in hypotonic 0.45% NaCl saline for 1 h at 37°C, before the 
supernatant was tested for lactate dehydrogenase (LDH) activity and absorbance at 540 nm, 
which relates to haemoglobin concentration (Souri et al. 1996).     
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The inhibition rate of each material on hypotonic haemolysis was calculated according to the 
Eq 5.1. 
 
Inhibition rate (%) ={1-                } × 100    Equation 5.1 
 
A1: OD540nm or LDH activity of the sample in hypotonic solution 
A2: OD540nm or LDH activity of the sample in isotonic solution 
B1: OD540nm or LDH activity of the control in hypotonic solution 










5.2.2.  Lactate dehydrogenase (LDH) assay 
As an abundant component of erythrocytes, LDH has been regularly used as a bio-marker of 
cell breakdown (Kraus, 1964 Science; Xue & Yeung, 1994). The haemolysis induced by 
hypotonic stress leads to a dramatic increase in LDH levels in the supernatant of the 
erythrocyte suspension, which can be quantified measurment of LDH activity. 
The reagents were added and mixed evenly at room temperature for 3 min, as described in 
Table 5.1. The absorbance of each tube was measured with 1 cm diameter cuvettes at 440 
nm, using distilled water as the background control. The LDH activities were calculated 
from absorbance readings according to the Eq 5.2. 
 
! 
LDH Activity (U/L) =
O.D.Sample - O.D.Sample Blank( )
O.D.standard - O.D.standard Blank( )
" standard (2 mmol/mL)" 1000 mL  
      Equation 5.2 
            
Table 5.1  Protocal of LDH activity measurement 
 
Standard Blank Control of Standard Sample 
Blank Control of 
Sample 
2 µmol/mL Pyruvic Acid (mL) 0.02 — — — 
Water (mL) 0.13 0.15 — 0.05 
Sample (mL) — — 0.1 0.1 
Matrix Buffer (mL) 0.25 0.25 0.25 0.25 
NAD+(mL) — — 0.05 — 
Mixed evenly, 37°C, 15 min 
2,4-Dinitrophenylhydrazine (mL) 0.25 0.25 0.25 0.25 
Mixed evenly, 37°C, 15 min 
0.4 M NaOH (mL) 2.5 2.5 2.5 2.5 
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5.2.3.  Inhibition of heat-induced haemolysis 
The inhibition of heat-induced haemolysis by Arg-Glc MPRs was measured according to 
reported methods (Abe et al. 1981) with modifications. Chick whole blood was collected 
from healthy roosters. EDTA was used to prevent blood coagulation. Erythrocytes were 
separated from blood by centrifuging at 350 g for 5min, and washed with isotonic normal 
saline (0.9% NaCl) three times.  The volume of erythrocytes was measured and restored to 
1% (v/v) suspension with normal saline. The suspension was prepared before each of the 
tests and was used fresh. 
Arg-Glc MRPs was dissolved in normal saline at various concentrations and incubated with 
red blood cells at a ratio of 1:1 (v/v) at 37°C for 2 h and washed with normal saline three 
times at room temperature. The cells were re-suspended and incubated at 56.5°C for 30 min 
to ensure high levels of cell lysis. Normal cells were incubated at 37°C for 2 h and used as 
control. The working concentration of Arg-Glc MRPs for each sample was 7.50, 3.75, 1.88, 
0.94, 0.47, 0.24, 0.12 mg/mL.  The supernatant of lytic cells was collected by centrifuging at 
3000 g for 3 min, and measured at 540 nm for absorbance. The protection rate against heat-
induced haemolysis was calculated according to the following equation Eq 5.3. 
 
! 
Protection Rate (%) = 100 " [
O.D.Sample heated - O.D.Sample Unheated( )
O.D.Control sample heated - O.D.Control sample unheated( )
# 100 ]  
         Equation 5.3 
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5.3.  RESULTS 
 
5.3.1.  Inhibitory effects of Arg-Glc MRPs on hypotonic haemolysis  
Inhibition of Arg-Glc MRPs on hypotonic haemolysis was investigated in three solvents: 
distilled water, 0.45% NaCl saline and normal saline (0.9% NaCl), respectively. As shown in 
Section 4.2.2.6, 31% of arginine and 39% of glucose remained uncombined as Arg-Glc 
MRPs. To examine the potential interference of arginine and glucose on haemolysis, a 
mixture of arginine and glucose was prepared immediately before the experiments in the 
same ratio and concentration as Arg-Glc MRPs, and was used as a control.   
As shown in Fig 5.1, more than 85% of erythrocytes were broken down in 0.45% saline, 
whereas less than 8% of cells broke down in the same saline following incubation with Arg-
Glc MRPs for 2.5 h. However, in pure water, referred to ‘0% NaCl’ in Fig 5.1, Arg-Glc 
MRPs failed to prevent haemolysis from occurring. The low osmotic pressure created by 
pure water was too severe for MRPs to cope with. Therefore, 0.45% NaCl was used in all 
further tests of MRPs’ anti-haemolytic effects. 
As a control, a mixture of arginine and glucose was examined for potential interference on 
hypotonic haemolysis but showed no effects. This implies that the inhibitory effect of Arg-
Glc MRPs was not attributed to the glucose or arginine left over from the Maillard reaction. 
The Maillard reaction products were the effective components, although their effective 
molecules remained unknown.  
A dose-response curve was drawn to evaluate whether the protection of Arg-Glc MRPs to 
erythrocytes was dependent to its concentration. As shown in Fig 5.2, Arg-Glc MRPs 
inhibited leakage of LDH or haemoglobin at all the concentrations tested, from 0.24 mM to 
15.0 mM. The optimum protection was achieved at 7.5 mM, which produced an inhibition 
rate of 96%. The haemolysis inhibition rate remained at a high level at concentrations that 
ranged from 3.75 mM to 15.0 mM, while the inhibitory effects became less efficient at lower 
concentrations. At 0.24 mM, the lowest effective concentration, the haemolysis inhibition 
rate dropped to 32% measured by LDH assay. Once again, the mixture of arginine and 




Figure 5.1  Inhibition effects of Arg-Glc MRPs on hypotonic haemolysis induced by different salt 
concentration in solution.  
0%, 0.45%, 0.90% NaCl refers to the saline concentration of erythrocytes in suspension. The 
concentrations of Arg-Glc MRPs, arginine and glucose were the same, 30 mM, in the measurement. 
**: the differences between Arg-Glc MRPs and normal Saline, or Arg+Glc and Arg-Glc MRPs, were 
highly significant (n=3, P<0.01).   
Figure 5.2  Inhibition of hypotonic haemolysis of Arg-Glc MRPs measured by LDH assay.   
Note: the inhibition rates on hypotonic haemolysis were calculated with LDH activity in supernatant 
of erythrocytes suspension. (◆) haemolysis in the cells incubated with Arg-Glc MRPs; (□) 
haemolysis in the cells incubated with a mixture of arginine and glucose.  Erythrocytes were 
suspended in 0.45% NaCl saline. (n=3, P<0.01) 
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Figure 5.3  Inhibition of hypotonic haemolysis of Arg-Glc MRPs measured by absorbance.   
Note: percent inhibition was calculated with OD540nm of supernatant of erythrocytes suspension. (◆) 
haemolysis in the cells incubated with Arg-Glc MRPs; (□) haemolysis in the cells incubated with a 
mixture of arginine and glucose.  Erythrocytes were suspended in 0.45% NaCl saline. (n=3, P<0.01) 
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5.3.2.  Inhibitory effects of Arg-Glc MRPs on heat-induced haemolysis 
As shown in Fig 5.4, Arg-Glc MRPs protected erythrocytes from heat-induced haemolysis at 
concentrations ranged from 0.12 to 1.88 mg/mL. The maximum protection rate was 76% at 
0.47 mg/mL but decreased at either higher or lower concentrations. No inhibition effect was 
observed at the concentration of 3.75 mg/mL and 7.50 mg/mL. In reverse, Arg-Glc MRPs at 
these two concentrations might slightly promote haemolysis, although the figures were not 
statisticly significant. 
 
Figure 5.4  Inhibition of heat-induced haemolysis of Arg-Glc MRPs measured by absorbance.  
Concentration for each sample was 7.50, 3.75, 1.88, 0.94, 0.47, 0.24, 0.12 mg/mL. (n=3, P<0.01) 
This work was conducted under the collaboration with Mr. Wei Lu from Institute of Biotechnology 




5.4.  DISCUSSION AND CONCLUSIONS  
Lowering the external concentration of saline will create a significant osmotic pressure 
gradient across the plasma membrane of a cell, and may induce a leakage of cell contents if 
the membrane fails to maintain its integrity against the growing pressure. Haemolysis can 
also occur when the environmental temperature is higher than the critical growth temperature 
of cells, usually 37°C. Lactate dehydrogenase assays and O.D. 540nm of haemoglobin are the 
indices of this leakage. The more the enzyme or haemoglobin appeared in supernatant, the 
more serious the leakage would be. 
Arg-Glc MRPs displayed cell-protective effects by inhibiting both hypotonic and heat-
induced haemolysis. According to the way the measurements were performed, this 
haemolysis inhibition activity is more likely to be a cyto-protective effect rather than other 
means of interference, such as a cell-reparative effect for example. Since the anti-haemolysis 
effects were achieved by incubating the MRPs with erythrocytes for 2 to 2.5 h in isotonic 
solutions and at physiological temperature, prior to exposing the cells to hypotonic or 
hyperthermic circumstance, Arg-Glc MRPs would only prevent erythrocytes from 
haemolysis, but not be able to reverse the haemolytic process once it starts.   
Furthermore, these experiments indicate that the cell membrane is the major site of the cyto-
protective action of MRPs. After incubation, the cells were washed with isotonic saline to 
remove the free Arg-Glc MRPs from the cell suspension. Only the MRPs that were bound to 
cells, or those who were absorbed by endocytosis, would remain in the suspension to prevent 
cells from hypotonic or thermally induced haemolysis. However, if Arg-Glc MRPs were 
taken into the cells, they would only increase the osmotic pressure between intracellular 
plasma and intercellular medium. This increase would certainly increase the risk of 
haemolysis, particularly when the intercellular medium was in hypotonic conditions. On the 
contrary, administration of Arg-Glc MRPs inhibited haemolysis. Therefore, the cell 
membrane becomes the most likely site for Arg-Glc MRPs to perform their cell protection 
activity. 
However, Arg-Glc MRPs acted differently on these two types of haemolysis. In hypotonic 
haemolysis, the degree of inhibition initially grew along the increase in concentration, but 
remained at the same level for concentrations ranged from 3.75 mM to 15.0 mM. In contrast, 
the effects of Arg-Glc MRPs on thermally induced haemolysis showed a biphasic protection-
concentration curve: (1) an increasing inhibitory effect at low concentration ranged from 
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0.12 to 0.47 mg/mL, and (2) a decreasing inhibitory effect at high concentrations ranged 
from 0.94 to 7.5 mg/mL.  
As shown in reported studies, some agents containing sugar moieties, i.e. plant saponins 
(Abe, 1981), cyclodextrins (Irie, 1982), inhibited both hypotonic and heat-induced 
haemolysis, and show biphasic stabilisation-lytic effects on haemolysis. At relatively low 
concentrations, these agents inhibit haemolysis, while the effects are reversed at higher 
concentrations.  My results from Arg-Glc MRPs were consistent with those reports, 
indicating that sugar moieties or derivatives might be responsible for MRPs’ haemolytic 
inhibition activities.   
In adults, the number of erythrocytes is about 5 million per microliter. The optimum ratio 
between Arg-Glc MRPs and cells for protection against hypotonic haemolysis, was 
approximately 1.5 µmol to 107 cells.     
How does Arg-Glc MRPs inhibit haemolysis and enhance the mechanical strength of cell 
membranes against osmotic stress and hyperthermal stress?  There are several possible 
mechanisms which can be attributed to the effects of MRPs: (1) chemical modification to 
endogenous components of membranes; (2) preventing denaturation of vital proteins in 
membranes; (3) membrane disruption induced by lamellar to non-lamellar phase transition in 
lipid bilayers.  
Firstly, chemical reactions, which might have occurred during the experiments, would result 
in modification of membrane components or the generation of membrane stabilising agents. 
However, the erythrocytes were incubated in mild conditions (2-2.5 h at 37°C) that were 
unlikely to allow extensive chemical reaction between MRPs and plasma membrane 
components.   
Secondly, inactivation of vital enzymes or denaturalization of structural proteins may 
contribute to heat-induce haemolysis at the experimental conditions, but not to hypotonic 
haemolysis. And as described in Section 5.1.2, at the mild thermal conditions of this study, a 
severe and irreversible denaturalization of proteins is doubtable. More importantly, Arg-Glc 
MRPs were efficient in inhibiting both types of haemolysis, implying its protective effects 
do not necessarily depend on preventing proteins/enzymes from denaturation.   
Thirdly, transformation of the membrane lipid bilayer from unilamellar to non-lamellar 
structures is directly relevant to haemolysis. Bilayer stabilisers can prevent the 
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transformation and subsequently prevent haemolysis, at a critical range of stabiliser-lipid 
ratios. When the concentration of stabiliser exceeds the upper limit of the range, the 
stabiliser can destabilise the bilayer by interfering with the general packing of lipids. The 
stabilisation of lipids bilayers becomes a reasonable mechanism whereby Arg-Glc MRPs 
impose an inhibitory activity on haemolysis.  
To sum up, Arg-Glc MRPs stabilised the plasma membrane of red blood cells and prevented 
both hypotonic and heat-induced haemolysis in a dose-response manner. This assumption 
will be examined by the following biophysical means of study, including differential 







EFFECTS OF MRPS ON PHYSICAL PROPERTIES  




6.1.  AIMS AND INTRODUCTION 
In the previous chapters, it has been proposed that MRPs act on the surface of the cell 
plasma membrane, and protect cells from virus infection and hypotonic or heat-induce 
membrane leakage. Here in this chapter, the interactions of the MRPs with phospholipid 
membranes and their effects on the molecular structure of lipid assemblies were investigated 
with three biophysical methods, namely surface pressure measurements, fluorescence spectra 
and differential scanning calorimetry (DSC). The studies on the fundamental structural 
transformations of lipid monolayers and bilayers were carried out in the hope of discovering 
the primary mechanism of MRPs’ cyto-protective and antiviral activities. 
 
6.1.1.  Langmuir monolayers of phospholipids 
Phospholipids form lamellar monolayers at the air-water interface, and serve as models for 
biological membranes. Since they resemble half a bilayer, with the hydrophilic head groups 
pointing down towards the aqueous sub-phase (Fig 6.1 and 6.2), they are most suitable to 
mimic the interactions occurred on the membrane surface. The effects of MRPs on the 
stability of lipid monolayers provide valuable information to predict their effects on the lipid 
bilayers (Brezesinski & Mohwald 2003). 
 
 
Figure 6.1  A schematic illustration showing the components of an amphiphile (left), and the 









Phospholipids form lamellar or non-lamellar structures at the corresponding conditions. The 
main factors, which are dominant in the formation of phospholipids assemblies, are (1) the 
types of head/tail groups of lipids, (2) the temperature and pH of subphase in which the 
lipids are dispersed through, and (3) the compounds interacting with lipids and thereby 
adjust the molecular packing of lipids, such as electrolytes, water, detergents and membrane 
fusion peptides.   
 
Figure 6.2  Schematic illustration of the states associated with lipid in monolayer.  
Isotherm of DMPE at 20°C, quoted from Graf’s diagram (Graf, 1998) and (http://www.mpip-
mainz.mpg.de/~grafk/Monolayer_LB.html). 
 
The appropriate phospholipids have to be chosen to accomplish the mission of revealing 
biophysical impacts of MRPs on the cell membranes by the methods mentioned above.  For 
example, DOPG has a negatively charged head group at physiological pH values and a 
double bond in its fatty acid tails. A monolayer resembled by DOPG will give a better 
representation on mimicking the negative charged cell membrane, than the monolayers 
composed by zwitterrionic lipids such as PC lipids. The double bond in the tails will create a 
bigger free volume between lipid molecules than the saturated phospholipids, and thereby 
allow the exogenous amphipathic compounds to cooperate with lipids more easily.  
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6.1.2.  Molecular packing of lipid bilayers sensed by fluorescent probes 
The effects of MRPs on the stability and fluidity of lipid bilayers were studied to elucidate 
their stabilising activities on the plasma membrane of erythrocytes. Two lipophilic 
fluorescent dyes, Laurdan and Merocyanine 540 (MC540) were employed to investigate the 
effects of MRPs on the molecular packing and orientation in the lipid bilayers.   
 
6.1.2.1.  Steady-state spectra of Laurdan 
As a hydrophobic fluorescent probe, Laurdan (2-dimethylamino-6-lauroylnaphthalene) has 
been widely used in natural and artificial lipid membrane systems, such as erythrocytes (Vest 
et al. 2004) and phospholipid liposomes (Parasassi et al. 1990), to study phase coexistence 
and membrane fluctuation in lipid bilayers. As shown in Fig 6.3 and 6.4 , Laurdan anchors in 
the phospholipid bilayers with its 12-carbon aliphatic tail while its fluorescent naphthalene 
moiety locates at the bilayer surface. Two possible sites have been indicated for the 
fluorescent moiety to reside: at the level of the glycerol backbone of the DOPC lipids (Zhang 
et al. 2006); (Sanchez et al. 2007) or somewhere around the choline group of the DLPC 
lipids (Vequi-Suplicy, Benatti & Lamy 2006). As the head groups of lipids normally bend 
down towards the interface between heads and tails, either site would mean that Laurdan 
mainly locates at the hydrophilic bilayer surface.  
Laurdan is known to be sensitive to the polarity of its micro-environment. A substantial red-
shift in emission wavelength results in polar solvents, compared to non-polar solvents 
(Parasassi et al. 1990). Thus, Laurdan is highly sensitive to the phases of phospholipid 
vesicles, as a result of the microenvironment polarity and viscosity of the system. Since the 
packing of membrane lipids defines the rigidity of water molecules around the fluorophore at 
the lipid bilayer surface, the intensity and λmax of Laurdan fluorescence emission is highly 
sensitive to the molecular packing of the lipid bilayer, both in the gel and liquid crystalline 
phases. The λmax of Laurdan centres at 440 nm in the gel phase, and at 490 nm in the liquid-
crystalline phase. This is also supported by measurements of the fluorescence anisotropy and 
spin labels of Laurdan that was incorporated at different positions in the Lα phase of DLPC 
and DPPG bilayers (Vequi-Suplicy, Benatti & Lamy 2006).  
Polarity changes appear as shifts in the Laurdan emission spectrum, between a short-
wavelength band centered at around 440 nm and a long-wavelength band at 490 nm. These 
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may be quantified by calculating the generalized polarization (GP) with the equation (Eq 
6.6) (Sanchez et al. 2007). The λmax of Laurdan displays a red shift of ~50 nm when the 
phase of bilayers goes from Lβ to Lα along with a rise in temperature (Parasassi et al. 1991). 
Long-wavelength emission predominates in the liquid crystalline phase, whereas short-
wavelength emission predominates in the gel phase.   
 
 
A       B 
Figure 6.3  Schematic representation of Laurdan fluorophore location. 
In (A) the phosphocholine bilayer (Zhang et al. 2006) and (B) the naphthalene moiety of Laurdan sits 
in the DOPC membrane at the level of the glycerol backbone, while the 12-C hydrocarbon chain 
inserts between the lipid tails. The water molecules (black dots) relocalised around the Laurdan dipole 
(arrows) are responsible for the 440-to-490 nm red-shift observed during the gel-to-fluid phases 




Figure 6.4  Laurdan may locate near the choline residue (dash line) of DLPC molecules (Vequi-
Suplicy, Benatti & Lamy 2006). 
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6.1.2.2.  Merocyanine 540  
In contrast to Laurdan, merocyanine 540 (MC540) lies parallel to the surface of bilayers in 
their Lα  phase, at the interface of hydrophilic and hydrophobic regions of outer leaflet, with 
the butyl residues penetrating into the hydrocarbon chains and the sulfate protruding to the 
level of amine. In Lα phase, the amphiphilic dye mainly exists as the monomer at the level 
slightly above the glycerol backbone of zwitterionic or negative charged lipids, whereas it is 
expelled from the bilayers in Lβ phase but still in contact with the polar head-groups of lipids 
(Lelkes & Miller 1980). The schematic representation of MC540 location in lipid bilayers is 
shown in Fig 6.5. 
The fluorescence of MC540 is enhanced when the lipophilic dye binds to artificial bilayers 
and enters the hydrophobic region of the membrane. Much more dye binds to multilamellar 
or unilamellar vesicles in the liquid-crystalline phase than the gel phase. MC540 senses the 
degree of lipid packing in bilayers and inserts preferentially into the bilayers with greater 
free space between lipids (Williamson, Mattocks & Schlegel 1983). MC540 detects the 
subtle differences in molecular packing of bilayers revealed by a 20-nm red-shift in emission 
λmax as lipids become less tightly packed (Langner & Hui 1999) (Stillwell et al. 1993) 




Figure 6.5  A schematic diagram presenting the location of MC540 in the lipid bilayers.  
MC540 lies parallel to the hydrophilic-hydrophobic interface of bilayer (Lelkes & Miller 1980). 
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6.2.  MATERIALS AND METHODS 
 
6.2.1.  Materials 
1,2-dioleoyl-sn-glycero-3-phosphoglycerol (DOPG) sodium salt, 1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPC), 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) and 1,2-
dioleoyl-sn-glycero-3-phosphoethanolamine-N-methyl (MeDOPE) were purchased from 
Avanti Polar Lipids Inc., USA, and used without further purification. Chloroform, methanol 
and buffers are all graded AR and purchased from Sigma-Aldrich (Irvine, UK). Laurdan was 
purchased from Molecular Probes (Eugene, OR). Merocyanine 540 was purchased from 
Sigma-Aldrich.  
 
6.2.2.  Langmuir Balance  
Lipid monolayers were assembled using a Langmuir film balance (NIMA Technology, 
Coventry, UK). The experiments were carried out at 293K. The lipid spreading solutions 
were prepared with chloroform at 200 µg/mL. 24 µg of lipid (120 µL spreading solution) was 
used for the assembly of monolayers in each of the measurements. MRP samples were 
dissolved in phosphate sodium buffer (pH7.4, 0.1 M). To form the monolayer, the stock 
chloroform solution of DOPG was dispersed on the surface of aqueous subphase (pH7.4, 0.1 
M PSB) by gently dropping with a micro-cylinder (Hamilton), followed by a wait of 10 mins 
to allow evaporation of the solvent. After each measurement, the trough was cleaned with 
chloroform, methanol and deionised water sequentially.   
The surface pressure of DOPG Langmuir monolayer was controlled in two ways: (1) an 
isotherm scan in which the surface pressure was gradually increased by reducing the surface 
area; (2) a scan in which the area of monolayer was adjusted to maintain a fixed surface 
pressure. In the first method, the surface pressure (π) – area (A) isotherms were recorded at a 
barrier speed of 200 cm2/min to measure the surface pressure change.  
In the second method, the stability of the lipid monolayers was studied by measuring the 
mean molecular area as a function of time at a constant surface pressure of 20 mN/m. 
Samples were added to the subphase by pipetting the solution underneath the trough barrier. 
The barrier was programmed to maintain the desired surface pressure, and the surface area 
 158 
was recorded. The surface area of each lipid monolayer was measured for 25 min prior to the 
injection of MRP samples. After injection, the surface area was recorded for 35 min. In the 
first 5 min immediately following injection, a change in the slope of the curve was observed 
as a magnetic stirrer dispersed the MRPs evenly throughout the subphase. Equation 6.1 was 
used for calculating of the mean molecular area of DOPG monolayer. Equation 6.2 was used 
for calculating of the mean molecular area of DOPG monolayer in the presence of Arg-Glc 
MRPs. Eq 6.3  was used for  calculating of the collapse rate of monolayer. 
 
mma (Å2) =86.298-0.0029×t,  R2=0.999    Equation 6.1 
 
mma (Å2) =80.291-0.0007×t,  R2=0.976    Equation 6.2 
 




Figure 6.6  Breakdown of a DOPG monolayer under 20 mN/m surface pressure.  
The mma was measured constantly for 60 min and used for the calculation of collapse rate. The results 





Figure 6.7  Breakdown of a DOPG monolayer under 20 mN/m surface pressure in the presence of 
Arg-Glc MRPs.  
The mma was measured for 20 min at the second half of monitoring and used for the calculation of 
collapse rate. The second half of the monitoring represented the monolayer incorporated with Arg-Glc 
MRPs. The results thereby represent the general effects of the MRPs on the monolayer breakdown. 
 
6.2.3.  Fluorescence spectrum of dye-labeled lipid vesicles 
6.2.3.1.  Anisotropic Fluorescence Spetrum probed by Merocyanine 540 
Steady-state merocyanine 540 (MC540) anisotropic emission and excitation spectrums were 
obtained at temperatures of 10˚C, 24˚C and 37˚C with a fluorospectrometer (Xe-900, 
Edinburgh Analytical Instrument) equipped with polarizers and two detectors aligned 90° to 
each other. Fluorescence intensity was measured with excitation and emission polarizers 
parallel to each other and repeated with the polarizers perpendicular to each other.  The 
emission spectrums were measured with λexcitation = 540 nm at the range of emission 
wavelength λemission = 550 ~ 700 nm with 1-nm steps. The laser light slit was set at 2 mm, the 
excitation slits was 2 mm and the emission slits was set at 5-6 mm in order to receive enough 
emission counts for calculation.  
MLVs of DMPC and DOPC were prepared as reported previously (Harroun et al. 2003) with 
modifications. Lipids, MRPs and MC540 were mixed thoroughly by vortex, and dried by 
nitrogen stream in the test tube and left in vacuum overnight to remove trace of solvent. A 
serial concentrations of Arg-Glc MRPs, at the lipid/MRPs molar ratios ranged from 100:1 to 
100:625, were introduced to the lipids. The lipids were re-hydrated at 37°C with phosphate 
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sodium buffer (pH7.4, 0.1M) and diluted to proposed concentration prior to being applied to 
fluorospectrometer.  Samples were kept in the dark during the preparation and measurement. 
The measurements were carried out at 37°C. Each sample was calibrated in the cuvette for 5 
min to equilibrate the temperature. The fluorescent emission intensities at both 90° and 0° 
were used for calculating the correction factor G and the anisotropey constant ‘r’, with Eq 
6.4 and 6.5.  
G=IHV/IHH      Equation 6.4 
Notes: H: horizontal, 90°; V: vertical, 0°.  IHV, fluorescence intensity of polarizers perpendicular to 
each other.  IHH, fluorescence intensity of both polarizers oriented at 90°.  
 
r = (I0-G×I90)/(I0+2×G×I90)    Equation 6.5 
Notes: I0, fluorescence intensity of polarizers parallel to each other and both oriented at 0°;  I90, 
fluorescence intensity of polarizers parallel to each other and both oriented at 90°. 
 
6.2.3.2.  Steady-state spectra of Laurdan 
Multilamellar vesicles (MLVs) (10 mM) were prepared as previously described in Section 
6.2.3.1, with phosphate sodium buffer (0.1M, pH7.4) at 37°C. Small unilamellar vesicles 
(SUVs) were prepared by sonicating MLVs for 15-30 mins at the temperature higher than 
the gel-liquid phase transition temperature, e.g. 37°C. Laurdan was dissolved in DMSO and 
added into the suspension of vesicles (50 µM) at the concentration of 5 mol%. MRP samples 
were then mixed evenly with vesicles. After equilibrated at 37°C for 30-60 min, 
measurements were carried out by a FLUOROMAX-3 spectrofluorophotometer (JOBIN 
YVON, Horiba, Japan). The emission spectrums of Ex=350nm and Ex=410nm were 
recorded with 1-nm steps in the wavelength range of 370~600 nm and 420~600 nm, 
respectively. The excitation spectrum of Em=440nm was recorded with 1-nm steps in the 
range of 200~420 nm. The lipid-alone base line in the absence of MC540 was subtracted 
from all spectra. The excitation generalized polarization (exGP) at 350 nm and 410 nm, and 




GPex = (Ig- Ilc)/(Ig + Ilc)     Equation 6.6A 
Notes:  Ig and Ilc are the steady-state emission intensities at 435 nm and 500 nm, respectively (Ashley 
et al. 2006); (Harris, Best & Bell 2002)(Parasassi et al. 1990). 
GPem = (Ig- Ilc)/(Ig + Ilc)     Equation 6.6B 
Notes:  Ig and Ilc are the steady-state emission intensities at 410 nm and 340 nm, respectively 
(Krasnowska, Gratton & Parasassi 1998)(Parasassi et al. 1990). 
 
6.2.4.  Differential scanning calorimetry 
The lipid MLVs were prepared as described in Section 6.2.3, but with an additional freeze-
thaw process.  After the lipids were dissolved in chloroform, the samples were added and 
mixed thoroughly by vortex and sonication. The lipid/sample suspensions were then dried up 
with nitrogen stream and left in vacuum over night. Lipid concentration in the corresponding 
vesicle suspension was 100 mM for all the samples. MRPs were dissolved in PIPES buffer 
(pH7.4, 20 mM, 150 mM NaCl) added as a serial molar ratios of 0, 1, 5, 10, 20, 30, 40, 50 to 
100 lipid molecules. The SIV peptide was dissolved in methanol and added to the lipid 
solution at 1 mol% and 2 mol%.  
The dried lipid film was rehydrated with PIPES buffer at a temperature higher than TM and 
vortexed to make 100 mM vesicle suspension. The suspension was sonicated for 1-2 min and 
soaked in liquid nitrogen (-180°C). The suspension was then defrosted at the temperature at 
least 20°C above the TM. The freeze-thaw cycle was repeated for 6 times to obtain an unified 
lipid packing by wiping off the memory of lipids on their thermal history. The vesicles were 
mixed thoroughly prior to being injected and sealed into the aluminum sample pan. The pans 
were weighted as both empty and sealed, thereby the actual amount of lipids sealed in the 
pan was calculated. A Pyris 1 Differential Scanning Calorimeter (Perkin Elmer, US) was 
employed, at a scan rate of 40 °C/min. The sample chamber held 30 µL vesicle suspension. 
Continuous heating scans were run from 0°C through to 55°C for DMPC MLVs, and from -
30°C through to 85°C for MeDOPE MLVs (Sykora et al. 2005). For the measurements on 
DOPC MLVs, it was heated from -30°C to -5°C at 20 °C/min. 
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The transition peak was analysis with the curve-fitting program (Pyris) based on nonlinear 
least-squares minimization. The onset phase transition temperature (TM, TQ and TH for 
melting transition, transition to cubic phase and transition to hexagonal phase, respectively), 
energy consumption (∆Hf), transition peak height (h) and peak area (A) were calculated 
automatically by the software. The transition peak height and peak area were then used to 
calculate the transition temperature range ∆T (Eq 6.7), presenting the homogeneous degree 
of phases existing in the phase transition. 
 
    
! 
"T =
2 # A #T
h # t
     Equation 6.7 
 T , temperature from the scan rate (°C);   t , time from the scan rate (s). 
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6.3.  RESULTS 
 
6.3.1.  Effects of MRPs on surface tension and molecular area of lipid 
monolayer 
The surface pressure and molecular area of DOPG Langmuir monolayer were measured by 
isotherm scan with Langmuir Balance. As shown in Fig 6.9, the mean molecular area (mma) 
of DOPG at 20 mN/m is 88 Å2, which is consistent with the reported mma (90 Å2) for DOPG 
(Backov et al. 2000). MRPs derived from RIE, Momordica charantia extracts (MCE) and 
Arg-Glc were dissolved in the subphase (pH 7.4, PB buffer), respectively. Arg-Glc MRPs 
(0.5 mg/mL) were demonstrated to increase the stability of DOPG monolayer by raising the 
mma to 91 Å2 at 20 mN/m (Fig 6.9A), while RIE MRPs and MCE MRPs at the same 
concentration decreased the mma to 82 Å2 and 84 Å2 (Fig 6.9B). The maximum surface 
pressure of DOPG monolayer was 44 mN/m. RIE MRPs and MCE MRPs decreased the 
maximum surface pressure to 33 mN/m while Arg-Glc MRPs had no impacts on this figure. 
However, Arg-Glc MRPs increased the molecular area of DOPG monolayer from 124 Å2 to 
137 Å2 at the low surface pressure (2 mN/m). Furthermore, in the presence of RIE MRPs and 
MCE MRPs, the maximum surface pressure of monolayer was reached at 70 Å2 and 
remained the same when the mma was decreased to 60 Å2.  
The effects of Arg-Glc MRPs on the stability of DOPG monolayers were determined by 
measuring the collapse rate of monolayer in pressure-control tests. As shown in Fig 6.8, the 
mean collapse rate of DOPG monolayer was 0.17 Å2/min under a surface pressure of 20 
mN/m, during 60 min. Arg-Glc MRPs (1.2 mg/mL) was injected into the buffer underneath 
the monolayer (indicated with arrow in Fig 6.8), after which the collapse rate of the 
monolayer was reduced to 0.04 Å2/min.  
The amphipathic properties of the MRPs were examined by measuring the surface tension of 
their solutions. As shown in the ‘surface pressure’ versus ‘mean molecular area’ isotherms of 
RIE MRPs and MCE MRPs (Fig 6.10), surface pressure was gradually increased as the 
surface area decreased at high concentration (5 mg/mL) and in the absence of lipids.  The 
mma of RIE MRPs and MCE MRPs were 18 Å2 and 19 Å2 at 20 mN/m, respectively. The 
maximum surface pressure observed on RIE MRPs and MCE MRPs was very close, 21.4 
mN/m and 21.6 mN/m respectively.  An increase in the surface pressure was not generally 
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observed on Arg-Glc MRPs, even at a higher concentration (10 mg/mL), except a minor 




Figure 6.8  The effects of Arg-Glc MRPs on the stability of a DOPG monolayer examined by 
pressure-control surface pressure measurements. 
Target surface pressure: 20 mN/m, Barrier speed: 200 cm2/min; Temperature: 293K.  DOPG M.W. 
786.1, 0.2 mg/mL, 120 μL, DOPG was settled down on the surface of PBS (170 mL) for 10 min. 
MRPs (100 mg/mL, 2 mL) were injected underneath the DOPG monolayer at 25 min after the surface 









Figure 6.9  The surface pressure-mean molecular area isotherm measurement of the effects of MRPs 
derived from MCE, RIE and Arg-Glc on DOPG by Langmuir Balance.  
Barrier speed: 200 cm2/min; Temperature: 293K. DOPG M.W. 786.1, 0.2 mg/mL, 120 μL, DOPG was 
settled down on the surface of PBS (170 mL) for 10 min. MCE MRPs and RIE MRPs, 100 mg/mL, 




Figure 6.10  Surface pressure-mean molecular area isotherm measurements of DOPG and MRPs 
derived from RIE, MCE, Arg-Glc. 
Barrier Speed: 200 cm2/min; Maximum Area: 265 cm2; Minimum Area: 30 cm2; Temperature: 293K. 
DOPG concentration: 0.2 mg/mL, 120 μL; MCE MRPs concentration: 100 mg/mL, 50 μL; RIE 
concentration: 100 mg/mL, 50 μL; Arg-Glc MRPs:  200 mg/mL, 50 μL. 
 
6.3.2.  Effects of MRPs on the molecular packing of phospholipid 
bilayers: the fluorescence studies  
6.3.2.1.  Effects of Arg-Glc MRPs on phospholipids molecular packing 
sensed by MC540 
As shown in Table 6.1, Figure 6.11, the anisotropy constant (r) of MC540 in DMPC vesicles 
varied along the different concentrations of Arg-Glc MRPs, and also across the gel to liquid-
crystalline phase transition of DMPC bilayers.   
As shown in Table 6.1 and Fig 6.11, at 10°C, DMPC vesicles are in the gel phase, where the 
r did not change or only increased slightly. When the temperature was raised up to 37°C, the 
presence of Arg-Glc MRPs increased r and thereby stabilised DMPC bilayers in their liquid 
crystal phase at a low concentration, ranging from 100:1 to 100:25. The r decreased as the 
bilayers destabilised at the higher concentrations (100:125 and 100:625). At 23.5°C, which is 
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close to the gel-to-liquid phase transition temperature (Taly 2002), r fluctuated between the 
values of r in gel phase and those in liquid-crystalline phase.  
6.3.2.2.  Effects of MRPs on lipid order determined by fluorescence probe 
Laurdan  
Emission and excitation spectra were obtained in multilamellar vesicles (MLVs) and small 
unilamellar vesicles (SUVs) of three phospholipids, DOPC, DOPG, DMPC, respectively. 
The three lipids assayed are composed of the neutral or negatively charged head groups, and 
the saturated or unsaturated fatty acyl chains. The excitation and emission Generalized 
Polarization (GP) was calculated from the fluorescence spectra by Eq 6.6, to evaluate the 
influence of RIE MRPs on the environmental polarity in the DOPC, DOPG and DMPC 
liposomes, particularly at the interface of hydrophilic and hydrophobic regions of bilayer. 
The polarity between the head groups of bilayers reflects the spacing of lipids, and thereby 
infers the order of lipids.  
As shown in Fig 6.12~6.17, the λmax of steady-state emission spectra was around 470 nm ~ 
490 nm in all the three lipids. In the presence of RIE MRPs, the λmax obtained both with 
excitation wavelength 350 nm and 410 nm, shifts towards the longer wavelength (490 nm) 
by 5-8 nm in DOPG and DMPC SUVs, as well as MLVs.  However, the λmax shifted neither 
in the emission spectra nor in the excitation spectra of DOPC.  The intensities of emission 
were altered among the three lipids, with the intensive changes observed in DOPG and 
DMPC, which is constant with the shift in λmax. For DOPC vesicles, the low concentration of 
RIE MRPs (16.6 µg/mL) did not cause significant changes in the intensities, whereas the 
high concentration (166 µg/mL) decreased the intensity by about 25% in MLVs (Fig 6.13). 
For DOPG vesicles, RIE MRPs produced the opposite effects on MLVs and SUVs: 
concentration-dependent decreases the intensity in MLVs (Fig 6.15); and ~70% increases 
were observed in SUVs (Fig 6.14).  For DMPC vesicles, RIE MRPs increased the intensity 
of emission spectra of the MLVs whereas the intensities were decreased in all the spectra of 
SUVs (Fig 6.16) and in the excitation spectra of MLVs (Fig 6.17).   
As shown in Table 6.2, the GPex of Laurdan in all the three lipids, obtained at excitation 
wavelength of 350 nm, decreased in the presence of RIE MRPs in a concentration-response 
manner. The GPex of Laurdan in pure lipids is correspondent to the polarities in the bilayers 
and can be directly related to lipid order (Harris, Best & Bell 2002) (Ashley et al. 2006). The 
melting temperatures of DOPC, DOPG and DMPC are -20°C, -18°C, 23°C, respectively. 
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Although they were all in the liquid-crystalline phase at the assayed temperature (37°C), the 
GPex for DOPC, DOPG and DMPC was -0.210, -0.187 and -0.009, respectively, which 
showed a gradual increase. The higher polarity in DOPG and DMPC suggests the more rigid 
packing in DOPG and DMPC MLVs than in DOPC, which is consistent with the melting 
temperatures of these three lipids. 
When the excitation wavelength of emission spectra was increased from 350 nm to 410 nm, 
the GPex of Laurdan decreased in all the lipid vesicles (Table 6.3).  For SUVs, RIE MRPs 
decreased the GPex, which is consistent with the decline observed in the GPex (Ex=350nm). 
The concentration-dependent decreases of GPex were also observed in the DMPC MLVs, 
whereas the concentration-dependent increases were obtained in DOPG MLVs. For DOPC, 
RIE MRPs at 16.6 µg/mL did alter the GPex, but increased it at 166 µg/mL.  
In contrast, instead of decreasing, the emission generalized polarization (GPem) of Laurdan in 
all the lipids vesicles increased in the presence of RIE MRPs, as shown in Table 6.4, which 
indicates an opposite effect on the polarization of microenvironment to the one obtained 
from the GPex. 
 
Table 6.1  Anisotropy constant (r) of DMPC MLVs in the presence of Arg-Glc MRPs (lipid/MRPs= 
100:0 ~ 100:625) at 10˚C, 23˚C and 37˚C. 
Lipid/MRPs 
molar ratio 
100:0 100:1 100:5 100:25 100:125 100:625 
10°C 0.148 0.139 0.139 0.148 0.150 0.156 
23°C 0.136 0.142 0.126 0.157 0.139 0.115 




Figure 6.11  Effects of Arg-Glc MRPs on the molecular packing of DMPC MLVs across the gel to 
liquid-crystalline phase transition.  




Figure 6.12  Normalized Laurdan emission and excitation spectra obtained in small unilamellar 
DOPC vesicles. 
DOPC SUVs liquid-crystalline phase at 37°C, at the absence and presence of RIE MRPs. Lipid, 50 
μM, SUVs was prepared by ultrasonic; Laurdan, 2.5 μM; RIE MRPs, 16.6 μg/mL. The excitation 
wavelength was at 350 ± 4 nm and 410 ± 4 nm for two emission spectra. The emission wavelength 
was at 440 ± 4 nm for excitation spectra. These parameters are applied for DOPG SUVs and DMPC 
SUVs. 
(△) Em440nm DOPC SUVs; (▲) Em440nm DOPC SUVs + RIE MRPs at 16.6 µg/mL. 
(○) Ex350nm DOPC SUVs;  (●) Ex350nm DOPC SUVs + RIE MRPs at 16.6 µg/mL. 





Figure 6.13  Normalized Laurdan emission and excitation spectra obtained in multilamellar DOPC 
vesicles. 
DOPC MLVs liquid-crystalline phase at 37°C, at the absence and presence of RIE MRPs. DOPC, 50 
μM, MLVs was prepared by re-hydration and vortex; Laurdan, 2.5 μM; RIE MRPs, 16.6 μg/mL and 
166 µg/mL. The excitation wavelength was at 350 ± 4 nm and 410 ± 4 nm for two emission spectra. 
The emission wavelength was at 440 ± 4 nm for excitation spectra. These parameters are applied for 
DOPG MLVs and DMPC MLVs. 
(△) Em440nm DOPC MLVs; (▲) Em440nm DOPC MLVs + RIE MRPs at 16.6 µg/mL; (▲) 
Em440nm DOPC MLVs + RIE MRPs at 166 µg/mL. 
(○) Ex350nm DOPC MLVs; (●) Ex350nm DOPC MLVs + RIE MRPs at 16.6 µg/mL; (●) 
Ex350nm DOPC MLVs + RIE MRPs at 166 µg/mL. 
(□) Ex410nm DOPC MLVs; (■) Ex410nm DOPC MLVs + RIE MRPs at 16.6 µg/mL; (■) 
Ex410nm DOPC MLVs + RIE MRPs at 166 µg/mL. 
 172 
 
Figure 6.14  Normalized Laurdan emission and excitation spectra obtained in small unilamellar 
DOPG vesicles. 
DOPG SUVs liquid-crystalline phase at 37°C, at the absence and presence of RIE MRPs. 
(△) Em440nm DOPG SUVs; (▲) Em440nm DOPG SUVs + RIE MRPs at 16.6 µg/mL. 
(○) Ex350nm DOPG SUVs;  (●) Ex350nm DOPG SUVs + RIE MRPs at 16.6 µg/mL. 




Figure 6.15  Normalized Laurdan emission and excitation spectra obtained in multilamellar DOPG 
vesicles.  
DOPG MLVs composed of liquid-crystalline phase at 37°C, at the absence and presence of RIE 
MRPs. 
 (△) Em440nm DOPG MLVs; (▲) Em440nm DOPG MLVs + RIE MRPs at 16.6 µg/mL; (▲) 
Em440nm DOPG MLVs + RIE MRPs at 166 µg/mL. 
(○) Ex350nm DOPG MLVs; (●) Ex350nm DOPG MLVs + RIE MRPs at 16.6 µg/mL; (●) 
Ex350nm DOPG MLVs + RIE MRPs at 166 µg/mL. 
(□) Ex410nm DOPG MLVs; (■) Ex410nm DOPG MLVs + RIE MRPs at 16.6 µg/mL; (■) 







Figure 6.16  Normalized Laurdan emission and excitation spectra obtained in small unilamellar 
DMPC vesicles.  
DMPC SUVs liquid-crystalline phase at 37°C, at the absence and presence of RIE MRPs. 
 (△) Em440nm DMPC SUVs; (▲) Em440nm DMPC SUVs + RIE MRPs at 16.6 µg/mL. 
(○) Ex350nm DMPC SUVs;  (●) Ex350nm DMPC SUVs + RIE MRPs at 16.6 µg/mL. 




Figure 6.17  Normalized Laurdan emission and excitation spectra obtained in multilamellar DMPC 
vesicles. 
DMPC MLVs composed of liquid-crystalline phase at 37°C, at the absence and presence of RIE 
MRPs. 
(△) Em440nm DMPC MLVs; (▲) Em440nm DMPC MLVs + RIE MRPs at 16.6 µg/mL; (▲) 
Em440nm DMPC MLVs + RIE MRPs at 166 µg/mL. 
(○) Ex350nm DMPC MLVs; (●) Ex350nm DMPC MLVs + RIE MRPs at 16.6 µg/mL; (●) 
Ex350nm DMPC MLVs + RIE MRPs at 166 µg/mL. 
(□) Ex410nm DMPC MLVs; (■) Ex410nm DMPC MLVs + RIE MRPs at 16.6 µg/mL; (■) 
Ex410nm DMPC MLVs + RIE MRPs at 166 µg/mL. 
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Table 6.2  Laurdan excitation Gerenalized Polarization (GPex) of Ex=350 nm obtained in 






Table 6.3  Laurdan excitation Gerenalized Polarization (GPex) of Ex=410 nm obtained in 
multilamellar and unilamellar phospholipids vesicles composed of liquid-crystalline phase at 37°C. 
 
The GPex was calculated from the emission spectra excited at 410 nm by Eq 6.6A. 
 
The GPex was calculated from the emission spectra excited at 350 nm by Eq 6.6A.  
 SUVs+Laurdan  MLVs+Laurdan 
 Lipids (50 µM) 
Lipids+RIE   
(16.6 µg/mL)  
Lipids 
(50 µM) 




DOPC -0.178 -0.194  ↓  -0.210 -0.215  ↓ -0.258  ↓ 
DOPG -0.084 -0.172  ↓  -0.187 -0.217  ↓ -0.223  ↓ 
DMPC 0.056 -0.004  ↓  -0.009 -0.015  ↓ -0.078  ↓ 
 SUVs+Laurdan  MLVs+Laurdan 
 Lipids (50 µM) 
Lipids+RIE   
(16.6 µg/mL)  
Lipids 
(50 µM) 
Lipids+RIE   
(16.6 µg/mL) 
Lipids+RIE   
(166 µg/mL) 
DOPC -0.405 -0.439  ↓  -0.439 -0.438 -- -0.399  ↑ 
DOPG -0.391 -0.454  ↓  -0.502 -0.498 ↑ -0.413  ↑ 
DMPC 0.086 -0.140  ↓  -0.133 -0.143 ↓ -0.151  ↓ 
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Table 6.4  Laurdan emission Gerenalized Polarization (GPem) of Em=440nm obtained in 
multilamellar and unilamellar phospholipids vesicles composed of liquid-crystalline phase at 37°C. 




 SUVs+Laurdan  MLVs+Laurdan 
 Lipids (50 µM) 
Lipids+RIE  







DOPC -0.541 -0.534  ↑  -0.494 -0.487  ↑ -0.415  ↑ 
DOPG -0.607 -0.593  ↑  -0.581 -0.572  ↑ -0.445  ↑ 
DMPC -0.474 -0.470  ↑  -0.488 -0.479  ↑ -0.395  ↑ 
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DMPC 
Figure 6.18  The effects of RIE MRPs on the general polarization of the MLVs of DOPC, DOPG and 
DMPC.  
 
6.3.3.  Effects of MRPs on phase transition of lipids  
The thermodynamic properties of phase transitions in phospholipids liposome were 
examined by differential scanning calorimetry, a technique that measures the heat 
consumption of transitions as a function of temperature, in multilamellar vesicles of DMPC 
and N-methyl-DOPE (MeDOPE). DOPC was tested for the lamellar phase transition, but is 
not well-suited to this type of study, due to its low phase transition temperature (-20°C) and 
poor reproducibility of TM. Therefore, vesicles composed of DMPC or MeDOPE were 
incorporated with different concentration of MRPs. The MLVs were prepared by six cycles 
of vortex-freeze-thaw, in order to erase the thermal memory of the lipids.  
 
6.3.3.1.  Phase transitions of phosphatidylcholine lipids in multilamellar 
vesicles 
In Fig 6.19, two diagrams of DSC scanning are given as examples of measuring transition 
temperatures and heat consumptions (∆Hf) of the gel (Lβ) to liquid crystalline (Lα) phase 
transition. The SIV peptide (lipid/peptide=100:2) decreased both of the transition 
temperatures and heat consumption of pre-transition and main transition. As shown in Fig 
6.20, during the Lβ-Lα phase transition of DMPC MLVs, Arg-Glc MRPs affected the 
thermodynamic properties of the lipids in a concentration-dependent way. TM, determined by 
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the initial temperature of the main gel-liquid crystalline transition, fluctuated as a function of 
MRP concentrations. However, in general, the differences were minor. The maximum 
difference was 1.25°C. It showed a “W” shape curve along the increase of concentration. TM 
dropped to ~24.4°C when the molar ratio of lipid versus MRPs was 100:3, whereas TM rose 
back to about the same as pure lipid (25.4°C) rapidly when the ratio was 100:5, 10:2 and 
10:3. At the concentrations higher than 10:3, TM gradually dropped again. 
In contrast to its effects on TM, the effects of MRPs on ∆Hf displayed a rather regular 
concentration-response curve. The value increased with the first two concentrations then 
decreased continuously with the higher concentrations. MRPs significantly increased ∆Hf by 
5 kJ/mol at a molar concentration of 100:1, and achieved a maximum increase of 12 kJ/mol 
at 100:3 (P<0.01). However, ∆Hf steadily decreased with higher concentration of MRPs, 
ranging from 100:5 to 10:5. At 10:4 and 10:5, the heat consumption of transition dropped 




A.  DMPC MLVs 
 
B.  DMPC MLVs in the presence of 100:2 (lipid/peptide molar ratio) SIV peptide 
Figure 6.19   Examples of phase transition peaks of DMPC MLVs in the presence of SIV peptide 
measured by DSC.  
A pre-transition peak (at ~19°C) and the main transition peak (at ~26°C) are presented in the 
diagrams. The continuous heating scans were performed from 0°C to 55°C at a scan rate of 40 
°C/min, and repeated for at least 5 times for each sample. The MLVs were prepared with PIPES 
buffer (pH7.4, 20 mM, 150 mM NaCl) at 100 mM. 30 μL MLVs was sealed in the sample pan for 




Figure 6.20  Effects of Arg-Glc MRPs on the thermodynamic properties of gel-liquid crystalline 
transition obtained in DMPC MLVs.   
The continuous heating scans were performed from 0°C to 55°C at a scan rate of 40 °C/min, and 
repeated for at least 5 times for each sample. The TM (○) and ∆Hf (■) of DMPC MLVs were 
presented in the diagram (n=4; P<0.01).  
 
6.3.3.2.  Effects of Arg-Glc MRPs on the phase transitions of MeDOPE MLVs 
In Fig 6.21, three examples of DSC scans are given as examples of the measurement of 
transition temperature and heat consumption. The diagrams of Lβ-Lα and Lα-HII phase 
transitions of pure MeDOPE are shown in Fig 6.21A&B, and those of Lα-QII and Lα-HII 
phase transitions of Arg-Glc MRPs integrated MeDOPE MLVs are shown in Fig 6.21C.  
There were three phase transitions observed in MeDOPE MLVs. In general, as shown in Fig 
6.22, Arg-Glc MRPs exhibited the concentration-dependent effects on the phase transitions 
of MLVs composed of unsaturated phosphatidylethonalamine, MeDOPE. Three phase 
transitions were measured: Lβ-Lα, Lα-QII and Lα-HII. Although the transition temperatures of 
all three phases were fluctuated with MRPs concentration, MRPs increased the transition 
temperatures at moderate concentrations (10:1 by molar ratio), but decreased them at higher 
concentrations, particularly at the highest concentration of 10:5 by molar ratio. The influence 
of Arg-Glc MRPs on ∆Hf varied between the three different phase transitions. When the Lβ-
Lα transition took the highest heat consumption of 30~50 kJ/mol, the Lα-QII took the least, 
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which was mostly below 2 kJ/mol. The heat consumption of the Lα-HII transition was higher 
than that of Lα-QII, but mostly below 5 kJ/mol. 
As shown in Fig 6.22A, the initial phase transition temperature (TM) was ~ -7.5°C. Arg-Glc 
MRPs decreased this temperature gradually along the increase in the molar ratio to ~ -8.2°C, 
with an exceptional but significant increase of 1.0°C at the molar ratio 10:1. Although both 
the decrease and increase were small by numbers, but were highly significant in statistics 
(n=4; P<0.01). The presence of 1 mol% MRPs didn’t affect the TM significantly, but 
remarkably increase the standard errors of measurements. The ∆Hf was decreased by the low 
concentrations of MRPs and reached the bottom of ~30 kJ/mol at 5% of MRPs. It was 
increased with higher concentrations of MRPs and became stable at ~50 kJ/mol.    
As shown in Fig 6.22B, the TM of Lα-QII was about 62°C. MRPs increased the initial 
temperature of transition (TQ) significantly to a maximum value of 68°C at a molar ratio of 
10:1. At both lower and higher ratios, MRPs decreased the TQ with greater standard errors 
(P<0.05). No Lα-QII phase transition was observed at molar ratios of 100:5 or 10:5. The ∆Hf 
of pure MeDOPE was about 4 kJ/mol, which dropped to ~ 1 kJ/mol in the presence of just 
1% Arg-Glc MRPs. The ∆Hf values fluctuated at higher concentrations.  
As shown in Fig 6.22C, the profiles of the Lα-HII phase transition were rather similar across 
the pure lipids and different concentrations of Arg-Glc MRPs. The presence of MRPs did not 
have a significant impact on the phase transition at several concentrations. However, there 
were two exceptions: MRPs at 100:5 and 10:5. At the former concentration, Arg-Glc MRPs 
decreased the Lα-HII phase transition temperature (TH) from 73.6°C of pure MeDOPE to 
69.9°C. This figure was further lowered down to 68.3°C in the presence of 10:5 molar ratio 
of the MRPs. In contrast, the ∆Hf did not change significantly at most of concentrations, and 
remained at around 3 kJ/mol. It was dramatically increased to 19 kJ/mol only when 10:5 
molar ratio of Arg-Glc MRPs was added.  
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A. The gel-liquid crystalline phase transition of MeDOPE MLVs. 
 
B. The lamellar-hexagonal phase transition of MeDOPE MLVs. 
 
C. The lamellar to non-lamellar transitions of MeDOPE MLVs in the presence of Arg-Glc MRPs at 
10:1 molar ratio.  
Figure 6.21   Differential Scanning Calorimetric diagrams of MeDOPE MLVs with and without Arg-
Glc MRPs at the scan rate of 40 °C/min.  
The continuous heating scans were performed from -30°C to 85°C, and repeated for at least 5 times 
for each sample to obtain the reproducible data. The MLVs were prepared with PIPES buffer (pH7.4, 
20 mM, 150 mM NaCl) at 100 mM. 30 μL MLVs was sealed in the sample pan for each 
measurement. The transition peaks were fit by Pyris DSC data-analysis software (Perkin Elmer, US). 
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A. Lβ-Lα phase transtition 
 
B. Lα-QII phase transition 
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C. Lα - HII phase transition 
Figure 6.22  Thermodynamic effects of Arg-Glc MRPs on lipid phase transitions of MeDOPE MLVs. 
Examined by differential scanning calorimeter at the scan rate of 40 °C/min. The continuous heating 
scans were performed from -30°C to 85°C, and repeated for at least 5 times for each sample.  
(A). Lamellar-lamellar (Lβ-Lα) phase transtition. ●: TM; ■: ∆Hf (n=4; P<0.01). 
(B). Lamellar-inverted cubic (Lα-QII) phase transition. ◆: TQ; ■: ∆Hf (n=4; P<0.05). 
(C). Lamellar-inverted hexagonal (Lα - HII) phase transition. ■: TH; ■: ∆Hf (n=4; P<0.01). 
 
6.3.3.3.  Effects of SIV fusion peptide on phase transitions of phospholipid 
MLVs 
As shown in Fig 6.23, SIV peptide decreased the TM and heat consumption ∆Hf of Lβ-Lα 
phase transition in DMPC MLVs (P<0.01), when the temperature range of the transition 
(∆TM) remained the same (P>0.05). However, the temperature range of the pre-transition 
was decreased significantly by 0.7°C at 100:1 SIV (lipid/peptide ratio, P<0.01) and 1.2°C at 
100:2 SIV (P<0.05).  
SIV peptide slightly decreased the TM of MeDOPE MLVs (P<0.05 at 100:2) but increased 
TH by 4°C (P<0.01, Fig 6.24). In terms of transition temperatures and heat consumptions, the 
higher SIV concentration (100:2) was eventually not more effective than 100:1, although it 
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did resulte in the greater standard errors. The heat consumptions of both transitions were 
reduced by SIV (P<0.01). The peptide decreased the temperature range of lamellar/non-
lamellar phase transition by 2°C, but slightly increased that of gel-liquid crystalline phase 
transition by about 0.3°C (P<0.01 for 100:1 SIV). 
 
A. Effects of SIV on TM (●; n=5, P<0.01) and ∆Hf  (□; n=5, P<0.01). 
 
B. Effects of SIV on ∆TM (n=5, P>0.05). 
Figure 6.23   Effects of SIV peptide on phase behaviour of DMPC MLVs by DSC.  
Scan rate: 40 °C/min. Temperature range of scanning: 0~55°C. Lipid concentration: 100 mM.  
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A. Effects of SIV on TM (●) and ∆Hf of Lβ-Lα transition  (□). 
 
B. Effects of SIV on TH (●) and ∆Hf of Lα-HII transition (□). 
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C. Effects of SIV on ∆TM (△) and ∆TH (◼). 
Figure 6.24  Effects of SIV peptide on phase behaviour obtained in MeDOPE MLVs with DSC. 
Scan rate: 40 °C/min. Temperature range of scanning: -30~85°C. Lipid concentration: 100 mM. (n=5; 
P<0.01) 
 
6.3.3.4.  Effects of Arg-Glc MRPs on the phase transitions of MeDOPE with 
SIV fusion peptide 
The impacts of Arg-Glc MRPs and SIV fusion peptide on the phase transition of MeDOPE 
are described in section 6.3.3.2 and 6.3.3.3, respectively. The influences of Arg-Glc MRPs 
on the membrane fusion effects of peptide were then observed in the MeDOPE MLVs in the 
presence of SIV fusion peptide. The results are shown in Fig 6.25. The effects of Arg-Glc 
MRPs on lipids in the absence of the peptide are included in the figures for comparison. 
Different effects of Arg-Glc MRPs on the phase transition profiles were observed in the 
MeDOPE vesicles in the presence or absence of SIV fusion peptide. 
In the Lβ-Lα phase transition (as shown in Fig 6.25A), the MRPs promoted the transition at 
100:5 (lipid/MRPs molar ratio), but inhibited the transition at the lower (100:2) or higher 
concentrations (10:1) in vesicles with or without SIV peptide. The TM of pure lipid was -
7.5±0.05°C, which was decreased by SIV peptide to -8.0°C. The MRPs increased the TM of 
MeDOPE vesicles containing 100:1 SIV peptide by 0.8°C at 100:2 (P<0.01), but decreased 
the TM to -8.2°C at 100:5 (P<0.05) and increased TM back to -7.5°C, the same number as that 
of pure lipid, at 10:1 (P<0.01). SIV peptide decreased the temperature range (∆T) of this 
phase transition in MeDOPE vesicles to 5.1°C when Arg-Glc MRPs increased it to 5.7°C at 
10:1 (P<0.01). However, in the presence of 100:1 SIV, the MRPs increased the temperature 
range of Lβ-Lα phase transition by 0.4°C at 100:5 (P<0.05), then decreased it by 0.3°C at 
10:1 (P<0.01).  
In the Lα-HII phase transition (as shown in Fig 6.25B), the effects of Arg-Glc MRPs were 
different from those in the Lβ-Lα transition. The MRPs promoted the transition at 100:5, but 
inhibited the transition at the lower (100:2) or higher concentrations (10:1) in vesicles in the 
absence of SIV. For 100:1 SIV, the effects of Arg-Glc MRPs became much milder. TH of 
pure lipid was 72.6±0.4°C, which was elevated to 75.9±0.5°C by the presence of 100:1 
peptide (P<0.01). It was even 1.6°C higher than the TH of vesicles containing 10:1 MRPs. 
 189 
Furthermore, in the presence of 100:1 SIV, the TH was decreased to 74.1±0.1°C by 100:5 
Arg-Glc MRPs (P<0.01), whereas 10:1 Arg-Glc MRPs raised the TH back to 75.1±0.1°C 
(P<0.01).  Furthermore, the ∆TH of Lα-HII phase transition was significantly affected by Arg-
Glc MRPs, but only at 100:2.  The opposite effects were observed in the presence or absence 
of SIV. The MRPs decreased the ∆TH by 3°C in the absence of SIV, but increased the ∆TH 
by 2.8°C in the presence of SIV (P<0.01). At the higher concentrations of the MRPs, 100:5 
and 100:10, the MRPs did not affect ∆TH as potent as it was at 100:2. 
6.3.3.5.  Effects of Arg and Glc on the phase transitions of MeDOPE MLVs 
As described above, Arg-Glc MRPs affected the phase transitions of MeDOPE MLVs in a 
concentration-dependent manner. As described in Section 4.2.2.6, there are 39% Glc and 
31% Arg remaining un-reacted in the Arg-Glc MRPs. Glc and Arg were examined 
respectively in MeDOPE MLVs to reveal the possible contribution of these un-reacted 
reactants to the MRPs’ effects on lipid phase transitions. The tests were conducted at the 
concentrations corresponding to 100:5 and 10:5 Arg-Glc MRPs. The concentrations are 
100:1.95 and 100:19.5 for Glc, 100:1.67 and 100:16.7 for Arg. 
As shown in Fig 6.26A, glucose, arginine and Arg-Glc MRPs decreased the TM and ΔTM, 
especially at the high concentration (10:5). However, the effects of these samples on the TH 
and ΔTH of MeDOPE MLVs were opposite between the reactants (glucose and arginine) and 
reaction products (Arg-Glc MRPs), responding to their concentrations (Fig 6.26B). The TH 
was increased by the reactants whereas decreased by Arg-Glc MRPs. The ΔTH was slightly 
decreased by the reactants whereas increased by the MRPs. The effects of these samples 
were stronger at the higher concentration (10:5) than at the lower concentration (100:5).  
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A. Effects of Arg-Glc MRPs on TM (□/■) and ∆TM (△/▲) of MeDOPE MLVs. 
 
B. Effects of Arg-Glc MRPs on TH (□/■) and ∆TH (△/▲) of MeDOPE MLVs. 
Figure 6.25  Effects of Arg-Glc MRPs on the phase transition behavior of MeDOPE MLVs obtained 
in the presence of 100:1 SIV peptide by DSC. 
Scan rate: 40 °C/min. Scanning temperature range: -30~85°C. Lipid concentration: 100 mM. Data of 




A. Effects of glucose or arginine on the TM and ΔTM of MeDOPE MLVs 
 
B. Effects of glucose or arginine on the TH and ΔTH of MeDOPE MLVs 
Figure 6.26  Effects of arginine and glucose on phase transitions of MeDOPE MLVs.  
Scan rate: 40 °C/min. Scanning temperature range: -30~85°C. Lipid concentration: 100 mM. The 
effects of Glc (at 100:1.95 and 100:19.5) and Arg (at 100:1.67 and 100:16.7) were measured to 
estimate the effects of Glc and Arg remained in Arg-Glc MRPs (100:5 and 100:50). The significant 
different TM and TH were observed in the presence of Glc, Arg and the MRPs, particularly in high 
concentration 100:50 (n=4; P<0.01). 
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6.4.  DISCUSSIONS AND CONCLUSIONS 
Lipids with a cylindrical shape and saturated fatty acid chains, e.g. DMPC, have a single, 
gel-liquid crystalline, transition around 24°C (Taly 2002). Other lipids with smaller head-
groups and bigger tail groups present a cone-shape, such as MeDOPE. This type of lipids 
forms non-lamellar phases and allows us to monitor the influence of MRPs molecules on 
phase transition between lamellar and non-lamellar phases and, because the bigger space 
between the head groups of MeDOPE than those of DMPC, MRPs could also process the 
different impacts even in the gel-liquid crystalline phase transition of MeDOPE vesicles.   
N-methyl-DOPE (MeDOPE) MLVs form different structures depending on three vital 
factors: temperature, concentration and thermal history of the sample. The polyphasic 
structural transformation of this lipid has been extensively studied with a variety of 
techniques (Kusube et al. 2006) (Harroun et al. 2003) (Colotto et al. 1996) (Siegel, Green & 
Talmont 1994) (Ellens, Bentz & Szoka 1986). Primarily, the MeDOPE forms three types of 
structure in its aqueous dispersions: lamellar, cubic and hexagonal. The cubic structure is 
observed as a metastable phase when the vesicles are transferring from lamellar phase to 
hexagonal phase. This depends on the temperature scan rate across the lamellar-to-hexagonal 
phase transition (Van Gorkom, Nie & Epand 1992).   
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6.4.1.  Stability and fluidity of lipid monolayer 
Despite the similarity in their chemical origin, three kinds of MRPs, referred to as RIE 
MRPs, MCE MRPs and Arg-Glc MRPs, produced different effects on DOPG monolayers.  
Under the experimental conditions of this study, each DOPG monolayer was in Liquid 
Expanded (LE) phase, which resembles liquid crystal phase (Lα) of the corresponding 
phospholipid bilayer.   
Arg-Glc MRPs increased the mean molecular area (mma) of DOPG in LE phase, which 
indicates an expanding of the monolayer and probably an increase in the rigidity of the 
molecular packing introduced by insertion of Arg-Glc MRPs into the hydrophilic head 
groups of lipid. This is in good agreement with other results, in which Arg-Glc MRPs 
decreased the collapse rate of the monolayer and thereby enhance its stability. In contrast, 
RIE MRPs and MCE MRPs decreased the mma and the maximum surface pressure, which 
indicates two possible effects. The MRPs could either induce a more rigid packing of lipids 
by filling up the free space between lipids and squeezing the fatty acyl chains, or cause a 
decrease in molecular order, and therefore a less rigid packing.  If the former assumption is 
true, a stabilised monolayer would have been demonstrated by observing a constant increase 
in surface pressure until it reached the maximum value as much as 44 mN/m of the 
homogeneous DOPG monolayer.  But the surface pressure of monolayer, in the presence of 
RIE MRPs and MCE MRPs, reached 33 mN/m at around mma 70 Å2 and remained at the 
same level while the mma was constantly compressed to 60 Å2 (Fig 6.9). Therefore, the 
decreased maximum surface pressure indicates RIE MRPs and MCE MRPs are more likely 
to induce the less rigid packing and a shrinking in the monolayer, and thereby destabilise the 
monolayers but probably improve the fluidity.  
Electrolytes, containing ions such as Ca2+ and Na+, can significantly decrease the surface 
tension of phosphatidylglycerol monolayer (Marra 1986). A phosphate sodium buffer (100 
mM) was used for all the measurement to give a constant electrolytic background in the 
subphase and monolayers. The effects of any endogenous electrolytes in the MRPs would 
have been swamped by the standardised Na+ background.  
Furthermore, the rising surface pressure in the π–A isotherms of RIE MRPs and MCE MRPs 
(Fig 6.10) indicates the amphipathic compounds from these MRPs may form a MRPs 
monolayer on the surface of buffer. In the presence of a lipid monolayer, these amphipathic 
molecules could possibly insert to the hydrophobic acryl chains of lipids and cause the 
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destabilisation of lipid monolayers. In contrast, the surface pressure of Arg-Glc MRPs 
merely rose, implying that MRPs do not form a monolayer at the air-water interface. The 
amphipathic components of Arg-Glc MRPs, if there are any, presumably do not contain 
strong hydrophobic groups. Arg-Glc MRPs prefer hydrophilic environments and could 
cooperate with the negative-charged phosphate head groups of DOPG and thereby stabilise 
the lipid monolayers. 
The opposing effects of the amphipathic characteristics of these three MRPs reflect the 
remarkable differences in their chemical compositions. RIE MRPs and MCE MRPs are 
generally bigger than Arg-Glc MPRs in terms of molecular weight, including some protein-
derived MRPs (see Chapter 4). The hydrophobic segments from proteins may enhance the 
interaction of the corresponding MRPs with lipids, particularly the hydrocarbon tails. This 
assumption is supported by the grafting copolymer casein-g-dextran, which is prepared by 
the Maillard reaction, and is capable of forming micelles and encapsulation of hydrophobic 
compounds (Pan et al. 2005). The micellisation of dairy proteins and their MRPs has been 
extensively studied in food science and colloid chemistry (Mu et al. 2006) (Pan et al. 2005)  
(Pellegrino et al. 1999).    
In Fig 6.10, mma was used to describe the response of RIE MRPs or MCE MRPs 
monolayers as a function of surface pressure. However, it has to be noted that the ‘mma’ 
values do not represent the real mean area of the MRP molecules of any single kind, due to 
the nature of MRPs being a mixture of products derived from the non-enzymatic 
glycosylation. The real mma will only be achieved by testing the purified amphipathic 
molecule from the MRPs.  
In conclusion, Arg-Glc MRPs stabilised monolayers of phospholipids by improving the 
rigidity of molecular packing, whereas RIE MRPs and MCE MRPs destabilised the 
monolayers and improved the fluidity. The different impacts of these MRPs are largely 
attributed to the different hydrophobic strength of their amphipathic compositions. Arg-Glc 
MRPs presumably cooperate with the negative-charged head groups of DOPG lipids, while 
the amphipathic compounds from RIE MRPs and MCE MRPs integrate deep into the 
hydrophobic fatty acid tails of the monolayers. 
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6.4.2.  Effects of MRPs on lipid order and molecular packing of lipid 
bilayers 
The effects of Arg-Glc MRPs on lipid order and molecular packing of bilayers were 
examined on phosphatidylcholine and phosphatidylglycerol lamellar vesicles, with the aids 
of two kinds of fluorescence probes, MC540 and Laurdan. The effects of RIE MRPs were 
examined with Laurdan for comparison.   
6.4.2.1.  Effects of Arg-Glc MRPs on the fluidity of phosphatidylcholine lipids 
MLVs 
Arg-Glc MRPs contributed a clear influence on the molecular packing of DMPC MLVs, 
across the melting temperature. The r values measured at 10°C (◆, Fig 6.11) were the 
highest and most stable, which are corresponding to the stable and rigid structure of bilayers 
in gel phase. The fluctuation of r measured at 23.5°C (☐, Fig 6.11) is consistent with the 
coexistence of two phases in the bilayers across the transition temperature. The lowest values 
of r, measured at 37°C (▲, Fig 6.11), indicating the crystalline phase of DMPC MLVs, and 
the concentration-dependant effects of Arg-Glc MRPs on the molecular packing of the 
bilayers.  For DMPC, the free space between the head groups is limited due to the rigid 
packing of the tails. The MC540 will possibly locate parallel to the bilayer surface, right 
above the glycerol backbone of the lipid, while Arg-Glc MPRs might fill up the space left 
over. The increase of r at lipid/MRPs ratio of 100:5/25/125 indicates the MRPs might help to 
hold the lipids together and encourage the more rigid molecular packing. As a result, the 
bilayers would become less fluid. This is constant with the fact that the bilayers in their gel 
phase have a generally higher r than in fluid phase. Furthermore, the correspondence of 
anisotropy constant to the MRPs concentration became clear when the lipids transferred to 
liquid-crystalline phase, implying the bilayers in the fluid phase are easier for the MRPs to 
incorporate with.  
Compare to the DSC measurements, the proportion of MRPs used in this fluorospectrometric 
study was much higher in terms of lipid/MRPs molar ratios, while the difference in the lipid 
concentration of the vesicle suspension was also remarkable. For example, the lipid 
concentration of MLVs was 10 µM for MC540 labeled measurements, 50 µM for Laurdan, 
but 100 mM for DSC. The highest lipid/MRPs molar ratio was 100:625 in MC540, while it 
was only 100:50 in DSC. At such a high proportion as 100:625, the profiles of MLVs should 
have been covered up by the profiles of MRPs. However, the typical spectrum profile of 
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lipid MLVs was obtained even at such a high proportion, indicating the molar ratio of 
lipid/MRPs in MLVs suspension does not necessarily reflect the real ratio between lipid and 
MRPs molecules on bilayers. A number of MRPs molecules may remain in the aqueous 
solution.  Apart from the amount of MRPs applied to the lipid system, the true ratio is also 
depending on the water content of the vesicle system, and the reversible binding of MRPs  to 
lipids bilayers. For example, in DMPC MLVs, the water content is ~93% (w/w) in DSC 
samples, while merely 100% (w/w) in fluorospectrometric measurements. The remarkable 
less amount of water in DSC samples provide a much higher possibility for the amphipathic 
MRPs molecules to interact with lipids rather than surrounding by water. Therefore, the ratio 
100:50 in 100 mM MLVs might allow much more contacts between MRPs and lipids than 
what the ratio 100:625 in 10 µM MLVs might conduct, and thereby is more close to the true 
lipid/MRPs ratio in bilayers. This can also explain the differences in the effective 
concentrations of the MRPs among the different types of measurements.  
However, the uncertainty remains in the measurements involved a high proportion of MRPs 
and a low concentration of lipids. The other biophysical methods like neutron diffraction and 
X-ray diffraction provide the better models to monitor the ratio between lipids and the MRPs 
in bilayers in the more accurate way.  
 
6.4.2.2.  Effect of RIE MRPs on the polarization and order of DOPC, DOPG 
and DMPC vesicles 
The emission wavelength and intensity of Laurdan are highly sensitive to the dipole 
relaxation and polarization of the environment, in case of lipid bilayer, the water penetration 
and polarity of the glycerol backbone region in lipid bilayer (Parasassi et al. 1990). As 
reported by Vequi-Suplicy, Laurdan in DPPG and DLPC bilayers has a maximum emission 
wavelength of ~440 nm in gel phase, whereas in the fluid phase the maximum emission 
wavelength showed a red-shifts to 490 nm. There are two average positions for Laurdan. 
Firstly, it sits inside the gel-phase bilayers with less mobility and less water relaxibility, 
mainly emitting at 440 nm. Secondly, it locates at the water/lipid interface of fluid-phase 
bilayers, rather mobile, mainly emitting at 490 nm (Vequi-Suplicy, Benatti & Lamy 2006). 
The 440-to-490 nm red-shift has been attributed to an increase in the accessibility of Laurdan 
to water molecules around the lipid head groups (Parasassi et al. 1991). In my studies, the 
three lipids assayed, DOPC, DOPG and DMPC, are all in the liquid-crystalline phase at 
37˚C. Their λmax varied from 470 nm to 490 nm, which is close to the reported wavelength 
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range of liquid-crystalline phase for PC and PG lipids. In the presence of RIE MRPs, the 5-8 
nm red-shifts were observed in DOPG and DMPC vesicles, accompanied by the increases in 
the emission intensity at the λmax. These results indicate RIE MRPs induce a higher fluidity 
in both of DOPG and DMPC bilayers, in which Laurdan gets access to more water 
molecules between the head groups of lipids.  
The fluidity-increasing effects of RIE MRPs are dominantly supported by the decreases in 
GPex induced by the MRPs. When the lipids transit from gel phase to liquid-crystalline phase 
in a homogeneous bilayer, the GP decreases dramatically, implying a much higher level of 
water penetration and a much lower lipid order. RIE MRPs caused the decreases in the GPex 
of Laurdan, which implies the less ordered lipid packing of the bilayers. RIE MRPs therefore 
disorder the bilayers of DOPC, DOPG and DMPC, improve the fluidity of bilayer. In DOPG 
monolayer (as described in Section 6.3.1), the decrease in the molecular area of lipids in the 
presence of RIE MRPs indicates two possible assumptions: RIE MRPs occupy part of the 
surface and squeeze the lipids to pack more rigid; or alternatively, RIE MRPs disorder the 
monolayer and accelerate the forming of micelles  and the break-down of monolayer. The 
decrease in GPex at the excitation wavelength of 350 nm finely supports the later assumption, 
in which a bilayer disordering effect of RIE MRPs is suggested. The GPex at Ex350nm has 
been widely used to determine the polarity of bilayers in various lipids (Harris, Best & Bell 
2002) (Ashley et al. 2006).  
However, some unexpected increases were observed in the GPex at Ex410nm and in GPem at 
Em440nm, which is in opposite to the decreases on the GPex at Ex350nm. A full 
understanding of this increased GP remains unknown, although the GP has been suggested 
to depend on the homogeneity of the membrane as well as the phase of lipids. GP become 
independent to the emission wavelength only when it is measured in the single-phase 
membrane (Parasassi et al. 1990). In single-phase vesicles, the GP is independent to the 
excitation wavelength, whereas in the multi-phase vesicles, a lower energy of excitation 
wavelength (i.e. 410-nm) selected populations with higher polarization (smaller GP), with 
respect to the 350-nm excitation. In the presence of RIE MRPs, a second phase of lipids 
might be formed in the vesicles apart from their native phase, which can be sensed by 
Laurdan at the longer or shorter excitation wavelengths. In my studies, among the three 
lipids observed, DOPG or DOPC vesicles are more mobile than DMPC vesicle (Table 
6.2&6.3), and have the higher polarization, which can be sensed by GPex at Ex410nm 
critically. The increase in the GPex at Ex410nm may suggest a second phase, relatively more 
rigid than the first phase, was created by incorporating of RIE MRPs to the bilayer, and 
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represented as lower polarization and higher rigidity. But in case of DMPC vesicle, RIE 
MRPs elevated the polarity and disorder the lipid packing. 
Another change in the GPex requires an attention is the opposite results observed in SUVs 
and MLVs of DOPG at Ex410nm.  For SUVs, the MRPs decreased the GPex, whereas an 
increase was observed for MLVs.  Although both types of vesicles are composed by lamellar 
bilayers, only 10% or less of the total phospholipid is found on the outer leaflet of MLVs, 
while around 60 to 75% of totoal phospholipid distributes on the outside surface of SUVs 
(Yeagle 1993). The enormous difference in the amount of phospholipids exposing to the 
membrane interactive agents may have affected the general polarity profiles of bilayers 
reported by Laurdan in this two types of liposomes.    
As mentioned above, the GP does not completely separate the contributions of the two 
excited states, which may refer to two phases of lipids. The areas of the two guassian peaks, 
which were fit to the emission spectra or excitation spectra of Laurdan in liposomes, are the 
better parameter than GP for analysing the structural changes occurred during the phase 
transition or the sub-phase transformation of lipid bilayers. For example, the gel-to-liquid 
crystalline transition of DPPG can be finely monitored by a dramatic decrease in the short-
wavelength peak area, which is paralleled by a dramatic rise in the long-wavelength peak 
area (Vequi-Suplicy, Benatti & Lamy 2006). This could be a better way of studying MRPs’ 
effects on the polarity of lipid membrane than the GP, for further studies.  
To sum up, Arg-Glc MRPs decrease the fluidity of unsaturated phospholipids bilayers when 
increase that of saturated phospholipids bilayers, implying a stabilising effect on the fluid 
phase of lipid. RIE MRPs enhance the polarity of hydrophilic region of lipid bilayer, which 
infers a disorder effect on the lipid packing in the fluid phase. However, an opposite effects 
from the same MRPs should be take into account, by which the RIE MRPs seems to improve 
the lipid order of highly mobile bilayers, e.g. the liposomes composed with DOPG or DOPC, 
without changing the phase of lipids. These assumptions are in a good agreement with the 
previous observations on lipid monolayer, in which Arg-Glc MRPs stabilised the DOPG 
monolayer while RIE MRPs presumably destabilised the monolayer. In conclusion, MRPs 
generally conduct a stabilisation effects on the liquid-crystalline phase of lipids, meaning the 
lipid bilayer tends to remain in lamellar fluid phase in the presence of MRPs, with a respect 
to the destabilisation effects of MRPs to the lamellar gel-phase.   
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6.4.3.  Stabilisation and destabilisation effects of Arg-Glc MRPs on 
phospholipids MLVs 
6.4.3.1. DMPC MLVs 
During phase transitions, the stabilisation of lipid bilayers may result in an elevated onset 
temperature of transition, while a destabilisation may reduce the transition temperature. On 
the other hand, it is not sure that a less ordered molecular packing of lipids will cause an 
increase or decrease of general heat consumption. This depends on two factors: when the 
transition started, and how long does the transition last for.  
In DMPC MLVs, Arg-Glc MRPs have minor effects on TM but significant impacts on ∆Hf. 
MRPs destabilised the rigid structure of DMPC vesicles by insert between the DMPC 
molecules. Since DMPC molecules have a cylindrical shape with almost equal sizes of head 
groups and tail groups, they pack in such a rigid way that even the insertion of a small 
amount of MRPs molecules can significantly disrupt the rigidity of a leaflet. The loss of 
rigidity leads to the drop in transition temperature. However, at the same time, the Arg-Glc 
MRPs molecules in the leaflet may act as a ‘connector’ to imobilise lipids around MRP 
molecules. This may create a subphase besides the gel phase. The heat consumption of 
transition would then be elevated to cope with the extra energy requirements for melting this 
new structure. However, when the concentration kept rising, a growing amount of MRPs 
inserted to the lipid bilayers and finally broke down part of the lamellar structure in gel 
phase, which caused the decrease in heat consumption.  
6.4.3.2. MeDOPE MLVs 
As shown in Fig 6.22, the TM of MeDOPE is -7.5°C, which is the same as that previously 
reported (Kusube et al. 2006). A wide range of temperature has been reported for the inverse 
hexagonal phase transition. As revealed in an X-ray diffraction study reported by Cherezov, 
the QII phase appears at 59.1°C while the HII phase appears at 63.5°C, at a scan rate of 1.5 
°C/h. The TH increased by 2°C when the scan rate was raised to 6 °C/h (Cherezov et al., 
2003).  However, Harroun et al. reported the TH at 64°C, and the TQ at about 75°C at the 
scan rate of 30 K/h (Harroun et al., 2003). In my measurements, there is a main phase 
transition at 72.6°C at the scan rate of 40 K/min which is presumably TH since hexagonal 
phase is the major structure visible at the high temperature for MeDOPE. My TH is much 
higher than the reported value. A remarkable difference among these measurements is the 
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scan rate. It is 40 °C/min in my DSC measurement compared to 1.5~30 °C/h in the X-ray 
diffraction measurements. There is also another phase transition at a lower temperature 
(~62°C), presumably the TQ, which did not appear in every single isothermal scan of DSC. 
Data is given in Fig 6.22B for reference.  
At a concentration of 100:5, Arg-Glc MRPs destabilised the lipid bilayers of MeDOPE in the 
lamellar phase, both in gel and liquid crystalline phases, and accordingly lowered the TM and 
TH (Fig 6.22A&C). However, when the ratio went up to 10:1, the MRPs stabilised the bilayer 
in the lamellar phase and elevated the TM, TQ and TH. At ratios higher than 10:1, the MRPs 
destabilised the bilayers again. But TH was constantly going down, like what occurred to TM 
and TQ. TH rose back to about the same temperature as that of pure MeDOPE, at ratio of 
10:4, indicating another stabilisation in the lipids structure before it transfers to inverted 
hexagonal phase. At the highest ratio, a bilayer broke down was implied by the acute drop in 
TH and rise in ∆Hf.  
The glucose and arginine remaining among the Arg-Glc MRPs increased TH but decreased 
the ∆TH, indicating a stabilising effect on bilayers and a shorter intermediate status during 
the phase transition. In contrast, at the corresponding concentrations, the Arg-Glc MRPs 
destabilised the lamellar phase and induced a longer intermediate status from lamellar phase 
to hexagonal phase. Therefore, the effects of Arg-Glc MRPs are not correlative to the 
glucose or arginine remaining in the MRPs. For the gel-to-liquid crystalline phase transition, 
the effects of Arg-Glc MRPs were similar to those of arginine, whereas were much weaker 
than those of glucose. Glucose has been predicted by a molecular dynamic simulation study, 
to interact directly with the headgroups of phospholipids through hydrogen bonds, thereby 
replace water bound to the bilayers. Glucose was also suggested to prevent the thermal 
disruption of lipid bilayers at a high temperature (Pereira, Hünenberger, 2006). The 
interaction of glucose with the headgroups of lipids may attribute to its effects on the phase 
transitions of MeDOPE MLVs.  
Taking together the effects of Arg-Glc MRPs across all three phase-transitions, a general 
pattern of MRPs’ effects emerges. The stabilisation actions of the MRPs are split into two 
stages. Firstly, the MRPs fill up the spaces in the head group region of leaflet and keep the 
hydrophilic heads away from each other. This prevents the development of negative 
curvature strain in the bilayers, and subsequently inhibits the lamellar/non-lamellar 
transition. The bilayers prefer to remain in gel or liquid crystal phase. MRPs at molar ratio of 
10:1 performed the strongest stabilisation effects of this kind. Secondly, when more MRPs 
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molecules accumulate in the bilayers, they start to destabilise the lamellar structure of lipids 
and favor the lamellar-inverted cubic transition. Once the lipids transfer to non-lamellar 
structure, the lipids prefer to stay in cubic phase rather than hexagonal phase. The best 
example for this kind is bilayers contain Arg-Glc MRPs at molar ratio of 10:4. MRPs 
decreased the TM and TQ, but raised the TH. At concentration beyond this point, the bilayer 
was further destabilised and became easier to transfer to inverted hexagonal phase. 
A drop in transition temperature can correlate with a rise in heat consumption, such as that 
observed in MeDOPE MLVs in the presence of Arg-Glc MRPs. For example, Arg-Glc 
MRPs, at the molar ratio of 10:5 in lipid bilayers, decreased the transition temperature of 
lamellar-inverted hexagonal and increased the heat consumption. Similar outputs were 
observed in the gel-liquid crystalline phase transition at higher molar ratios than 10:1. This 
implies that Arg-Glc MPRs destabilise the lipid bilayers at the high concentrations and 
promote the phase transition from an ordered status to a less ordered status. At the 
meanwhile, due to the possible coexistence of several sub-phases induced by interference of 
MRPs, the amount of energy, in terms of heat as a function of time, was increased to 
overcome the overall energy barrier and encourage the formation of a regular structure.   
In comparison with DMPC, Arg-Glc MRPs have almost the opposite effects on MeDOPE. 
At lipid/MRPs molar ratios ranging from 100:1 to 10:4, the MRPs have opposite effects on 
the stabilities of the two lipids. For example, MRPs stabilise DMPC bilayers at 100:5, but 
destabilise MeDOPE bilayers at the same concentration. At the molar ratio of 10:5, both 
lipids vesicles are destabilised. A similar trend is found in the heat consumption of the phase 
transitions. This difference could be considered as a result of different free volume between 
the lipid molecules.    
 
6.4.4.  Effects of SIV fusion peptide and Arg-Glc MRPs on phase 
behavior of lipid vesicles 
SIV fusion peptide raises the TH of MeDOPE by 4°C but decreases TM at 40 K/min. This is 
in agreement with X-ray diffraction data from Harroun (Harroun et al. 2003), in which the 
SIV peptide (lipid/peptide=100:1) raises TH by 10°C (to about 74°C) at the temperature scan 
rate of 30 °C/h, while at 100:2 SIV, the hexagonal phase is eliminated. In contrast, at 100:1 
SIV raises TH to about 76°C at the scan rate of 40 °C/min in my DSC studies. And at 100:2 
SIV, the hexagonal phase is still observed as TH is about 77°C. It has been described for TH 
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to be scan-rate-dependent (Colotto et al. 1996), which is presumably to be varied along the 
different temperature scan rate. This might explain why the TH of MeDOPE MLVs obtained 
in my DSC study is higher by 2°C than that of X-ray data at 60 °C/h. However, one can also 
attribute this variation to the differences in the sensitivity of the two methods. By analysing 
the Gaussian peaks, a minor change in structure of bilayers can be detected and examined 
with X-ray scattering. DSC is capable of examining main phase transition events like 
lamellar-to-hexagonal phase transition, but has a limited capacity to track transient structures 
of intermediates, e.g. cubic phase, at the relatively high scan rate employed in this study.  
SIV promotes the breakdown of lamellar structure and the formation of cubic phase 
(Harroun et al. 2003). Some effects of SIV on lamellar-to-cubic phase transition, such as 
lowering the TQ, are not readily to be measured by DSC as shown in Fig 6.22B, since the 
transient phases are in the continuous change. However, the fusogenic nature of the peptide 
is still implied by the drop in ∆TH and heat consumption of Lα-HII phase transition. The 2°C 
decline in the temperature range of this transition, in the presence of 100:1 SIV, possibly 
suggests a relatively uniform lipid packing is installed in the transient structure prior to the 
occurring of Lα-HII transition. Furthermore, in terms of its effect upon TM, TH, ∆Hf and ∆TH, 
100:2 SIV peptide is more potent than 100:1 SIV, but not much. It is also consistent with 
previous X-ray diffraction data reported by Harroun et al..  
Arg-Glc MRPs partly offset the effects of SIV peptide on MeDOPE phase transition, in a 
concentration-dependent manner. In the presence of 100:1 SIV, the MRPs at 100:2 and 10:1 
stabilise the gel phase when 100:5 MRPs destabilises the gel phase and liquid crystal phase. 
However, due to the lack of reproducible data upon cubic phase, no assumption can be 
drawn from DSC data to explain the effects of Arg-Glc MRPs.  
In conclusion, Arg-Glc MRPs expand and stabilise the DOPG monolayer, reinforce the 
rigidity of molecular packing in DMPC bilayers and stabilise the lamellar phase of MeDOPE 
MLVs at a suitable concentration (100:2 or 10:1 for example). RIE MRPs destabilise the 
DOPG monolayer, increase the polarization and fluidity of phospholipids bilayers. The 
MRPs reversed the destabilising effects of SIV fusion peptide on the lamellar phase of 
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7.1.  AIMS OF THIS CHAPTER 
In the previous chapters, the interactions of Arg-Glc MRPs, RIE MRPs and MCE MRPs 
with lipid bilayers have been investigated with various methods that have evaluated their 
effects on the molecular packing, polarization, stability, fluidity and phase transition of 
phospholipid monolayers and bilayers. In this chapter, the insertion and positioning of MRPs 
in the lipid bilayers was studied by neutron diffraction to reveal the distribution pattern of 
the MRPs in DOPC and DMPC bilayers. The position of MRPs in bilayer provides 
fundamental structure information on the mechanism of the interaction of MRPs with 
phospholipids.  
Arginine has been shown to be a major component of the roots, as described in Chapter 4, 
and in published studies (Xiang et al. 2007) (Dong & Liu 2001), and is a promising molecule 
for generating MRPs. The disappearance of three quarters of the free arginine after boiling 
water extraction adds weight to this argument. Therefore, together with RIE MRPs, the Arg-
Glc MRPs prepared by the Maillard reaction between equal molar amount of arginine and 
glucose was used as a modelled material in this study. 
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7.2.  METHODS AND MATERIALS 
7.2.1.  Sample Preparation 
Lipids were purchased from Avanti Polar Lipids or Sigma. 20 mg samples were dissolved in 
chloroform and deposit onto quartz microscope slides by a nitrogen propelled artist's 
airbrush. The slides were then placed in a vacuum for 2 h in order to remove all traces of the 
solvent. Samples were hydrated in a humid atmosphere with water containing 8.06% or 25% 
2H2O. The samples were protected from light and oxygen whenever possible in order to 
reduce the chance of lipid peroxidation. 
7.2.2.  Neutron data collection 
Neutron-diffraction measurements were carried out on the D16 membrane diffractometer at 
the Institut Laue et Langevin, Grenoble, France, or the V1 membrane diffractometer at the 
BENSC, Helmholtz Zentrum Berlin, Germany. Humidity control was achieved by changing 
the temperature of the sample can (at ILL) or changing the saturated salts solutions in the 
sample can (at BENSC). At ILL, the difference between the ambient temperature in the 
sample can and the temperature of water slots at the bottom of the sample can was adjusted 
individually with water baths.  
Each sample was quickly transferred straight from a humid tube into the sample can. After a 
minimum 6 h equilibration, a series of continuous θ-2θ scans were initiated (from θ= 1.5° to 
20.0° for DOPC, 1.8° to 16.0° for DMPC). The samples were run at 298 ~ 303 K for DOPC, 
and at 310K for DMPC.  
 
7.2.3.  Data analysis 
The two-dimensional array of detector counts for each frame of data was corrected for 
variations in pixel response. The complete set of frames from each scan were then collapsed 
into a linear spectrum and combined to generate a pseudo θ-2θ scan. All of the analysis to 
this stage was carried out by the software LAMP on D16 or CARESS on V1. The 
background around each peak was fitted and subtracted using PeakFit (Systat Software Inc., 
USA) or Igor Pro (Version 6.0, WaveMetrics Inc., Oregon, USA). Gaussian distributions 
were then fitted to the Bragg reflections and the angular position, width and area of each 
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peak recorded. Absorption and Lorentz corrections were applied and the square-root of the 
intensities taken to produce the structure factor amplitudes. 
 
Figure 7.1  Gaussian-fitting of a lamellar diffraction peak (1st order) of DMPC bilayers at 96% RH in 
the presence of 8% 2H2O. 
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7.3.  RESULTS AND DISCUSSIONS 
7.3.1.  Distribution of Arg-Glc MRPs, RIE MRPs and MCE MRPs across 
the DOPC bilayers 
Neutron scattering length density profiles were calculated from the structure factors in Table 
7.1. Difference profiles were calculated by subtracting the profile of DOPC bilayers from 
each of the DOPC+MRPs profiles in turn. The results are shown in Fig 7.2. Since any profile 
constructed from an incomplete set of structure factors will contain termination error – 
artefactual structure resulting from the abrupt termination of the Fourier series of structure 
factors – models of the MRP distributions were constructed and fitted in reciprocal space, to 
avoid this problem. The models consisted of calculated diffraction patterns of pairs of 
Gaussian distributions, which were fitted to the difference structure factors by least-squares 
refinement. Each Gaussian fitting profile represents the distribution of one population of the 
sample. The results of this model fitting are shown in Fig 7.2, Fig 7.3 and Table 7.2. 
Termination error often manifests itself in the form of small peaks or “ripples”, such as those 
seen in the DOPC+MCE MRPs plots. The criterion for determining whether the features are 
real or artefacts is to see if Gaussian peaks can be fitted to them in reciprocal space.  
Possibly the most important observation is that the three products have significantly different 
interactions with DOPC. One criticism that has been leveled against MRPs as 
pharmaceutical agents is that the preparation produces a spectrum of products, so any 
interaction with cellular components is expected to be vague and ill defined. These results 
clearly refute this argument; the different products have different distributions across the 
phospholipid bilayer system. It is worth noting that biological membranes tend to comprise a 
mixture of molecular species, yet membranes from different sources (e.g. mitochondria, 
bacteria, nerve axon) have well defined, but very different molecular composition and 
physico-chemical properties. 
The RIE MRPs results reveal that the principal site of interaction is a well-defined peak 19.5 
Å from the centre of the bilayer. This position lies in the interface region of the bilayer, close 
to the glycerol backbone of the phospholipids (in neutron scattering profiles of 
phospholipids, the maxima are caused by relatively low hydrogen content of the glycerol and 
the phosphates). The peak accounts for 65% of the total scattering density; the other 35% lies 
deeper, at 10.4 Å from the bilayer centre. Of the three products studied, RIE MRPs is the one 
that inserts deepest into the bilayer. 
 208 
The difference profiles for MCE MRPs display some similarity to the RIE MRPs profiles, 
but in this case, all of the MRPs lie in the interface region, a bit closer to the centre of bilayer 
(18.1 Å). Gaussian fitting reveals that the small ripples observed at around 6.5 Å from the 
bilayer centre are actually artefacts caused by Fourier series truncation, indicating that none 
of the MCE MRPs penetrates into the fatty-acyl region of the bilayer, in contrast to the RIE 
MRPs, in which 35% of the total is found deep within the bilayer core. 
Although the synthetic MRPs (Arg-Glc MRPs) and RIE MRPs distributions are not the 
same, there are also some similarities between the two. In the Arg-Glc MRPs profiles, there 
is a major peak at 14.9 Å from the bilayer centre. This lies much closer to the fatty-acyl 
region than the MCE MRPs peak, indicating that the Arg-Glc MRPs is able to penetrate deep 
into the core of the bilayer, similar to the RIE MRPs. This is very interesting, because the 
presence of arginine in the reaction mixture would lead us to expect the resulting charged 
MRPs to interact with the polar environment of the water layer and the surface of the bilayer. 
 
Table 7.1  Neutron structure factors for bilayers composed of DOPC and of DOPC with each of the 
three types of MRPs. 
  F*(1) F*(2) F*(3) F*(4) F*(5) 
7.13 -5.35 -3.20 -1.09 1.04 DOPC 
±0.26 ±0.22 ±0.16 ±0.11 ±0.11 
8.57 -5.98 -3.56 -1.25 1.16 DOPC+RIE MRPs 
±0.31 ±0.25 ±0.19 ±0.14 ±0.14 
8.44 -5.35 -3.01 -0.83 1.11 DOPC+Arg-Glc MRPs 
±0.29 ±0.21 ±0.16 ±0.11 ±0.11 
8.12 -5.73 -3.54 -1.19 1.17 DOPC+MCE MRPs 
±0.28 ±0.22 ±0.17 ±0.12 ±0.12 
 
The bilayers were hydrated with 8% 2H2O, since water of this isotopic composition has a net neutron 
scattering length density of zero.  
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Table 7.2  Gaussian models of bilayer distributions of (a) MRPs and (b) water. 







Gaussian 1 Position* - 26.0 Å 19.5 Å 18.1 Å 
 Width# - 6.0 Å 6.6 Å 6.9 Å 
 Occupancy - 35% 65% 100% 
Gaussian 2 Position* - 14.9 Å 10.4 Å - 
 Width# - 7.6 Å 7.3 Å - 
 Occupancy - 65% 35% - 
 








Gaussian 1 Position* 24.5 Å 23.2 Å 23.4 Å 22.9 Å 
 Width# 5.7 Å 6.7 Å 6.2 Å 5.5 Å 
 Occupancy 100% 77% 73% 74% 
Gaussian 2 Position* - 14.7 Å 15.6 Å 15.3 Å 
 Width# - 5.6 Å 5.3 Å 4.9 Å 
 Occupancy - 23% 27% 26% 
 
The position, width and size of Gaussian distributions were fitted, in reciprocal space, to difference 
neutron structure factors.  Five orders of diffraction were used in the fitting procedure.  * The position 
of each label site is expressed as distance from the centre of the bilayer;  # the width is the half width 




Figure 7.2  Neutron scattering length density profiles of the distribution of each of the three different 
types of MRP across DOPC bilayer. 
The profiles were reconstructed from difference structure factors and therefore only show changes in 
neutron scattering length density brought about by the introduction of MRPs. The top panel shows a 
bilayer profile of DOPC, for comparison and orientation. In each case, the structure factors for 
bilayers hydrated with 8% 2H2O were used to calculate the profiles (Table 7.1), since water of this 
isotopic composition has a net neutron scattering length density of zero. The top panel also gives an 
indication of the errors. The dashed lines represent the maximum and minimum neutron scattering 
length density at each point, based on reconstructions using all possible combinations of structure 
factors within the range defined by the calculated errors shown in Table 7.1. The three panels below 
give the profiles of three MRPs across DOPC bilayers. The dashed lines are the difference profiles 




Figure 7.3  Difference profiles of the neutron scattering length density of water (2H2O) in stacked 
phospholipid bilayers of DOPC and DOPC with each of the three types of MRPs.  
The dashed lines are the difference profiles, and the solid lines are the corresponding best-fit Gaussian 
distributions for these difference profiles. Structure factors for bilayers hydrated in 8.1% H2O were 




However, 65% of the Arg-Glc MRPs are actually lying below the level of phosphates, 
indicating that the interaction is not simply based on charge. The minor peak (35%) in the 
bilayer distribution of Arg-Glc MRPs is centred at 26.0 Å, in the water layer, very close to 
the phosphate headgroups of the lipid molecules, which lie at 25.5 Å (Fig 7.2). This may 
have something to do with amino groups left after the Maillard reaction. About 31% of 
arginine and 39% of glucose remain in the Arg-Glc MRPs. The overall pattern of interaction 
of the Arg-Glc MRPs is similar to that of the RIE: there are two peaks in the distribution 
(though the relative heights of the peaks differ between the two types of MRPs, suggesting 
that the simple arginine-glucose preparation does not fully replicate the complexity of the 
RIE MRPs); and one of the peaks penetrates deep into the hydrophobic core of the bilayers.  
The two populations of density observed in the Arg-Glc MRPs and the RIE MRPs may 
result from saturation of preferred membrane locations, with the excess material forced to 
occupy a second, less-favourable location, or it could simply reflect different populations of 
MRPs. Given the relatively unregulated nature of the Maillard reaction, the second 
suggestion is a strong possibility. The d-repeats, which refer to the thickness of each 
repeating unit, comprising one bilayer and one water layer of the lipid stack, are about 52.0 
Å, which is consistent with the lamellar spacing values of DOPC bilayer measured by X-ray 
diffraction at 30°C and 98% RH (Hung et al., 2008). The introduction of RIE MRPs and 
Arg-Glc MRPs slightly expanded the d-repeat of the system, when MCE MRPs decreased 
the d-repeat slightly (d-repeats at 25°C, 97% RH: DOPC 51.74 Å; DOPC + RIE MRPs 51.96 
Å; DOPC + Arg-Glc MRPs 52.06 Å; DOPC + MCE MRPs 51.57 Å). However, these 
differences in d-repeat are very small and probably not significant.  
Fig 7.3 shows water difference profiles, calculated by subtraction of an 8.1% 2H2O profile 
from the corresponding 25.0% 2H2O profile. The results reveal the distribution of water 
across the unit cell, because everything cancels out in the subtraction except for the different 
neutron scattering length density of the 25% 2H2O water. As with the MRPs distributions 
(Fig 7.2), Gaussian distributions were fitted to the water distributions, using the structure 
factors rather than the profiles themselves, in order to avoid Fourier series truncation errors. 
The results are shown in Table 7.2(b). One complication with the MRPs’ distribution-
difference profiles, as described above, is that the profiles report all changes to the bilayer 
structure caused by the introduction of the MRPs. This means that any phospholipid 
rearrangements will also contribute to the difference profile, as long as there is a net shift of 
scattering density along the bilayer normal. For this reason, the water-difference profiles can 
be particularly informative, since all other contributions are cancelled out. 
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The water profile for pure lipid bilayers (Fig 7.3 top panel) was entirely consistent with 
previous neutron studies of phospholipid membranes (Harroun et al. 2005). The peak (split 
between the two ends of the profile in the figure) represents a block of water confined 
between adjacent bilayers in the multi-bilayer stack. Although the peak was fitted (in 
reciprocal space) to a pair of Gaussians, centred at 24.5 Å from the middle of the bilayer and 
5.7 Å wide (full width at 1/e height). These Gaussians represent the hydration shells around 
the phosphate-containing headgroups of the lipids and describe a typical water distribution 
profile across a DOPC system. The minor fluctuations between 10 Å and 40 Å are caused by 
termination error, due to the finite number of Bragg peaks used in the reconstructions.  
As shown in Table 7.2(b), water penetrated deep into the lipid bilayers in the presence of 
MRPs. Consistent with the observation (above) that the RIE MRPs has the deepest 
penetration into the bilayer, the main peak of water boundary went from 24.5 Å of pure 
DOPC to 23.4 Å of RIE MRPs and occupied 73% of total, while reducing the width of the 
first peak by 0.4 Å. The second peak appeared at 15.6 Å, but not as deep as the RIE MRPs 
10.4 Å. Similar to this, insertion of Arg-Glc MRPs mainly lied at 23.2 Å, when the width 
was expanded by 1.0 Å. The second peak appears at 14.7 Å, and comprised 23% of total 
water, consistent with the observation of Arg-Glc MRPs above.  
In the water profiles of DOPC and MCE MRPs, there are two Gaussian peaks, one at 22.9 Å 
and another at 15.3 Å. The former one accounts for 74% of the total, when the latter one lies 
deeper than the 18.1 Å subsidiary peak of MCE MRPs distribution. This implies that 
insertion of MCE MRPs brought water closer to the hydrophobic centre of bilayer, and 
demonstrated again the different modes of influence of MRPs on phospholipid bilayers. 
It is possible to calculate the location of the water boundary for each sample from the data in 
Table 7.2(b). Subtracting the half-width values from the Gaussian centre for each sample 
reveals that the edge of the water peak lies at 24.5 Å in the pure-lipid bilayers and slightly 
closer to the bilayer centre in all of the samples containing MRPs (DOPC + RIE MRPs 23.4 
Å; DOPC + MCE MRPs 22.9 Å; DOPC + Arg-Glc MRPs 23.2 Å). Thus, although there are 
some variations in the location and width of the water peaks in the samples containing MRPs 
from different sources, the width of the bilayer from water boundary to water boundary 
changes only very slightly. This is significant since it implies that none of the products 
disrupt the bilayer (disturb the side-by-side packing of the phospholipid molecules in such a 
way that water is allowed to penetrate between them), consistent with a model in which the 
MRPs repairs or protects the bilayer. 
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Our results support the earlier observation that RIE MRPs changes the membrane properties 
of erythrocytes membranes (Chen et al., 2006), by demonstrating a direct molecular 
interaction between RIE MRPs and phospholipid molecules. Intercalation of the MRPs 
molecules between the phospholipids would be expected to modify the biophysical 
properties of cell membranes and may also indicate a mechanism by which RIE MRPs could 
prevent influenza virus induced haemagglutination, as previously observed by Chen and co-
workers (Chen et al., 2006).  It is interesting to note that the other TCM preparation used in 
our study, MCE MRPs, also interacts with phospholipid membranes, though in a subtly 
different way. Since both reagents are MRPs, the similarities are not surprising; it is more 
remarkable that the two are not identical. The interaction of MCE MRPs with membrane 
phospholipids warrants further investigation, as it may form the basis of the anti-diabetic 
properties of this TCM by indicating how MCE MRPs helps to maintain the integrity of cell 
membranes against damage by free radicals or other molecular species (Xiang, Huang, et al. 
2007). 
 
7.3.2.  Distributions of MRPs and their reactants in DMPC bilayers 
7.3.2.1. Distributions of RIE MRPs, Arg-Glc MRPs and MCE MRPs in the 
DMPC bilayers 
The influence of presence of Arg-Glc MRPs in DMPC bilayers was firstly investigated in 
D16 of ILL (Grenoble, France), by measuring the neutron scattering length density around 
the phase transition temperature of DMPC. Arg-Glc MRPs had significant different 
distribution across DMPC bilayers at gel phase and liquid crystal phase, but didn’t change 
the d-repeats of systems, which were about 55 Å as measured, in both gel and liquid crystal 
phase. The Gaussians distribution of water in pure lipid bilayer represented not only a 
hydration shells around the phosphate headgroups of the lipids, but also a small block of 
water penetrated towards the hydrophobic area of lipid tails. However, water shouldn’t 
appear at the hydrophobic area in the absence of another molecule that breaks the strong 
hydrophobic force between the lipid tails.  
This abnormal observation may be attributed to the sample temperature. As described in 
Section 7.2.2, the relative humidity of sample slide was controlled by adjusting the 
temperature of the sample can. However, the sample temperatures used in ILL measurement 
were so close to the Lβ -Lα transition temperature (~24°C) of DMPC. This may result in the 
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coexistence of gel and liquid crystalline structure, thereafter affect the accuracy and 
reliability of measurements. Thus, a new set of neutron diffraction measurements on the 
DMPC and different types of MRPs have been conducted on instrument V1 (BENSC, 
Helmholtz Zentrum Berlin, Germany). In order to illuminate the distribution of Arg-Glc 
MRPs across DMPC bilayer in Lα phase, the neutron scattering was measured at 37 °C, 
which is 13 °C higher than the transition temperature, and at various humidity created by 
saturated salts solutions. 
Table 7.3  The difference structure factors and estimated maximum overall errors. 
 F*(1) F*(2) F*(3) F*(4) F*(5) 
24.37 -15.28 -10.66 -2.20 2.05 
DMPC 
±1.47 ±1.02 ±0.79 ±0.37 ±0.36 
27.98 -15.08 -10.87 -1.80 2.43 DMPC+Arg- 
Glc MRPs 
100:5 ±1.61 ±0.96 ±0.75 ±0.30 ±0.33 
28.65 -15.88 -11.52 -2.05 2.49 
DMPC+Arg 
±1.69 ±1.06 ±0.84 ±0.37 ±0.39 
33.76 -18.82 -16.58 -4.63 3.88 
DMPC+Glc 
±1.99 ±1.24 ±1.13 ±0.53 ±0.49 
23.71 -15.92 -9.34 -1.95 2.04 DMPC+RIE 
MRPs ±1.44 ±1.05 ±0.73 ±0.36 ±0.36 
26.71 -12.02 -9.38 -2.40 2.29 DMPC+MCE 
MRPs ±1.63 ±0.90 ±0.76 ±0.42 ±0.41 
27.92 -12.26 -10.04 -3.04 2.06 DMPC+Arg- 
Glc MRPs 
100:2 ±1.69 ±0.91 ±0.78 ±0.45 ±0.40 
25.68 -13.97 -8.78 -2.18 2.24 DMPC+Arg- 
Glc MRPs 
100:10 ±1.56 ±0.98 ±0.72 ±0.39 ±0.39 
 
Error F(n) = 0.0499×F(n) + 0.2014 
Neutron structure factors for bilayers composed of DMPC and of DMPC in the presence of MRPs, 
arginine, glucose and Arg-Glc MRPs on three lipid/MRPs ratios. The bilayers were hydrated with 8% 
2H2O thoroughly before each angular scan, since water of this isotopic composition has a net neutron 
scattering length density of zero. 
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 Similar to the previously measurements on DOPC, the neutron scattering length density 
profiles of bilayers were calculated from the structure factors in Table 7.3.  Difference 
profiles were calculated by subtracting the profile of DMPC bilayers from each of the 
DMPC+MRPs profiles in turn. The models of the MRPs distributions were constructed and 
fitted in reciprocal space to avoid the termination error. The results of model-fitting are 
shown in Figure 7.4 and Table 7.4(a). The d-repeat of DMPC bilayer in Lα phase was 49 Å, 
which is about 3 Å thinner than the DOPC bilayer. This is consistent with the fact that 
DMPC has a shorter acryl chain (14 carbons) than DOPC (18 carbons).  
A profile diagram together with errors is shown in the top panel of Figure 7.4 to give an 
image of estimated maximum errors and tend (Table 7.3). The most accurate profiles are 
ranged from 10 Å to 20 Å. Figure 7.5 shows water difference profiles, calculated by 
subtraction of an 8.1% 2H2O profile from the corresponding 25.0% 2H2O profile. The result 
reveals the Gaussian distribution of water across the unit cell of DMPC. The results are 
shown in Table 7.4(b).  
Generally, all the three types of MRPs have two-Gaussian distribution profiles in DMPC 
bilayers. RIE MRPs and Arg-Glc MRPs share the similar distributions in both of 
hydrophobic and hydrophilic regions, whereas MCE MRPs lie mainly in the hydrophilic 
region and present the strongest scattering density, as shown in Fig 7.6. Arg-Glc MRPs 
slightly increased the d-repeat of unit cell when RIE MRPs and MCE MRPs had little effects 
on the d-repeat. Arg-Glc MRPs have the least scattering density. In water distributions, Arg-
Glc MRPs associated with the greatest amount of water whereas MCE MRPs attracted the 
least amount of water.  
The distribution of Arg-Glc MRPs on DMPC was different to that on DOPC bilayer, 
although the proportions of MRPs population lies in the hydrophilic and hydrophobic region 
were rather similar. It reflects a truth that the two lipids share the same headgroup but 
different length of acryl chains. DOPC bilayer has a d-repeat of about 52.0 Å at 25 °C (96% 
RH), which is 3~4 Å thicker than DMPC’s 48.6 Å at 37 °C (96% RH), both in Lα phase. The 
thickness of one leaflet is 26.0 Å and 24.3 Å for DOPC and DMPC, respectively. The 
distances of Arg-Glc MRPs to the bilayer center are different between these two kinds of 
phosphatidylcholine, centering at 14.9 Å in DOPC bilayers versus 12.7 Å in DMPC bilayers. 
Apparently, Arg-Glc MRPs lied about 2.0 Å closer to the hydrophobic region in DMPC 
bilayer than in DOPC bilayer. However, as shown in Table 7.4(b), a deeper water 
penetration was not observed in the DMPC bilayers. On the contrary, in the presence of Arg-
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Glc MRPs, the distribution of water centered at 14.7 Å in the DOPC bilayers, which is 2.3 Å 
closer to the hydrophobic core than that in the DMPC bilayers. If the length difference of 
lipid tails (1.5~2.0 Å) were taken into account, Arg-Glc MRPs distribute at the same level of 
hydrophobic tails in lipid leaflet, and the water lie about 4 Å deeper in DOPC bilayer than 
that in DMPC bilayer. Therefore, the presence of Arg-Glc MRPs causes a stronger water 
penetration in DOPC bilayers than in DMPC bilayers.  The unsaturated fatty acid tails of 
DOPC tilt and cause a bigger head-to-head space than that of DMPC bilayers, which allow a 
deeper water penetration. The shorter distance of the MRPs to the DMPC bilayer center is 
attributed to the shorter myristoyl chains (14 carbons) of DMPC than the oleoyl chain (18 
carbons) of DOPC.  
As shown in Table 7.2 & 7.4, the major population (68%) of RIE MRPs lays in the 
hydrophobic region of the DMPC bilayers, right below the level of glycerol back bone, 
whereas a minor population (32%) was observed in hydrophilic bilayer surface. Although 
the majority of RIE MRPs (65%) was located at the headgroup region in DOPC bilayers, but 
the minority of the MRPs was 2 Å further into the hydrophobic tails of DOPC than those of 
DMPC. Despite the differences described above, the water distributions on the lipid bilayers 
in the presence of RIE MRPs were rather similar in DOPC and DMPC: about 70% of water 
remains at the surface of bilayers (at ~23 Å) while about 30% of water penetrates into the 
bilayers at ~16.0 Å. RIE MRPs help to attract more water to the lipid head groups and 
thereby enhance the hydration of bilayer, which is in a good agreement with the increasing 
polarization of lipid bilayers by the MRPs detected with Laurdan fluorescent spectra.   
Unlike their location in DOPC bilayers, MCE MRPs mainly lie on the surface of DMPC 
bilayer, whereas 17% of the MRPs appear at the hydrophobic core of the bilayer, at 5.3 Å 
from the center. However, the water distribution profile did not agree with the penetration of 
MCE MRPs, since the water only sit on the top of bilayer, at 22.2 Å. This indicates the MCE 
MRPs perform a partial insertion to the bilayer without introducing any water into the 
hydrophobic site. A similar phenomenon has been observed in the MD simulation study with 
a myristoylated decapeptide in DMPC bilayers (Khandelia, Ipsen, & Mouritsen, 2008). As 
described in Section 6.3.1, the strong hydrophobic compositions from MCE MRPs formed 
monolayer at the air/water interface. The water was associated to the hydrophilic part of the 
MRPs, and was kept away from the hydrophobic core of the bilayer. In DOPC bilayers, there 
was 26% of water penetrate to the acyl group, at 15.3 Å. The double-bond containing acyl 
chains allow the DOPC to pack less rigid than the DMPC, which consequently results in the 
penetration of water. 
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Figure 7.4 Neutron scattering length density profiles of the distribution of the three types of MRPs in 
DMPC bilayers.  
The top panel shows a bilayer profile of DMPC, for comparison and orientation. The dashed lines 
represent the maximum and minimum neutron scattering length density at each point, based on 
reconstructions using all possible combinations of structure factors within the range defined by the 
calculated errors shown in Table 7.3. The three panels below give the profiles of three types of MRPs 
in DMPC bilayers.  Dot line: the difference profiles, represents the measured distribution profiles of 
sampling substance (minus DMPC). Solid line: model of profiles, represents the corresponding best 
theoretically fitted Gaussian distributions for these different profiles. In each case, the structure 




Figure 7.5  Difference profiles of the neutron scattering length density of water (2H2O) in stacked 
phospholipid bilayers of DMPC and DMPC with each of the three types of MRPs.  
The dashed lines are the difference profiles, and the solid lines are the corresponding best-fit Gaussian 
distributions for these difference profiles. Structure factors for bilayers hydrated in 8.1% H2O were 
subtracted from corresponding 25% 2H2O structure factors and the result used to calculate the profiles 
shown. 
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Table 7.4  Gaussian models of bilayer distributions. 







Gaussian 1 Position* - 20.6 Å 22.1 Å 21.1 Å 
 Width# - 7.9 Å 7.4 Å 6.0 Å 
 Occupancy - 32% 32% 83% 
Gaussian 2 Position* - 12.7 Å 10.5 Å 5.3 Å 
 Width# - 5.5 Å 6.8 Å 5.0 Å 
 
 Occupancy - 68% 68% 17% 
 







Gaussian 1 Position* 21.8 Å 22.4 Å 22.9 Å 22.2 Å 
 Width# 5.0 Å 5.9 Å 5.3 Å 5.3 Å 
 Occupancy 100% 86% 69 % 100% 
Gaussian 2 Position* - 17.0 Å 16.3 Å - 
 Width# - 7.0 Å 4.6 Å - 
 Occupancy - 14% 31% - 
 
Gaussian models of bilayer distributions of (a) the three types of MRPs at lipid/MRPs molar ratio 
100:5 and (b) water. The position, width and size of Gaussian distributions were fitted, in reciprocal 
space, to difference neutron structure factors.  Five orders of diffraction were used in the fitting 
procedure. *, the position of each label site is expressed as distance from the centre of the bilayer; #, 
the width is the half width at 1/e height. 
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Figure 7.6  The neutron scattering length density profiles of three types of MRPs distributing across 
the DMPC bilayer.  
The profiles of the MRPs are overlapped for comparison: Arg-Glc MRPs (solid line); RIE MRPs (dot 
line); MCE MRPs (dash line).    
 
7.3.2.2. Concentration-response in the distributions of Arg-Glc MRPs in the 
DMPC bilayers 
As shown in Table 7.5 & Fig 7.7, the Gaussian models of Arg-Glc MRPs’ distributions in 
DMPC bilayers varied corresponding to the lipid/MRPs ratios. At the lowest concentration 
of MRPs (100:2), most of the MRPs located at the hydrophilic region (Fig 7.7, dot line) and 
decreased the d-repeat by 0.5 Å. At the middle concentration (100:5), the majority of Arg-
Glc MRPs inserted into the hydrophobic tails of lipids at a position (12.7 Å) close to the 
hydrophobic-hydrophilic interface, right next to the glycerol back bone of lipids. The MRPs 
had a mild effect on the d-repeat. At the high concentration (10:1), the majority of the MRPs 
stayed with the hydrophilic head groups whereas about one fifth of which partially inserted 
deep into the hydrophobic site at 8.5 Å, and increased the d-repeat by 1.0 Å.  
The water distributions in the presence of Arg-Glc MRPs were consistent with the 
observations described above. The majority of water remained on the surface of DMPC 
bilayers while a small amount of which associated with the phosphate group, at about 17.0 Å 
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(Table 7.5(b)).  At the low concentration (100:2), only 5% of water associated with the 
phosphate group, which is usually not considered as a significant distribution. With the rise 
of concentration, 14% of water sat around the phosphate group, indicating that Arg-Glc 
MRPs attract water and increase the hydration degree of lipid head groups at lipid/MRPs 
molar ratio 100:5. At the higher concentration (10:1), the water remained at the level of 
phosphates with a slightly less proportion, 11%. The partial insertion of high-concentration 
Arg-Glc MRPs did not induce a deeper water penetration in the bilayers. This shares a 
similarity with the insertion of RIE MRPs in DMPC bilayers, described in Section 7.3.2.1. 
Table 7.5  The Gaussian models of bilayer distributions 







Gaussian 1 Position* - 21.1 Å 20.6 Å 22.0 Å 
 Width# - 5.9 Å 7.9 Å  8.2 Å 
 Occupancy - 96% 32% 78% 
Gaussian 2 Position* - 18.0 12.7 Å 8.5 Å 
 Width - 3.9 5.5 Å 4.9 Å 
 
 Occupancy - 4% 68% 22% 
 







Gaussian 1 Position* 21.8 Å 22.0 Å 22.4 Å 22.1 Å 
 Width# 5.0 Å 5.4 Å 5.9 Å 5.0 Å 
 Occupancy 100% 95% 86% 89% 
Gaussian 2 Position* - 17.4 Å 17.0 Å 17.3 Å 
 Width# - 10.8 Å 7.0 Å 4.3 Å 
 Occupancy - 5% 14% 11% 
Gaussian models of bilayer distributions of (a) Arg-Glc MRPs at 100:2, 100:5, 10:1 lipid/MRPs molar 
ratio and (b) water. The position, width and size of Gaussian distributions were fitted, in reciprocal 
space, to difference neutron structure factors.  Five orders of diffraction were used in the fitting 
procedure. *, the position of each label site is expressed as distance from the centre of the bilayer; #, 
the width is the half width at 1/e height. 
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Figure 7.7  The scattering density length profiles of the distribution of Arg-Glc MRPs at three 
different concentrations on DMPC bilayers.  
The molar ratio (lipid/MRPs) concentrations of the MRPs were 100:2 (dot line), 100:5 (solid line) and 
10:1 (dash line).  
 
7.3.2.3. The distributions of arginine and glucose in the DMPC bilayers 
As described in Chapter 4, there were about 31% of arginine and 39% of glucose remained 
un-reacted in Arg-Glc MRPs. The distributions profiles of arginine (100:1.65) and glucose 
(100:1.95) in DMPC bilayers were measured to estimate the possible influences of these two 
reactants remained in Arg-Glc MRPs (100:5). The molar ratios of arginine and glucose 
chosen in the measurement were mimicking their amounts remaining in the 5% Arg-Glc 
MRPs.   
As shown in Table 7.6(a), two Gaussian profiles were identified for arginine, on the surface 
of DMPC bilayer (at 22.8 Å) and in the interface region of bilayer (at 14.0 Å). Most of the 
arginine (94%) settled in the interface region, which is around the glycerol backbone of the 
lipid. However, observed in the water distribution profiles, all the water lied on the surface 
of bilayer in the presence of arginine. Arginine did not introduce any water to the glycerol 
groups, and did not affect the d-repeat of the bilayer.  
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In case of glucose, its distribution fitted a single Gaussian profile that centered at 17.2 Å, 
around the phosphate group. D-glucose can interact with the phosphate group of lipid, 
probably with its hydroxyl groups by hydrogen bonding (Crowe et al. 1987). It would not 
cause a profile change deeper than where the phosphate group lies. There is a small ‘ripple’ 
at about 6.5 Å, which occupied less than 5% of glucose population and is considered as an 
experimental false. Glucose introduced one forth of water to the level of phosphate while the 
rest of water remained on the surface, promoting a stronger hydration effect on the lipid head 
groups than the Arg-Glc MRPs. No water penetration was observed in the acyl chain region, 
thereby glucose did not change the thickness of the bilayers. 
The majority of Arg-Glc MRPs were found at the deepest insertion to the bilayer and a 
minor distribution at the headgroups, compared with arginine and glucose (Fig 7.8). The 
distribution profile of the MRPs does not equate to the combined profile of arginine and 
glucose, indicating the MRPs have their own membrane interactive properties. The Gaussian 
profiles of Arg-Glc MRPs observed in lipid bilayers mainly represent the distributions of the 
reaction products, but not those of the reactants.  
In aqueous environments, arginine tends to be positively charged with a pKa of ~13 (Li et al. 
2008), due to its guanidinium side chain. The positive charge stops arginine from moving 
into the hydrophobic core of bilayer with a large free energy barrier (Dorairaj & Allen 2007), 
but associate arginine with the negative charged phosphate group. This explains well why 
the location of arginine in the lipid bilayer is near the phosphates. Furthermore, the Maillard 
reaction between the guanidinium of arginine and aldehyde of glucose can neutralise the 




Figure 7.8  Bilayer profiles of the distribution of Arg-Glc MRPs (solid line), arginine (dot line) and 
glucose (dash line) across the DMPC bilayers were presented with the best-fit model curve.  
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Table 7.6  Gaussian models of bilayer distributions of Arg-Glc MRPs, arginine and glucose. 







Gaussian 1 Position* 20.6 Å 22.8 Å - 
 Width# 7.9 Å 5.1 Å - 
 Occupancy 32% 6% - 
Gaussian 2 Position* 12.7 Å 14.0 Å 17.2 Å 
 Width 5.5 Å 6.5 Å 4.6 Å 
 Occupancy 68% 94% 100% 
 







Gaussian 1 Position* 22.4 Å 22.2 Å 22.9 Å 
 Width# 5.9 Å 6.2 Å 6.1 Å 
 Occupancy 86% 100% 75% 
Gaussian 2 Position* 17.0 Å - 16.9 Å 
 Width# 7.0 Å - 5.8 Å 
 Occupancy 14% - 25% 
 
Gaussian models of bilayer distributions of (a) Arg-Glc MRPs, arginine, glucose and their deuterated 
counterparts and (b) water. The position, width and size of Gaussian distributions were fitted, in 
reciprocal space, to difference neutron structure factors.  Five orders of diffraction were used in the 
fitting procedure. *, The position of each label site is expressed as distance from the centre of the 
bilayer; #, the width is the half width at 1/e height. 
 
 
7.4.  CONCLUSIONS 
The three types of MRPs, referring to Arg-Glc MRPs, RIE MRPs and MCE MRPs, present 
different distribution pattern across the two types of PC lipid bilayers. RIE showed the most 
potent interaction with DOPC bilayers among the three candidates observed. It has a major 
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distribution above the phosphate group and a minor distribution among the hydrocarbon 
chains of bilayer, near to ester carbonyls. The overall distribution pattern of Arg-Glc MRPs 
in DOPC bilayer is similar to that of the RIE: there are two Gaussian peaks with differed 
relative heights, while one of which penetrates deep into the hydrophobic region of the 
bilayers. MCE MRPs appeared only above the phosphate and induced an enhanced hydration 
in the hydrophilic section of bilayer. The water distribution of bilayer, incorporated with 
MRPs, is correlated to the MRPs’ distribution. 
The introduction of RIE and Arg-Glc MRPs (at 100:5) slightly expanded the d-repeats of the 
DOPC and DMPC bilayers, when MCE MRPs decreased it, but not significantly. Arg-Glc 
MRPs at 10:1 expanded the d-repeat of DMPC by 1.0 Å. The arginine and glucose do not 
affect the thickness of DMPC bilayer. It implies that none of the products disrupt the bilayer, 
consistent with a model in which the MRPs repairs or protects the membrane bilayers, or 
stabilises the DOPG monolayer. 
Arg-Glc MRPs expanded the d-repeat of DMPC bilayers by 1.0 Å at high concentration 
(lipid/MRPs molar ratio 10:1), when it decreased the thickness of unit cell by 0.5 Å at low 
concentration. In agreement with DOPC, MCE MRPs decreased d-repeat of DMPC slightly. 
The insertion of Arg-Glc MRPs to DMPC bilayer was described in a concentration-
dependent mode, in which MRPs at its highest concentration achieves a deepest insertion to 
the hydrophobic core of bilayer.    
Arginine and glucose each distribute across the hydrophilic region of bilayer, from the 
phosphate, to the ester carbonyls. The distribution profiles are very different from that of 
Arg-Glc MRPs, in terms of either the Gaussian distribution center or the scattering density. 
Although they could possibly be accounted for a small part of the scattering intensity of Arg-
Glc MRPs at the regions of hydrophilic region of lipid bilayer, the influences of these two 
reactants on the distribution profiles of Arg-Glc MRPs are minor. Neither the arginine nor 
the glucose penetrated into the hydrophobic hydrocarbon chains of lipids, which is in 
agreement with the hydrophilic nature of arginine and glucose. The water distribution 
profiles finely support the observation above: water appears mainly at the surface of bilayers 









8.1.  INTRODUCTION & AIMS OF CHAPTER 
8.1.1.  Introduction 
8.1.1.1.  Viral infection and membrane fusion  
In order to infect the host cell, both enveloped and nonenveloped viruses have to penetrate 
the barrier of a cellular membrane. For enveloped viruses, influenza virus A for example, 
penetration involves membrane fusion. For nonenveloped viruses, picornaviruses for 
instance, penetration involves membrane lysis or pore formation (Marsh & Helenius 2006). 
Non-lamellar structures have been discovered either at the sites of membrane fusion or 
membrane pore formation. Peptides or proteins, which promote membrane fusion or lyse 
membrane, facilitate the formation of non-lamellar phases, either micelles, cubic phases or 
hexagonal phases (Epand 1998).    
Membrane fusion is critical early event for an influenza virus to transfer its genetic 
information to human epithelial cells and complete its replication. From there, the new virus 
particles are formed and released to infect other cells. Nevertheless, membrane fusion is also 
involved in the budding of newly formed virus particles before they are released from the 
host-cells.  
A framework is given as Fig 8.1 showing the life cycle of influenza viruses and the 
occurrence of membrane fusion. Increased understanding of membrane fusion has the 
potential to reveal new targets for attacking enveloped viruses before they can attach to and 
enter the host-cells for replication. 
 230 
 
Figure 8.1  A schematic diagram of influenza virus life cycle and membrane fusion.  




Figure 8.2 Schematic representation of the fusion of two lipid bilayers (Harrison 2005). 
(A) Two parallel lipid bilayers, with a substantial barrier to close approach. (B) The semi-fusion stalk. 
(C) Proposed intermediate structure of transition. (D) Fusion pore formation. (E) The semi-fusion 
diaphragm. (F) A model includes the perforation of a semi-fusion diaphragm as the step essentially 
toward the fusion pore formation. The diagram was originally adapted by Harrison from the diagram 
of (Jahn, Lang & Südhof 2003), see also (Chen, Markosyan & Melikyan 2002). 
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8.1.1.2.  Fusion peptide and membrane fusion 
A class of hydrophobic peptides, commonly known as membrane fusion peptides, actively 
participate in fusion events, such as the entry of enveloped viruses into their host cells, or 
cell-cell fusions induced by viruses. The fusion peptide of influenza A viruses refers to the 
20 NH2-terminal amino acids of the HA2 subunit of hemagglutinin. Here is an example of 
amino acid sequence of this wild type fusion peptide: GLFGAIAGFIENGWEGMIDG-
amide (Harrison 2005). The sequence, which varies slightly between different strains of the 
virus, is rich in hydrophobic residues (Lear & Degrado 1987). In an acidic environment, the 
binding of protons stimulates a conformational change in HA that exposes the fusion 
peptide, thereby triggering the fusion event. Most strains of influenza viruses have a critical 
pH of about 5-5.5 (Harrison 2005).   
The fusion peptide (GVFVLGFLGFLA) from simian immunodeficiency virus (SIV) 
transmembrane glycoprotein gp32 belongs to a family of “oblique-orientated peptides”, and 
inserts into cellular membranes at an angle of 30˚ (Lear & Degrado 1987). SIV gp120 and 
gp32 contain amino acid sequences share with HIV-1 gp120 and gp41. SIV fusion peptide 
belongs to the same family (class I fusion proteins) with that of influenza A virus (Harrison 
2005). However, unlike fusion peptide from influenza HA2, SIV fusion peptide does not 
require a low pH to trigger the fusion-inducing conformation.  
 
8.1.1.3.  Oblique insertion of SIV fusion peptide 
The oblique membrane insertion of SIV fusion peptide has been directly observed with 
neutron diffraction on the stacked multi-bilayers of DOPC (Bradshaw et al. 2000). As shown 
in Fig 8.3C, SIV fusion peptide associates with lipids in the bilayer at the hydrophobic and 
hydrophilic interface. The effects of this peptide on the phase transition of MeDOPE bilayers 
have been studied by a temperature-resolved X-ray diffraction (Harroun et al. 2003). SIV 




Figure 8.3  Molecular models of SIV peptide oriented in one-half of a bilayer.  
The vertical line is the z-axis scale parallel to the membrane normal. The center of the bilayer is 
represented by the lower mesh, and the hydrophobic and/or hydrophilic interface is suggested by the 
upper mesh at the approximate value of 16 Å. The peptide helix is represented as a coiled ribbon. The 
diagram is quoted from Bradshaw’s publication (Bradshaw et al. 2000). 
 
8.1.1.4.  Lipids and formation of non-lamellar structures 
Representing typical non-lamellar structures, the inverted cubic and inverted hexagonal 
phases are crucial in the mechanism of membrane fusion. The chemical composition of 
phospholipids influences the formation of lamellar and non-lamellar phases. Lipids with a 
big headgroup and a pair of saturated fatty acid tails, i.e. DMPC, do not form structures with 
negative curvature, such as and cubic or hexagonal phases, under physiological conditions, 
while un-saturated lipids with small headgroups, e.g. MeDOPE, promote negative curvature 
and allow non-lamellar phases to form above TH or TQ (Fig 8.4). Membrane fusion inhibitors, 
such as lysophosphatidylcholine (LPC), stop the lipid bilayers from transferring to non-
lamellar structures by inserting into the bilayer and occupying the spare space between the 
lipid headgroups, thereby prevent the negative curvature. Amphiphilic molecules like some 
compositions of MRPs may have the potential to inhibit membrane fusion by a similar 
mechanism.   
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Figure 8.4  Schematic diagram of the shape of lipids composed of different types of polar headgroup 
and apolar tails.  
The shape depends on the relative size of headgroup to tails. If the cross-sectional areas of the 
headgroup and acyl chains are similar, the lipid is cylindrical in shape (phosphatidylcholine (PC), i.e. 
DMPC), whereas the lipids with a small headgroup (phosphatidylethanolamine (PE), i.e. MeDOPE) 
are cone-shaped. If the tail is a single fatty acid chain, the lipid molecule has a relatively small surface 
area and thereby has the shape of an inverted cone (LPC). The head-to-tail length of lipid molecules 
varied among the different types of lipids. The diagram is adapted from Sprong’s graph (Sprong et al. 
2001). 
 
8.1.2.  Aims of this chapter 
In previous studies, we have determined that a group of Maillard reaction products (MRPs) 
insert between the phospholipids of bilayers and affect the molecular packaging of lipid 
leaflet. The insertion of MRPs affects the thermal stability of bilayers in a concentration 
dependent manner. As revealed by the differential scanning calorimetery, the 
thermodynamic changes (in terms of the phase transition temperature (T) and energy flow 
(∆H) during the phase transitions of lipid MLVs have been measured in the presence and 
absence of MRPs.  
The study presented here aims to examine the possible inhibitory effects of MRPs on 
membrane fusion induced by the SIV fusion peptide. To characterise the structural 
rearrangements involved in the transition processes, small angle X-ray scattering (SAXS) 
was used to investigate the transitions from lamellar phase (Lα) to inverted hexagonal phase 





8.2.  METHODS 
The inhibition of membrane fusion could be investigated by various methods, depending on 
what aspect the candidate molecule might target. Two methods, small angle X-ray scattering 
(SAXS) and lamellar X-ray diffraction (LXD), were employed here to investigate the effects 
of MRPs and/or SIV fusion peptide on the phase transition and structural transforming of 
lipid bilayers. N-methylated dioleoyl-phosphatidylethanolanmine (MeDOPE) adopts 
lamellar phase at low temperatures, and two non-lamellar phases at higher temperatures. The 
non-lamellar structures are believed to relate to the initiation of peptide-induced membrane 
fusion. The presence of non-lamellar structure in MeDOPE samples indicates a 
destabilisation of the lipid layers, thus MeDOPE MLVs was used as a model lipid system for 
evaluating the effects of MRPs on membrane fusion induced by SIV peptide.   
 
8.2.1.  Sample preparation 
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-methyl (MeDOPE) was purchased from 
Avanti Polar Lipids Inc., USA (purity >99%), and used without further purification. For X-
ray diffraction measurement, the MLVs were prepared by dispersing 15 wt% of MeDOPE, 
as described in Section 6.2.3 and 6.2.4, in PIPES buffer (pH7.4, 20 mM, 150 mM NaCl), 
Sigma-Aldrich (Irvine, UK). Various samples including Arg-Glc MRPs, RIE MRPs, SIV 
fusion peptide (GVFVLGFLGFLA, >99%), lysophosphatidylcholine (LPC), arginine and 
glucose, were dissolved in deionized water or methanol and mixed thoroughly with lipid 
MLVs by vigorous vortex for 2 min.  
SIV fusion peptide, rather than influenza virus fusion peptide, was used in this study for 
several reasons. SIV has a shorter amino acid sequence which means it is easier to 
synthesise. It acts similarly as the influenza HA fusion peptide which promotes on 
lamellar/inverted phase transitions in dipalmitoleoylphosphatidyl-ethanolamine (DiPOPE) 
(Siegel & Epand 2000). The SIV peptide has been studied by a number of well-established 
methods, including an X-ray diffraction study on SIV’s effects on the phase behaviour of 
MeDOPE MLVs (Harroun et al. 2003), which allows the comparison of the experimental 
data from this study with the published data. 
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8.2.2.  Temperature-resolved SAXS 
The X-ray diffraction experiments were performed on the Austrian SAXS beamline at 
ELETTRA, Trieste, Italy (Amenitsch et al. 1998) (Rappolt et al. 2003). Diffraction patterns 
of MeDOPE MLVs were recorded by a one-dimensional position sensitive detector 
(Petrascu, Koch & Gabriel 1998) covering the corresponding s-range of interest from ~1/450 
Å-1 to 1/12 Å-1 (s=2πSin(θ)/λ). As shown in Fig 8.5&8.6, the angular calibration was 
performed with silver-behenate (CH3(CH2)20 -COOAg) for the detector: d001=58.378 Å, 
λ=1.54 Å (Huang et al. 1993). The specimen-to-detector length was approximately 0.75 m. 
The Eq 8.1 was obtained for the calculation of s-range (Fig 8.6) by drawing a linear curve of 
‘s’ as a function of detector channels. Each sample was sealed in a steel chamber with a pair 
of thin mica film on both the entrance and exit windows, held in a steel block which was in 
thermal contact with a water circuit connected to a programmable temperature control unit 
(Unistat CC, Huber, Offenburg, Germany). The temperature was continuously monitored 
with a thermocouple fixed to the sample chamber in a linear fashion at a heating rate of 60 
K/h, and written into the data files automatically. Each frame of data collection lasted for 10s 
~ 20s depended on the scattering intensity, and for every 0.5˚C (collecting for 10s) or 1.0˚C 
(collecting for 20s). The X-ray beams conduct a minimal effect of thermal radiation.   
 
8.2.3.  X-ray diffraction data analysis 
The raw data were corrected for detector efficiency. The background scattering of water and 
the sample chamber was subtracted from the corrected raw data. The location, width and 
amplitude of each Bragg peak were then fitted by Lorentzian distributions (SigmaPlot, Systat 
Software Inc.). After the sample temperature curve was drawn as a function of frames, the 
transition temperature of each sample was determined by identifying the initiate point of 
non-lamellar phases. The square root of the peak intensity was used for determination of the 
form factor F of each individual reflection. The electron density maps of the phospholipid 
samples in the HII phases were derived from the small-angle x-ray diffractograms by 




Figure 8.5 X-ray diffraction pattern of AgBE  
λ=1.54 Å, detector channels=1~1024. The s-range of diffraction was calculated by Eq 8.1.  
 
Figure 8.6  The standard curve for calculating the s-range.   
 
The following equation was used for calculating the s-range of diffracton. 
S (Å-1) = 0.0001× channel - 0.008, R2=1.000   (Equation 8.1) 
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8.2.4.  Lamellar X-ray diffraction (LXD) 
Lamellar X-ray diffraction (LXD) was used to determine the structural phase of MeDOPE, 
in the presence or absence of SIV fusion peptide, LPC and Arg-Glc MRPs. The 
measurements were carried out with synchrotron radiation at the beam line 13A1 SW6, 
HsinChu, Taiwan. The sample to detector distance was 906.6 mm. The X-ray wavelength 
λ=1.03 Å, when the beam size was 1 mm in wide and 300 µm in high. Two aluminium 
stripes were installed (as shown in Fig 8.12) to give a total attenuation of 1120 times 
(40×28=1120). 
For each diffraction sample, 10 mg MeDOPE was dissolved in 200 µL methanol to make a 
50 mg/mL lipid solution. The samples were dissolved in methanol (for SIV, LPC) or in 
deionized water (for Arg-Glc MRPs). After the sample was mixed with the lipid methanol 
solution thoroughly by vortext and sonication, 10 µL lipid-sample mixture were spread on a 
small piece of silica plate and dried out by evaporating and keeping in the vacuum for 1-2 h. 
The silica plate was then place in the sample chamber and installed horizontally. The sample 
humidity was increased gradually by decreasing the temperature difference between sample 
plates and water baths. The temperature of water bath was increased from 20°C to 28°C, at a 
rate of 1°C per step. The highest and lowest humidity in this measurement was 93% RH and 
63% RH, respectively. The samples were exposed to X-ray for certain time, in order to 
obtain a diffraction pattern strong enough for analysing but not over-loaded. The exposure 
time was varied from 5 s to 180 s. 
As shown in Fig 8.13, the position, intensity and width of Bragg diffraction peaks can be 
calculated by MATLAB (MathWorks Inc., USA). The other structure profiles, i.e. the d 
spacing of the lipid stack and the structure factors can be calculated accordingly. Further 
data analysis needs to be done for revealing effects of Arg-Glc MRPs and/or SIV fusion 
peptide.  
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8.3.  RESULTS AND DISCUSSIONS 
The lipid used in this study, N-methyl-dioleoyl-phosphatidylethanolamine (MeDOPE), 
exhibits two or three phases in vesicle suspensions, depending on the temperature and the 
heating rates of the system (Harroun et al. 2003). According to the results determined by 
DSC (Section 6.3.3.4), the TH of MeDOPE multilamellar liposome vesicles (MLVs), from 
the lamellar phase (Lα) to the inverted hexagonal phase (HII), was 72.0 ~ 73.0˚C, when the TQ 
between lamellar phase (Lα) and the inverted cubic phase (QII) was about 62.0˚C. The 
heating rate in the DSC measurements was 40 ˚C/min, at the temperature ranging from -30˚C 
to 85˚C.  
As shown in Fig 8.7, three phases, the lamellar, cubic and hexagonal phase, were observed 
with temperature-resolved SAXS in MeDOPE MLVs by determining the membrane 
structure-corresponding scattering density profiles at a heating rate of 1 ˚C/min. At least two 
cubic structures, possibly the diamond and primitive bicontinuous phases, were observed 
while two orders of diffraction peaks in lamellar and hexagonal phase each were measured. 
The continuous existence and coexistence of different phases makes it possible to evaluate 
the influence of MRPs, SIV fusion peptide, fusion inhibitor (LPC) and reactants of Maillard 
reaction on MeDOPE MLVs. For example, the Lα-to-HII and Lα-to-QII phase transitions were 
also observed in the presence of Arg-Glc MRPs (100:5), as shown in Fig 8.8, though at the 
decreased TH and TQ. All the results are reported here.  
 
8.3.1.  Pure lipid and  MRPs 
As shown in Fig 8.7 and Fig 8.10A, the coexistence of HII and QII phase was observed in 
pure lipid bilayers. The TH was 69.3˚C (Fig 8.10), at where the Lα phase also ended. The 
inverted cubic phase started at 72.2˚C. The scattering profile indicates that lipids bilayer in 
the cubic phase have more than one structure, possibly the double-diamond (Pn3m) and 
primitive phase (Im3m). It is finely supported by the lattice spacing (Fig 8.11) and the electron 
density profiles of hexagonal phase (Fig 8.10B).  
The addition of 100:2 Arg-Glc MRPs to the pure lipid vesicles raised the TH to 70.9˚C, and 
the TQ to 74.3˚C (Fig 8.9). However, when the concentration of Arg-Glc MRPs was 
increased to 100:5, the TQ decreased to 69.4˚C, while the TH decreased to 66.9˚C. At this 
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proportion, the MRPs induced a 2˚C gap between the Lα and HII phase where no structure 
was observed.  
When the proportion of Arg-Glc MRPs reached 10:1, the TH and TQ were 68.0˚C and 68.5˚C, 
respectively, which was 1.3˚C and 3.7˚C lower than the normal vesicle. However, TH of the 
MRPs at 10:1 was 1.1˚C higher than the at 100:5, when TQ was 0.9˚C lower than that. 
As shown in Fig 8.9 “RIE 5%”, RIE MRPs decreased the TH and then end of Lα phase by 
0.6˚C, and decreased the TQ by 4.0˚C. The effects are similar to those of Arg-Glc MRPs at 
high concentration (10:1), which indicates a destabilisation of the lamellar phase.  
 
8.3.2.  SIV fusion peptide and Arg-Glc MRPs 
As described above, the SIV fusion peptide induces membrane fusion by oblique insertion 
into the phospholipids bilayers, promoting negative curvature, and thereby encouraging the 
formation of non-lamellar structures of lipid packing around the insertion site. 
SIV fusion peptide (1 mol%) lowered the TQ to 64.3˚C, but increased the TH to 85.0˚C. SIV 
weakened and broadened the scattering profile of liquid crystalline phase, and extended the 
end of this phase to 72.7˚C (Fig 8.9, ‘SIV 1%’). However, since the shape and intensity of 
Bragg peak were not identical to those of the normal Lα phase, a further analysis needs to be 
performed on the lattice spacing and electron density. Different from the pure lipid, SIV 
induced a coexistence of Lα and QII phase at the temperature ranged from 64.3˚C to 72.7˚C, 
and a coexistence of QII and HII phase at the temperature ranged from 85.0˚C to the end of 
scan (90˚C). This indicates the dominant impacts of SIV on the lipid phase behaviour. 
The low concentration of Arg-Glc MRPs (100:2) raised the TH to 85.5˚C in the lipid bilayer 
with 1% SIV, which was slightly higher than the TH of SIV, whereas the TQ was not affected. 
The end of the lamellar phase was raised up by 6.9˚C, which narrowed down the gap from Lα 
to HII. The rise in the TH and the extension of lamellar phase both suggest a stabilising effect 
of Arg-Glc MRPs (100:2) on SIV containing lipid bilayers. The TQ remains the same as that 
of SIV, which implies the cubic phase is more preferable than the hexagonal phase in the 
presence of the MRPs. 
At the medium concentration, Arg-Glc MRPs lowered all of the TH, TQ and the end of Lα 







Figure 8.7  Contour plot of X-ray scattering of MeDOPE MLVs. 
Temperature scan rate of 1˚C/min. The figure shows a Lα to HII transition around 70˚C and a 
coexisting of HII and QII. 
 
 
A. Temperature-resolved 3D scattering density profiles of lipid MLVs with 100:5 Arg-Glc MRPs. 
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B. The scattering profiles as function of s-range at 74.4°C.  
Figure 8.8  Scattering profiles of MeDOPE MLVs in the presence of Arg-Glc MRPs (100:5).  
(A) Temperature-resolved 3D scattering density profiles; (B) The scattering density profiles as 
function of s-range at 74.4°C (TH + 7.5°C). L(1) refers to the 1st order scattering peak of Lα phase. 
L(2) refers to the 2nd order scattering peak of Lα phase. QII refers to the inverted cubic phase, in which 
three diffraction peaks were observed, labelled with *. HII (1,0)/(1,1)/(2,0)/(2,1) refer to the first and 
second order of the inverted hexagonal phase. 
 
phase (Fig 8.9). This indicates a destabilising effect of MRPs on the lamellar structure. And 
the stronger scattering intensity of all the phases observed upon 100:5 MRPs may suggest a 
more ordered packing of lipids in each phase. 
 
8.3.3.  Arginine and glucose: effects of reactants of MRPs 
The arginine (100:1.55) and glucose (100:1.95) were tested for their effects on the phase 
transitions, as a control of the un-reacted reactants in Arg-Glc MRPs (100:5). The cubic 
phase was not observed in the MeDOPE MLVs containing either arginine or glucose. The TH 
for these two reactants was 68.5˚C and 69.3˚C, respectively, which was at the same level as 
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pure lipid. Alike the pure lipid and 5% RIE MRPs, arginine or glucose presented a 
continuous transfer from Lα to HII phase. There is no inverted cubic phase observed in the 
presence of these two reagents.  
 
8.3.4.  LPC and Arg-Glc MRPs 
LPC, lysophosphatidylcholine, is a potent inhibitor against SIV peptide induced membrane 
fusion, by strongly inhibiting the formation of negative curvature (Harroun et al. 2003). 2 
mol% of LPC induced a broad and weak the scattering profile (data not shown, but available 
on request), which may indicate either a disordered lamellar phase or a mixed structures of 
different phases. No measurable phase transition temperature was observed since the phase 
transformation was not clear. The addition of Arg-Glc MRPs (at 100:5) did not show a 
significant influence on the phase behaviour of lipid bilayer with LPC, although a sign of 
increase in TH was noted in the contour diagram of scattering pattern (data not shown, but 






Figure 8.9  Schematic summary of the phase behaviour of MeDOPE MLVs and the MeDOPE in the 
presence of Arg-Glc MRPs and/or SIV fusion peptide and fusion inhibitor.  
The transition temperatures were measured by a temperature scanning at 1˚C/min from 30˚C to 90˚C 
with the temperature-resolved X-ray diffraction.  
 
60      62     64      66     68      70     72      74      76     78     80      82     84      86      88     90 
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        A.              B. 
Figure 8.10  Electron density of the HII phase of pure MeDOPE MLVs at 74.8°C (TH + 5.0°C).  
For calculating the electron density, the first first five peaks of the hexagonal phase were fitted by 
Lorentzians to deduce the form factor values F1-F5, and then a Fourier Transform was applied. The 
electron density diagram was reconstructed by Dr. Michael Rappolt, Elettra, Italy.   
 
 
Figure 8.11 The lattice unit spacing of MeDOPE across the three phases.  
The first order peak of Lα and HII, and sqrt(2) peak of the Im3m phase was fitted as a function of 
temperature for each scan. This diagram was reconstructed by Dr. Michael Rappolt, Elettra, Italy. 
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8.3.5.  Humidity-resolved LXD 
As shown in Fig 8.12, at the relative humidity lower than 81% RH, MeDOPE was fully in 
HII phase, although the distance between each peak was decreasing when the humidity was 
raising up, which indicates the happening of phase transition from invert hexagonal phase to 
lamellar phase. At the humidity higher than 81% RH, the lipid bilayer was gradually 
transited to Lα phase. The proportion of lipids in Lα phase increased step by step until Lα 
phase became dominant at 93% RH.  
 
A.        B. 
Figure 8.12  Diffraction of MeDOPE  
In the presence (A) and absence (B) of Arg-Glc MRPs (100:5) at four humidities, 63% RH, 73% RH, 
85% RH and 93% RH.    
 
The addition of Arg-Glc MRPs (100:5) generally weakened the lipid diffraction signal in HII 
phase, which resulted in a longer exposure time to X-ray for the same amount of lipids, and a 
smaller peak-to-peak distance (Fig 8.12). Furthermore, at the highest humidity, 93% RH, the 
lipid bilayers haven’t been fully transited to Lα phase since a weak diffraction of HII phase 
was observed in both of the figures. The appearance of Lα phase was at 81% RH in the 
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presence of Arg-Glc MRPs, the same as the pure MeDOPE. The weakening of diffraction 
indicates that the MRPs disorders the HII phase and makes it easier for lipid bilayers to 
transit to Lα phase.  
The presence of SIV fusion peptide (1 mol%) generally enhanced the diffraction signal of HII 
phase, which indicates a stabilisation effect. This is constant with the previous studies 
(Harroun et al. 2003). Arg-Glc MRPs dramatically decreased the scattering intensity of this 
lipid-peptide system in HII phase. Arg-Glc MRPs inhibited the effects of SIV peptide on 





Figure 8.13 MeDOPE scattering profiles measured at 64% RH, 28°C.   
(A) The diffraction pattern. (B) Diffraction peak at detector position (517, 433), (Qx,Qy) of the peak is 






8.4.  CONCLUSIONS 
By measuring the phase transition as a function of temperature with SAXS, the influences of 
Arg-Glc MRPs and RIE MRPs on the SIV peptide induced membrane fusion are revealed. 
The rise in the transition temperature of non-lamellar phases, induced by 100:2 Arg-Glc 
MRPs, implies a stabilisation of lamellar structure conducted by the MRPs. However, the 
effects of Arg-Glc MRPs on TH and TQ are reversed by increasing their proportion in lipid 
bilayer, to 100:5. The MRPs destabilise the lamellar bilayer and encourage the formation of 
non-lamellar phase. At a higher proportion of 10:1, the inverted hexagonal phase promoting 
effects Arg-Glc MRPs become weaker, while the TQ is even lower than 100:5. This implies 
the high concentration of Arg-Glc MRPs have a mild effects on Lα-to-HII transition when 
present a stronger promoting on Lα-to-QII transition. The effects of RIE MRPs are similar to 
those of Arg-Glc MRPs at 10:1. This observation is in a good agreement with the phase 
transition studies conducted with DSC, and the molecular packing profiles sensed by 
fluorescent probes.  
The action of fusion peptides on the inverse hexagonal phase is separated from their ability 
to inducing inverse cubic phase (Darkes et al. 2002). It has been reported that SIV peptide 
dramatically delayed the inverse hexagonal phase while induced ‘a gap between the phase 
where no structure was presented’ (Harroun et al. 2003). In my study, SIV acts very 
similarly except the gap between Lα and HII phases is covered up by the extension of a 
lamellar-like phase. SIV tends to promote the formation of inverse cubic phase when 
bypasses the intermediate structures leading to the hexagonal phase. 100:2 Arg-Glc MRPs 
stabilise the bilayer and increase the temperature range of lamellar phase by about 7°C. 
However, the MRPs at 100:5 destabilise the lamellar phase and promote the formation of the 
inverse cubic phase and inverse hexagonal phase.   
Arginine and glucose show very mild effects on TH, and inhibit the formation of cubic phase.  
LPC (2 mol%) releases the curvature-strain and fully inhibit the formation of non-lamellar 
phases. The Arg-Glc MRPs at 100:5 has no significant effects upon the LPC incorporated 
lipids bilayers.  
As revealed by the humidity-resolved LXD study, the presence of SIV fusion peptide (1 
mol%) generally enhances the diffraction signal of HII phase, which indicates a stabilising 
function of the peptide on non-lamellar phase. Arg-Glc MRPs dramatically decrease the 
scattering intensity of this lipid-peptide system in HII phase, implies an inhibitory effect on 
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SIV induced formation of negative curvature and thereby the non-lamellar structures, in a 
concentration dependent manner. 
In summary, Arg-Glc MRPs stabilise the lamellar phase and inhibit the SIV-induced 
negative curvature-strain of bilayer at a low concentration (100:2), but destabilise the 









This study contains two major parts. Part one, including Chapters 3, 4 and 5, focuses on 
biochemistry studies of the chemical composition and biological activities of MRPs. Part 
two, including Chapters 6, 7 and 8, describes biophysical studies of the interaction between 
MRPs and membrane phospholipids in several artificial model membrane systems.  
In summary, significant anti-influenza viruses effects were demonstrated in vitro in RIE 
MRPs, but not in the cold water extracts of the fresh roots. The heat processing contributed 
to the antiviral activity of RIE MRPs. By observing the heat-induced chemical changes, the 
Maillard reaction was identified as the dominant chemical reaction occurring during the heat 
processing. It generated significant quantities of products which were conjectured as a new 
class of active compounds protecting cells from influenza viruses’ infection. Determination 
of the amino acids and monosaccharides contents of the roots showed that, of all the possible 
reactants for Maillard, arginine and glucose were the major ones. The composition changed 
as the heat processing progressed. Their Maillard reaction products, Arg-Glc MRPs, 
possessed a similar anti-influenza viruses activity as RIE MRPs, whereas no significant 
antiviral effects were identified either on the native proteins from the fresh roots or on the 
glycated proteins from sun-dried roots. These results demonstrate the antiviral effects of RIE 
are related to the MRPs formed in the heat involved processes, and indicate that Arg-Glc 
MRPs are suitable to be used as a model MRPs for the mechanism studies of RIE’s antiviral 
effects.  
RIE and Arg-Glc MRPs bound to the cell membranes of erythrocytes and MDCK cells and, 
remarkably, altered the membranes’ properties. With incorporation of the MRPs into their 
membranes, cells became less susceptible to influenza virus infection or 
hypotonic/hyperthermic haemolysis. Based on these observations, an antiviral mechanism 
was hypothesised for RIE MRPs: the MRPs bind to the cell membrane to provide cyto-
protective effects against viral infection, rather than directly inactivate the viruses. To test 
the hypothesis, the interaction between MRPs and membrane lipids was investigated with a 
serial of biophysical experiments, on several artificial phospholipids monolayer and bilayer 
systems. Arg-Glc MRPs help lipids to pack more rigidly in monolayers or bilayers, and 
stabilise the liquid lamellar phase of lipids. In contrast, RIE MRPs and MCE MRPs increase 
the polarity of lipid bilayer and thereby improve the fluidity of membrane.  
Both Arg-Glc MRPs and RIE MRPs insert into the hydrophobic region of bilayer, though at 
different strengths. The insertion of MRPs causes either stabilisation or destabilisation on the 
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lamellar structures of bilayers, in a process that is highly dependent on the concentration and 
overall distribution pattern of the MRPs. Arg-Glc MRPs reduce the SIV fusion peptide 
induced curvature-strain of bilayer at a low concentration (100:2, molar ratio) by stabilising 
the lamellar structures. The MRPs may thereby inhibit the SIV fusion peptide induced 
membrane fusion. However, an exceptional lamellar-destabilising effect was also observed 
for the MRPs at a higher concentration (100:5).   
The mechanism of the anti-influenza virus activity of RIE is correlated to the interaction 
between MRPs and phospholipid bilayers, which prevents the formation of negative 
curvature and eventually membrane fusion.  It is possible to view the interactions in terms of 
distinct stages. In the first stage, insertion of the MRPs into the spaces between head groups, 
pushes the hydrophilic heads away from each other. This would have the effect of decreasing 
negative curvature strain and would inhibit membrane fusion. The second stage is reached 
when the inter-head group spaces are filled, and MRP molecules start to accumulate in the 
bilayer core. This would tend to destabilise the lamellar structure of lipids. As the 
concentration of MRPs continues to increase, they incorporate across the whole thickness of 
the bilayer, and have no significant affect on monolayer curvature strain. 
By combining the results from neutron diffraction, X-ray diffraction and DSC 
measurements, a model of the interaction between Arg-Glc MRPs and PE lipids emerges, as 
shown in Fig 8.1. It includes three concentration-dependent stages of interaction, described 
as below. 
1) At low concentrations (e.g. 100:2), Arg-Glc MRPs mainly lie between the hydrophilic 
head groups of the lipids and relax negative curvature strain. The formation of non-lamellar 
structures is subsequently prevented by filling up the space between inverted-cone shaped 
phosphatidyethanolamine groups.  
2) At a medium concentration (e.g. 100:5), the additional MRPs accumulate in the 
hydrophobic-hydrophilic intermediate region of bilayer, and thereby promote the formation 
of non-lamellar structures by pushing lipid tails away from each other. 
3) At a high concentration (e.g 10:1), about 1/3 to 2/3 of the MRPs population sits close to, if 
not in, the hydrophobic region of bilayer, while the rest of MRPs remains in the hydrophilic 
head group. This results in a balanced state of the lipid bilayer under a joint influence of 
head group space filling and tails expelling.  
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This model fits well with the bilayer distribution profiles of RIE MRPs and their impacts on 
the formation of non-lamellar structures in liposomes. RIE MRPs interact with bilayers in a 
similar manner to high-concentrations (10:1) of Arg-Glc MRPs. Among the three 
concentrations of MRP employed in the study, the lowest one is closest to the realistic 
concentration of MRPs in blood or in the cell culture. Consideration of the results from this 
concentration be more valuable when trying to understand the effects of MRPs on the 
structure and function of cell membranes.  
 
Figure 9.1 Schematic diagram of Arg-Glc MRPs’ interaction with MeDOPE bilayer at 3 different 
concentrations. 
Based on these findings, for the first time, MRPs are identified as the quantitatively 
predominant and biologically active compositions in RIE. A new anti-viral mechanism can 
be proposed for MRPs, in which MRPs bind to cell membranes and insert into phospholipid 
bilayers, which prevents the formation of negative curvature strain and eventually membrane 
fusion (as shown in Fig 9.2).  
The most prominent feature of this proposed mechanism is that instead of blocking the virus 
infection and proliferation pathways at a specific point, virus infection is prevented by the 
overall strengthening the cell membrane. It is not unreasonable to speculate that these 
findings may form the basis of a broad spectrum antiviral agent with few adverse side 
effects. As an novel anti-viral mechanism, it echoes recent observations of anti-viral action 
through interaction with cell membranes (Wolf et al., 2010), which proposed a new antiviral 
molecule, belong to the rhodanine derivatives, has been demonstrated to act on a broad range 
of enveloped viruses by specifically intercalating into viral membranes. This paper is highly 
relevant to my hypothesis, though the target membranes differ between the two studies.  
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: MRPs  : viral fusion peptide   : membrane (in red or blue) 
 
Figure 9.2  Schematic diagram showing the anti-viral mechanism of MRPs.  
The upper three graphs show the fusion pore formation induced by the viral fusion peptide. 
The lower three graphs show that MRPs stabilise the cell membrane, inhibit the membrane 
negative curvature potentially induced by the insertion of fusion peptide, and eventually stop 
the membrane to occur.  
 
The membrane-protection effects of MRPs provide a most plausible mechanism to the well-
recorded clinical observations of preventing/treating viral infection with Chinese herbal 
medicine, which is mean to operate by strengthening the defending force of the patient’s 
body. Above all, it is anticipated that the proposed mechanism will eventually lead to an 
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